Guideline for Care of Patients with the Diagnoses of Craniosynostosis: Working Group on Craniosynostosis by Mathijssen, I.M.J. (Irene)
Copyrigh
Received April
Accepted for p
The authors rep
This is an open
Commons A
it is permiss
cited. The w
Copyright # 20
ISSN: 1049-22
DOI: 10.1097/S
ORIGINAL ARTICLE
The Journal oGuideline for Care of Patients With the Diagnoses of
Craniosynostosis: Working Group on Craniosynostosis
Irene M.J. Mathijssen, MD, PhDt © 20
30, 2015.
ublication
ort no co
access a
ttribution-
ible to do
ork canno
15 by Mu
75
CS.00000
f Cranio5;26: 1735–1807)(J Craniofac Surg 201
haired by Irene M.J. Mathijssen, MD, PhDC
Participants:
The Dutch National Cranial and Facial Deformities Patients and
Parents Association (LAPOSA)
The Netherlands Society for Ophthalmology
The Netherlands Society for Anesthesiology
The Netherlands Society for Otorhinolaryngology
The Dutch Association for Pediatrics
The Netherlands Society for Oral Medicine and Oral and Max-
illofacial Surgery
The Netherlands Society for Neurosurgery
The Netherlands Society for Plastic Surgery
The Society for Orthodontists
The Netherlands Society for Clinical Genetics
The Dutch Association of Psychologists
The Netherlands Society for Relationship Counseling and
Family Therapy
Address correspondence and reprint requests to Irene M.J.
Mathijssen, MD, PhD, Deptartment of Plastic and Reconstructive
Surgery, and Hand Surgery, Room Sk-1202, Erasmus Medical
Center-Sophia, Wytemaweg 80, 3015CN Rotterdam, The Nether-
lands. E-mail: i.mathijssen@erasmusmc.nl
ABSTRACT
This guideline for care of children with craniosynostosis
was developed by a national working group with representatives
of 11 matrix societies of specialties and the national patients’
society. All medical aspects of care for nonsyndromic and syn-
dromic craniosynostosis are included, as well as the social and
psychologic impact for the patient and their parents. Managerial
aspects are incorporated as well, such as organizing a timely
referral to the craniofacial center, requirements for a dedicated15 Mutaz B. Habal, MD. Unautho
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facial Surgery  Volume 26, Number 6, Sepcraniofacial center, and centralization of this specialized care. The
conclusions and recommendations within this document are
founded on the available literature, with a grading of the level
of evidence, thereby highlighting the areas of care that are in need
of high-quality research. The development of this guideline was
made possible by an educational grant of the Dutch Order of
Medical Specialists.
The development of this guideline was supported by an edu-
cational grant of the Dutch Order of Medical Specialists.
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1. GENERAL INTRODUCTION
Objective
This guideline provides recommendations for medical practice
on suspicion of craniosynostosis and after confirmation of this
diagnosis. It is based on the results of scientific research and
subsequent forming of opinion by a multidisciplinary working
group, composed of representatives of the medical specialties
involved in the treatment of craniosynostosis, related professional
disciplines, and other parties involved.
The wishes of parents and health professionals regarding the
organization of health care for craniosynostosis were inventoried.
The guideline document addresses the important issues for the
support of parents with a child with a craniosynostosis.
Method Employed by the Working Group
The content of this guideline is based on evidence from published
scientific research. Relevant articles were identified using systematicrized reproduction of this article is prohibited.
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guidelines were specifically searched for in online accessible inter-
national andnational guideline clearinghouses. Searcheswere limited
to theDutch,English, andFrench languages. In addition, articleswere
extracted from reference lists of relevant literature. This resulted in
additional articles for several basic questions.
Care for children with craniosynostosis was introduced in the
late 1960s and consequently the English literature from those years
onwards was included. Searches were performed until December 1,
2009 and articles available as ‘‘Epub ahead of publication’’ at that
date were included as well.
The following search terms were used: craniofacial, craniosy-
nostosis combined with: genetics, hydrocephalus, Chiari, cerebral
pressure, otitis, hearing, vision, psychology, anesthesia, compli-
cations, infection, development, growth, maxilla, mandible, dis-
traction, osteotomy, Fort, midface, RED, halo, monobloc, facial
bipartition, median faciotomy, and hypertelorism.
Relevant articles extracted from reference lists of retrieved litera-
ture and several relevant publications until November 1, 2009 were
included as well. Under the headings Summary of the literature/
Conclusions only published studies/guidelines are discussed. Case
reports and letters were excluded, unless they reported a complication.
The selected articles were assessed on methodological quality
graded by level of evidence according to the standard classification:
see Table 1. After selection, those articles remained that are listed to
underpin the various conclusions. The articles are assessed under
the heading ‘‘Summary of the literature.’’ Next, the scientific
evidence is briefly summarized in ‘‘Conclusions.’’ The main lit-
erature on which a conclusion is based is mentioned as well,
including the level of evidence (see Table 2).
Other aspects than scientific evidence may be relevant to making a
recommendation aswell, such as patient preferences (derived from the
results of the focus group sessions or relevant literature on the patient
perspective), costs, availability, or organizational aspects. These kinds
of aspects, provided they have not been subject of research, are
mentioned under the heading ‘‘Considerations.’’ The experience
and the opinion of the working group members have been key to
the other considerations. The ‘‘Recommendation’’ results from the
combination of the available evidence and the other considerations.
Patient Perspective
When developing this guideline, the working group particularly
strived for incorporating the patient perspective. The working group
therefore included representatives of the LAPOSA patient associ-
ation. Besides, in collaboration with LAPOSA 2 focus group
sessions were held: 1 with parents of a young child with aCopyright © 2015 Mutaz B. Habal, MD. Unautho
TABLE 1. Classification of Methodological Quality of Individual Studies
Intervention Diagnostic Accuracy Asses
A1 Systematic review of at least 2 mutually
independent studies of A2-Level
A2 Randomized double-blind comparative
clinical study of good quality and
sufficient size
Study comparing with a refe
with previously defined c
assessment of the results o
regarding a sufficiently la
who all were administered
B Comparative study, but not possessing all
qualities mentioned under A2 (this
category also includes patient-checkup
study, cohort study)
Study comparing with a refe
qualities mentioned under
C Noncomparative study
D Expert opinion
This classification only applies to situations in which controlled trials are not feasible for et
1736craniosynostosis and 1 with young adults with craniosynostosis
and parents of older children with a craniosynostosis. The working
group incorporated outcomes of these sessions in the guideline.
Finally, focus group participants were asked to comment on a draft
version of the guideline.
Note
This guideline was drafted on the guidance of the Appraisal of
Guidelines for Research & Evaluation (AGREE) instrument. This
instrument was developed at a European level to enable assessment
of the procedural quality of guidelines. By incorporating AGREE
aspects in the introduction to the guideline it is made clear what
quality requirements have been met.
2. INTRODUCTION TO CRANIOSYNOSTOSIS
Craniosynostosis is a congenital cranial malformation in which 1
or more cranial sutures have fused already in utero. The cranial
sutures separate the skull bone plates and enable rapid growth of the
skull in the first 2 years of life, in which growth is largely dictated
by growth of the brain. Cranial sutures are essential to skull growth
in the first 2 years (the period of rapid brain growth). Thereafter the
process of appositional growth and internal resorption of the skull is
the major process by which the skull increases in size.
Premature fusion of cranial sutures impedes normal growth of the
skull, resulting in characteristic anatomic malformations of the skull.
Craniosynostosis occurs in 1 in 2100 to 1 in 2500 births and may
be either nonsyndromic (also referred to as isolated) or syndromic.
In syndromic craniosynostosis, other birth defects are present next
to the craniosynostosis. In syndromic craniosynostosis, usually
more than 1 cranial sutures have prematurely fused, typically
involving both coronal sutures.
The distinction between nonsyndromic and syndromic ismade on
the guidance of dysmorphologic evaluation and genetic evaluation.
Owing to advances in genetic diagnostics, nonsyndromic patients are
increasingly recognized as syndromic patients. The discovery of the
P250Rmutation in theFGFR3 gene in patientswith a uni- of bilateral
coronal suture synostosis clearly illustrates this phenomenon.
Approximately 60% of all craniosynostoses are of the nonsyn-
dromic type and approximately 40% are of syndromic type. Within
the group of nonsyndromic craniosynostoses the sagittal suture
synostosis is the largest group, followedbymetopic suture synostosis.
Recently, the prevalence of metopic suture synostosis has clearly
risen both in Europe and the United States, but this has not been
explained. Synostosis of 1 or both lambdoidal sutures is very rare.
Of the syndromic types the Muenke syndrome is the most
frequent, followed by Crouzon syndrome, and Pfeiffer syndrome.rized reproduction of this article is prohibited.
sment
Harm or Side Effects, Etiology,
Prognosis
rence test (a ‘‘criterion standard’’)
ut-off values and independent
f study test and criterion standard,
rge series of consecutive patients
the index- and the reference test
Prospective cohort study of sufficient size
and follow-up, adequately controlled for
confounding and with satisfactory
exclusion of selective follow-up
rence test, but not possessing all
A2
Prospective cohort study, but not
possessing all qualities mentioned under
A2, or retrospective cohort study or
patient-checkup study
hical or other reasons. If they should be feasible, the classification for interventions applies.
# 2015 Mutaz B. Habal, MD
TABLE 2. Level of Evidence for the Conclusion
Conclusion based on
1 Level A1 study or at least 2 mutually independent Level A2 studies
2 One Level A2 study or at least 2 mutually independent Level B studies
3 One Level B or C study
4 Expert opinion
The Journal of Craniofacial Surgery  Volume 26, Number 6, September 2015 Diagnoses of CraniosynostosisThe Apert syndrome has the lowest prevalence. The distinction
between Crouzon syndrome and Pfeiffer syndrome was made on the
basis of deformities of the big toe and thumb: if these were broad and
short the syndrome was referred to as Pfeiffer syndrome. Because
FGFR2 mutations, however, were identified in both Crouzon and
Pfeiffer syndrome, which can even be completely identical, the
distinction between these 2 syndromes can be considered irrelevant.
Before the discovery of TWIST1mutations and deletions in Saethre-
Chotzen syndrome and the P250R FGFR3 mutation in Muenke
syndrome it was hard to distinguish between these patients. New
mutations are expected to be found in the future, on account of which
the group of nonsyndromic craniosynostoses will further decrease.
The following types of craniosynostosis are distinguished:
Nonsyndromic:
Sagittal suture synostosis (scaphocephaly)
Metopic suture synostosis (trigonocephaly)
Coronal suture synostosis, unilateral (frontal plagiocephaly)
Coronal suture synostosis, bilateral (frontal brachycephaly)
Lambdoid suture synostosis (pachycephaly)
Syndromic:
Apert syndrome (FGFR2 mutation Ser252Trp and Pro253Arg,
deletion exon IIIc, Alu insertion exon IIIc)
Crouzon or Pfeiffer syndrome (FGFR2 mutations exclusive of
Apert mutations)
Saethre-Chotzen syndrome (TWIST1 mutations or deletions)
Muenke syndrome (Pro250Arg FGFR-3 mutation)
Craniofrontonasal dysplasia (EFNB1 mutations)
Complex craniosynostosis (syndromic picture without known
mutation, often 2 or more synostotic sutures)Each type of craniosynostosis may vary in its severity of pres-
entation. Notably, sagittal suture synostosis and metopic suture
synostosis can show a very mild phenotype in which only a bone
ridge at the afflicted suture is palpable and/or visible. The severe form
of sagittal suture synostosis is characterized by considerable frontal
bossing and punctiform occipital prominence in combination with
saddle deformity in the midline of the skull. The severe form of
metopic suture synostosis is characterized by a large wedge-shaped
forehead with underdeveloped lateral parts of the supraorbital ridge,
temporal depressions, and hypotelorism. Synostosis of 1 coronal
suture causes orbital dystopia, inwhich theorbital cone at the afflicted
side is placed higher than of the unafflicted side, retrusion of the
forehead at the afflicted side with compensatory bossing of the con-
tralateral side, and asymmetry of the skull base and the face. Con-
sequently, displacement of the ear and lateral deviation of the nose
occur. Bilateral synostosis of the coronal sutures result in retrusion of
the forehead and the supraorbital rim with a broad skull. Syndromic
craniosynostosis is usually characterized by synostosis of both cor-
onal sutures, but other types of craniosynostosis are seen as well.
Indications for surgical treatment of nonsyndromic craniosy-
nostosis are the risk of increased intracranial pressure (ICP) and the
abnormal skull shape. Since the first surgical intervention for
craniosynostosis, a great many surgical techniques for the variousCopyright © 2015 Mutaz B. Habal, MD. Unautho
# 2015 Mutaz B. Habal, MDtypes of craniosynostosis have been described. A broad distinction
is that between osteoclastic techniques and remodeling techniques,
osteoclastic techniques involve resection of bone, thereby allowing
the developing and expanding brain to change the shape of the skull,
also because the adverse impulse to the growth direction of the skull
is removed. The remodeling techniques, on the other hand, do not
rely on the selfcorrecting capacity of the skull and the brain, but
attempt to obtain the desired skull shape by a reconstruction.
The surgical treatment of patients with syndromic craniosynos-
tosis was developed in Paris in the early 1970s. Treatment has a 2-
fold aim: to enlarge the cranial volume so as to prevent sequelae of
ICP (mental retardation and impaired vision), and to correct
morphologic abnormalities of the cranium, the orbits, and the upper
jaw. Multiple corrections of the skull and/or the face may be
needed, although naturally it is strived for to restrict the number
of interventions as much as possible.
The group of complex craniosynostoses is managed in the same
way as the syndromic craniosynostoses, as these patients often
experience similar problems of cognition and ICP.
Syndromic craniosynostosis, notably, the Apert and Crouzon/
Pfeiffer syndromes, are associated with skeletal hypoplasia of the
midface. The result may be narrowed airway causing obstructive
sleep apnea syndrome (OSAS) in approximately 50%, exorbitism
with risk of cornea injury, malocclusion, and esthetic/psychosocial
problems.
Associated brain abnormalities in syndromic craniosynostosis
include raised intracranial pressure (ICP), Chiari I malformation,
ventriculomegaly, and hydrocephalus.
In all types of syndromic synostosis hearing loss is described.
Vision, refraction and motility abnormalities in the nonsyndromic
craniosynostoses are in fact only seen in unilateral coronal suture
synostosis. In the syndromic group, abnormalities such as astig-
matism and strabismus are very frequent.
Deformities of the extremities are notably restricted to the
syndromic craniosynostoses, and in patients with Apert syndrome
always present in a severe form. In the other syndromic types,
deformities of the extremities are generally very mild.
Parents are often confronted with health professionals who do
not recognize the craniosynostosis shortly after the birth of the
child. This can be a source of stress for parents and lead to a delay in
diagnosis and treatment. Nonsyndromic and syndromic craniosy-
nostosis may co-occur with cognitive impairments and behavioral
disorders. These may occur both intrinsic to the congenital defect
and secondary to, for example, increased cranial pressure or abnor-
mal physical appearance. Notably, families of a child with syn-
dromic craniosynostosis may experience psychosocial problems,
such as having to cope with negative reactions from others, a
possible discrepancy between deviating physical appearance and
cognition, and problems with school choice.
3. REFERRAL AND DIAGNOSTICS
Basic Questions1. Hrizow to optimize recognition of craniosynostosis in the primary
and secondary healthcare sectors?2. How to organize referral?3. What additional diagnostic procedures are applied in the
tertiary healthcare sector?Introduction
Craniosynostosis should be recognized timely for optimal treat-
ment. It appears, however, that craniosynostosis patients often areed reproduction of this article is prohibited.
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recognition of craniosynostosis is the high incidence of positional
head shape deformities. It may be expected that recognition, and
thus referral of patients with craniosynostosis will happen earlier if
health professionals in the primary and secondary healthcare sectors
are facilitated to make this distinction.
Preceding the referral to a tertiary healthcare center, we often see
overuse of diagnostic imaging, which is associated with further
delay in referral, an extra burden and insecurity for patient and
parents as well as unnecessary expenditure. This should be
restricted to a minimum. There are many options to diagnose
isolated craniosynostosis or any associated abnormalities. To
restrict both underdiagnosis and overdiagnosis, basic question 3
concerns further diagnostic procedures in a tertiary healthcare
center. Areas of attention are diagnostic imaging, genetic diagnos-
tics, and the role of the pediatrician.
Inclusion of a clinical geneticist in a multidisciplinary cranio-
facial team provides the opportunity to address questions from
parents and attending physicians.
Parents will first of all want to know if their child is healthy
otherwise, what may have caused the deformity, how great the
chance is of recurrence in a new pregnancy in the family and/or in
the next generation, and what prenatal diagnostic methods are
available. For the attending physician it is important to know if
there are any associated anomalies (to be expected) next to the
craniosynostosis that may be of influence to the treatment plan and
the prognosis of the child.
Basic Question 1: How to Optimize Recognition
of Craniosynostosis in the Primary and
Secondary Health Care Sectors?
Summary of the Literature
The abnormal skull shape is recognized by parents themselves,
midwife, obstetrician, general practitioner, infant health clinic
(physician, nurse), (pediatric) physiotherapist, pediatrician,
(pediatric) neurologist, and helmet maker. Occasionally, it is
recognized later by other specialists and sometimes not until a
craniofacial team is involved. Most of the children (50%–90%)
were referred via the pediatrician, others via the infant health clinic,
or parents themselves via the GP. These data are from the Birming-
ham craniofacial center and could therefore well compare with the
situation in the Netherlands.1,2 For the situation in the Netherlands
only the information from an article by Bredero-Boelhouwer is
available,3 in which 18 children were identified by the referrers as
having craniosynostosis and in 14 of whom this diagnosis was
confirmed in the tertiary center. Of the 89 referrals with the initial
diagnosis nonsynostotic occipital plagiocephaly (NSOP) made by
the referrer, 10 patients appeared to have a craniosynostosis. Thus,
professionals in the primary and secondary healthcare sectors
wrongly diagnosed 14 of the total of 107 patients (13%).
Recognition of the condition is complicated by an increase in
positional plagiocephaly (current prevalence 20% to 48%) since the
early 1990s when supine sleep position was recommended to prevent
cot death.2,4–6 The increase in positional head deformities carries the
risk of missing the diagnosis of craniosynostosis in more patients.
A craniosynostosis or positional skull deformity is primarily
recognized by physical examination, notably skull shape4,6 in
combination with history taking,3,5 and an imaging study is rarely
indicated.6 Both history taking and physical examination are well
possible in the primary and secondary healthcare sectors. This
deserves great attention because early recognition and surgical
correction are essential to a satisfactory treatment outcome.6 Pedia-
trician and infant health clinic carry the main responsibility to
recognize skull deformities. Ridgeway recommends a number ofCopyright © 2015 Mutaz B. Habal, MD. Unautho
1738diagnostic steps that should lead to early diagnosis, in which history
taking and physical examination yield the most important infor-
mation to distinguish between positional head shape deformities
and craniosynostosis.5
Using this information in a flowchart at intake appears to be a
safe method to make this distinction at the earliest. This will prevent
delay in start of treatment as a possible consequence of the increase
of patients of positional head shape deformities.3 This flowchart has
been validated only in a tertiary center. There are no other publi-
cations on referral patterns in children with abnormal skull shape.
History Taking
History taking should address the distinction between positional
head shape deformities and craniosynostosis on the one hand, and
risk factors and associated anomalies on the other hand.
Craniosynostosis is present at birth, positional head shape deform-
ities usually not.3–6 Improvement of abnormal head shape is seen in
positional head shape deformities, but not in craniosynostosis. Pre-
sence or absence of a preferred sleep position is essential in the
diagnostics of positional head shape deformities.3–6
Analysis of a flowchart to differentiate positional head
shape deformity versus craniosynostosis by means of a question-
naire (completed by telephone or e-mail) showed that the ques-
tionnaire recognized no more than 61.5% of the positional head
shape deformities. Nurse practitioner contacts increased this per-
centage to 75%. A craniosynostosis was never missed (false-
positive¼ 0%, which implies high sensitivity).3 In that study, the
essential questions were: Irizes deformity present at birth?
 Is there a preferred sleep position?
 Is there improvement of the deformity?The following risk factors for craniosynostosis are described:
smoking habit, mother’s antenal stay at high altitude, paternal
occupation,6–8 maternal alcohol use,7,8 maternal substance use,8
vitamin D deficiency or receptor insensitivity, chronic renal failure,
hypophosphatemia, hyperthyroidism, mucopolysaccharidosis,5,9 and
maternal drug use: phenytoin, retinoids, valproate, aminopterin/
methotrexate, fluconazole, cyclophosphamide, folic acid nitrosates,
thyroid gland medication, and vitamins.5,7,10,11 Also a high age of
father and mother increases the risk of craniosynostosis.7,12
Physical Examination of Skull and Face
More in detail the different craniosynostoses can be recognized
as follows:Sagittal synostosis:d reprodfrontal bossing, prominent occiput, bone ridge palpable on
sagittal suture, decreased biparietal diameter, long and
narrow head, tapering from parietal to sagittal suture,
with usually a head circumference >2 SD.1,5,6,8Metopic synostosis: wedge-shaped forehead, including cranial part of the orbits,
ridge on metopic suture, and hypotelorism.5,12Unicoronal synostosis: flattened forehead at afflicted side, including flattening of
cranial part of the orbits, flattened cheek, nose deviation
to unaffected side, orbital dystopia with higher position
of the ipsilateral orbital rim, and bossing of contralateral
side of forehead.5Lambdoid synostosis: unilateral occipital flattening, depression of lambdoid
suture ridge, low-positioned ipsilateral ear and back of
the skull base.5Bicoronal synostosis: broad head, flattened forehead and supraorbital rim.5Additional characteristics of skull and face are the following:
The anterior fontanel shows earlier fusion or is triangular
shaped rather than diamond shaped in synostosis of 1 adjacentuction of this article is prohibited.
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# 2suture.6 In Apert syndrome, there is even a large midline defect
initially.13
Mid-face hypoplasia, proptosis, and hypertelorism are found
particularly in the syndromic types of craniosynostosis.5,8,13
These and other syndrome-specific facial features are discussed
in the genetics section of this chapter, including additional
deformities of the extremities in particular.The following characteristics may help to distinguish craniosy-
nostosis from positional head shape deformities:
Positional plagiocephaly, such as a ‘‘parallelogram’’ seen from
above, that is, ipsilateral occipital flattening, curved forehead,
and ear more anterior ipsilateral.4,5 This in contrast with the
‘‘trapezium’’ shape in unilateral coronal suture synostosis, that
is, ipsilateral flattening of the forehead and cranial part of orbit
and occiput.5,6
American Cleft Palate-Craniofacial Association (ACPA) recom-
mends that craniofacial teams provide education to health
professionals in obstetrics and neonatology as well as GPs and
infant health clinic physicians so as to improve early recognition
of children with craniofacial deformities.9Grol emphasizes that effective implementation of guidelines
requires behavioral changes in physicians.14 Interactive instruc-
tion methods via CD-rom and information-sites on Internet seem
very effective. E-mail consultations improve the quality of
decision-making, notably as they are easily accessible.15 Intensive
instruction to small groups of physicians and peer review appeared
little effective, however, in improving quality of care.16 Medical
audits in the GP practice seems promising for quality of care
improvement, but should be further developed.17 Availability of a
good computer-aided medical information system is very import-
ant to recognize clinical pictures. Audit programs are most effec-
tive when integrated with other educational and research
programs.18
ConclusionsLevel 3opy
015 MTriage (with the use of a flow diagram) at intake of children with
abnormal skull shape is likely to be effective to recognize
craniosynostosis and to timely refer the children to the
appropriate specialist.B Bredero-Boelhouwer, 20093Level 3 Craniosynostosis is often hardly recognized and recognition is even
more complicated by the increase in positional skull deformities
since supine sleep position was recommended to prevent cot death
in the early 1990s.C Komotar, 20066C Parameters ACPA, 20079C Ridgeway, 20045C White, 20102Level 3 Craniosynostosis can be distinguished from NSOP on the basis of
medical history and physical examination.B Bredero-Boelhouwer, 20093C Komotar, 20066C Ridgeway, 20095Level 3 Easily accessible (computer assisted) information in the primary and
secondary health care sectors on history taking, physical examination,
and use of decision tree improves quality of care.C Grol, 200014C Smeele, 199916C Grol, 199517C van der Weijden, 199615C Grol,198518right © 2015 Mutaz B. Habal, MD. Unautho
utaz B. Habal, MDConsiderations
Often it takes long before parents and the child with craniosy-
nostosis are referred to the tertiary center, which may lead to
treatment delay and confusion, and consequently a great deal of
parental stress.
The flow diagram to discriminate between positional skull
deformities and craniosynostosis was validated in a tertiary care
setting, where it was applied by secretaries who were not specifi-
cally trained in distinguishing between these 2 conditions. Con-
sequently, we do not expect great differences in its reliability when
applied in primary and secondary care settings. Ideally, validation
for primary and secondary care settings finds place in these settings,
but this does not seem to be practically feasible in view of the very
low frequency of craniosynostosis compared with positional skull
deformities.
Additional imaging studies to differentiate between positional
skull deformities and craniosynostosis are rarely performed in
tertiary centers. On clinical diagnosis of a positional skull deform-
ity, skull x-ray or ultrasound are advised against to prevent
unnecessary medical imaging (with associated costs, radiation
exposure, burden for patient and parents, lack of added value,
and required experience in interpretation). Consultation with a
tertiary craniofacial center is indicated in suspected patients, for
which submitting normal pictures (front view, lateral view, anterior
view, and view from above) will usually suffice.
Recommendations
The following measures are essential to optimize recognition of
craniosynostosis in the primary and secondary care sectors:1. Eriznsure that easily accessible, reliable, and unambiguous
information is available about skull deformities, either as
appendix to this guideline, or via separate guidelines;
preferably with many illustrations, clear terminology/defi-
nitions and addresses.
3
2. Ensure that the flow diagram (Appendix II) is used.3. Provide structured education and training instruction to infant
health center physicians, GPs, midwives and obstetricians about
over skull deformities via centers of expertise with an initiating
role for the tertiary centers.4. Provide feedback about the referral pattern on the basis of an
analysis of national registry data (focus on patient’s age at
referral to tertiary center).The craniosynostosis centers should develop a website with
relevant information for the primary and secondary healthcare
sectors, providing an e-mail address for online consultations. They
should stimulate inclusion of the decision tree in the ICT-systems
used by GPs and infant health center physicians, as well as in
training programs for GPs, infant health center physicians, mid-
wives, pediatricians and gynecologists. An interactive CD on
history taking and physical examination in skull deformities is
being prepared.
Collaboration with specialized centers for diagnostics and treat-
ment of positional skull deformities will facilitate knowledge
transfer.
Basic Question 2: How to Achieve Effective
Referral?
With the exception of the study by Bredero-Boelhouwer there is
no literature available about the referral pattern in the Netherlands.3
From the focus group sessions it became also clear that parentsed reproduction of this article is prohibited.
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on focus groups).
Early recognition is important; delayed referral is associated
with a risk of medical complications and less satisfactory operation
results.1 This article describes 47 referrals of scaphocephaly
patients to the Birmingham craniofacial center during 3 years’
time. The pediatrician was the first to recognize the condition in
64% of patients, the GP in 11%, and the parents in 25%. Timely
referral to a specialized center is recommended to prevent use of
inappropriate diagnostic procedures and resources.
Another study from the same center showed a shift in the years
2007 to 2008 as compared with 2003 to 2004: referrals from
pediatricians dropped from 67% to 55%; referrals from GPs
increased from 8% to 15%; referrals from specialists increased
from 25% to 30%.2 The deformity is recognized at birth in one-third
of patients, at median age 0.5 months, mean 3.1 months, range 0 to
24 months, while the referral is at a later stage: pediatricians refer
earlier (mean 8 months, median 3 months, range 0.25–78 months),
the GPs and parents later (mean 24 months, median 16.5 months,
range 2–36months).1 Delay is often because of the pediatrician’s or
GP’s expectation that the condition will revert to normal.1
Furthermore, diagnostics by pediatricians and GPs (eg, compu-
terized tomographic (CT)-scan) delays referral, and it is recom-
mended, therefore, to refer the child immediately without further
diagnostics.1 Pediatricians are expected to be able to recognize skull
deformities and to diagnose them as either craniosynostosis or a
positional skull deformity.5 A child with craniosynostosis should be
referred to a craniofacial center,4,5 but this is not necessary for a
child with a positional skull deformity.5
In the Netherlands, 9 specialized centers offer diagnostics for
acquired skull deformities and helmet therapy, and they closely
collaborate to achieve early recognition and referral of patients with
craniosynostosis.4
The formal institution of craniofacial centers (4 centers to
56 million people in the United Kingdom) leads to concentration
of craniofacial care.2
ConclusionsLevel 3Copyrig
1740Early recognition and referral of patients with craniosynostosis is
important to prevent treatment delay and complications.C Chatterjee, 20091C Ridgeway, 20045C White, 20092Level 3 Additional diagnostic imaging by pediatrician or GP delays referral
and is therefore advised against.C Chatterjee, 20091C White, 20092Considerations
The focus group has made clear that the period between first
contact with a physician and the eventual referral to the craniofacial
center is too long. This is in part is because of delayed referral from
the primary care setting to a pediatrician, but the workgroup is of the
opinion that management by the pediatrician in the patient’s own
environment is of great value at this stage and in the subsequent
stage. Still, rapid further referral should be guaranteed.
Consultation with a tertiary craniofacial center is indicated in
suspected patients, for which submitting normal pictures (front view,
lateral view, anterior view, and view from above) will usually suffice
Recommendations
When an abnormal skull shape is noted the primary care
sector should refer the child to pediatrician, without additionalht © 2015 Mutaz B. Habal, MD. Unauthodiagnostics. At suspicion of craniosynostosis, this is done without
delay.
The pediatrician is the designated professional for initial man-
agement in the secondary health care sector and to further explore
the options. The anamnestic flowchart of Bredero serves as a
guideline to distinguish craniosynostosis from positional skull
deformities. The pediatrician refers the child to a tertiary center.
Diagnostic imaging in the primary and secondary care sectors is
advised against, unless performing skull x-rays has been approved
by the craniofacial center and provided this does not lead to delay in
referral. At suspicion of craniosynostosis this will be done at the
shortest possible term.Basic Question 3: What Additional Diagnostic
Methods (Imaging and Genetic) Are Used in
the Tertiary Center?
Diagnostic Imaging
X-ray of the skull (a-p, lateral, Towne of Tschebull) is con-
sidered the first radiologic diagnostic test for craniosynostosis.1,2,4–
6,9,19–21
A CT of the skull is always performed on suspicion of cranio-
synostosis.1,6,7,11,13,22–24
Magnetic resonance imaging (MRI) is performed on indication
in syndromic craniosynostosis (see chapters onICP, hydrocephalus,
and Chiari I malformation).
A three-dimensional CT scan will reliably diagnose craniosy-
nostosis.19–21,25 X-skull is reliable as well, but less reliable
than three-dimensional CT scan.19–21 For both methods, experi-
ence in imaging and evaluation provides for greater reliability.21
From a cost-effective analysis, Medina concludes that radiologic
screening for craniosynostosis in all children (low risk of cranio-
synostosis) is not justified. In children with skull deformities
(moderate risk of craniosynostosis), an X-skull is indicated first,
followed by a three-dimensional CT scan if the X-skull raises
suspicion of craniosynostosis. On clear clinical suspicion of cra-
niosynostosis (high-risk craniosynostosis), an immediate three-
dimensional CT scan is indicated, without an X-skull.21 Cerovac
concludes from a retrospective study involving 109 single-suture
craniosynostoses, that an experienced clinician can make a clinical
diagnosis with 100% certainty.20 X-skull should confirm the
diagnosis, even though this is less reliable (91%). Three-dimen-
sional CT scanning should be reserved for suspected patients or for
surgery planning.20
It appeared that ultrasound could well visualize a craniosynos-
tosis in 26 children with craniosynostosis aged from 2 to 7 months
and in 23 of the 24 children with craniosynostosis aged from 1 to 11
months.26,27 Echography could therefore well serve as an alterna-
tive to imaging.
ConclusionsLevel 3rized reprodX-skull is considered the first radiologic diagnostic test for
craniosynostosisC Komotar, 20066C Ridgeway, 20095C White, 20092C Parameters ACPA, 20077C Gellad, 198519C Cerovac, 200220C Medina, 200221Level 3 (three-dimensional) CT is always performed on suspicion of
craniosynostosisC Chatterjee, 20091uction of this article is prohibited.
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# 2015 Mutaz B.C Cohen, 199313C Komotar, 20066C Bruce, 199622C Mathijssen, 200724C Parameters ACPA, 20077C Strauss, 199823C Medina, 200221Level 3 Ultrasound is an alternative to imaging as first diagnostic test
for craniosynostosisC Regelsberger, 200626C Simanovski, 200927Considerations
The clinical diagnosis of craniosynostosis by means of physical
examination forms the basis. Even though an X-skull is not always
reliable, notably at very young age (several months old), as first
further diagnostic test, it provides much information and can exclude
craniosynostosis if all cranial sutures are clearly open. It is essential,
however, that it is performedandevaluatedby experienced clinicians.
A three-dimensional CT scan images a craniosynostosis in a reliable
way and is the most reliable objective diagnostic method. A stan-
dardly performed three-dimensional CT scan to objectivize the
deformity is highly recommended for operative planning
Recommendations
X-skull (a-p, lateral, Towne for back of the head, Tschebul for
forehead) is always performed in (suspected) craniosynostosis. If
unclear, because of very young age of the patient, it is recom-
mended to repeat X-skull after 1 or 2 months.
If X-skull confirms, or does not exclude, a synostosis, a CT-scan
with three-dimensional-reconstruction is performed.
In case of very strong suspicion of craniosynostosis, the X-skull
is skipped and a CT-scan with three-dimensional reconstruction is
performed without delay.
Ultrasound of the cranial sutures can be performed as an
alternative to X-skull.
Genetic Diagnostics
Etiologic diagnostics and genetic counseling is the task of the
clinical geneticist. An etiologic or classifying diagnosis allows for
making a prognosis (not so much regarding the craniosynostosis, but
rather regarding the child’s general and psychomotor development
and possible associated anomalies). An etiologic diagnosis also
provides for determining the risk of recurrence as well as the
alternative choices in new pregnancies, such as prenatal diagnostics.
Craniosynostosis is a birth defect that can present both in
isolated form and syndromic form. If next to the craniosynostosis
congenital anomalies are present (either major anomalies or minor
anomalies/dysmorphias), this is referred to as syndromic craniosy-
nostosis. In line with the international literature, we distinguish
between nonsyndromic and syndromic craniosynostosis.
Dysmorphologic examination may distinguish between nonsyn-
dromic and syndromic patients on the basis of the presence of
dysmorphic characteristics. In addition, several bodily measure-
ments are made and compared with reference values. On indication,
dysmorphologic examination (of the whole patient) is repeated.
Possible indications are the development of new physical problems
and newly observed delay in development in the course of time.
The January 2009 issue of the American Journal of Medical
Genetics Part A is fully devoted to dysmorphologic examination of
the face and extremities. 2015 Mutaz B. Habal, MD. Unautho
Habal, MDThe adequate performance and interpreting of dysmorphologic
examination is one of the specific medical competencies of a
clinical geneticist.
Summary of the Literature
The craniofacial unit of Hoˆpital Necker des Enfants Malades is
‘‘the’’ referral center for craniosynostosis in France. Data of patients
referred from 1985 through 1989 and of patients referred from 2003
through 2007 were compared on relative incidence of occurrence of
the various types of craniosynostoses.28 The first group included
472 patients, the second group 814 patients (in total 1286 patients)
(Table 3).
The total number of patients increased 1.7-fold. The ratio
nonsyndromic versus syndromic remained almost similar. In
approximately 2 of every 15 children the craniosynostosis is of
the syndromic type, in 1 in every 8 of them other than Apert,
Crouzon of Saethre-Chotzen syndrome.
The article does not make clear how syndromic and nonsyn-
dromic craniosynostosis were distinguished.
The associated anomalies in the syndromic types of craniosy-
nostosis notably were anomalies of the face and of the extremi-
ties.29,30
Table 4 shows the major features of the 7 most frequent
syndromes.
The London Dysmorphology Database (version 1.0.12) includes
192 syndromes of which 1 of the characteristics is craniosynostosis.
In a part of the syndromes, the craniosynostosis is a major charac-
teristic, in another part the craniosynostosis is an ‘‘occasional
abnormality.’’
More than half of the 192 syndromes follow a Mendelian
inheritance pattern; some are the result of teratogens (including
vitamin A and valproate). Chromosomal disorders are seen in a
proportion of patients with a craniosynostosis (including 9p-, 11q-).
Frias and Carey reviewed 4 population studies that established
relations between the occurrence of minor anomalies and the risk of
a major anomaly.31 Although these 4 studies differed in their
methods, they all demonstrate a clear relation between number
of minor anomalies and the risk of a major anomaly. In the different
studies, having 3 or more minor anomalies was associated with a
19.6%, 26%, 31%, 90% risk, respectively, of a major anomaly.Scaphocephaly
From the same center in Paris, Lajeunie in 1996 published a
series of 561 patients with a nonsyndromic scaphocephaly (of a total
of 1408 craniosynostosis-patients admitted between 1976 and
1994).32 The man:woman ratio was 3.5:1. In 6% of the patients,
a positive family history was documented.
This article does not provide the number of syndromic scapho-
cephaly patients.
Also the remaining literature does not provide information on
the ratio between nonsyndromic versus syndromic scaphocephaly.
Lajeunie33 reports that most patients of scaphocephaly and trigo-
nocephaly are nonsyndromic. A striking finding was 4.2% of the
patients was one of the twins.
In 2002, Kan34 described that in none of the 13 patients with
scaphocephaly an FGFR2 mutation was found in a comprehensive
screening of the whole gene. Butzelaar35 describes a pilot study in
30 consecutive patients with scaphocephaly, which retrospectively
analyzed how many patients had consulted the Clinical Genetics
department, what genetic tests were used, and what the test results
were. In addition, the parents were sent a questionnaire on risk
factors. Maternal alcohol use and smoking habit did not differ fromrized reproduction of this article is prohibited.
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TABLE 3. Data of Patients Referred From 1985 Through 1989 and of Patients Referred From 2003 Through 2007 to the Craniofacial Unit of Hoˆpital Necker des Enfants
Malades, Paris
1985–1989 2002–2007 total
472 814 1286
Number of Patients % % %
Scaphocephaly 214 369 583
Trigonocephaly 49 193 242
Plagiocephaly 59 81 140
Brachycephaly 20 31 51
Oxycephaly 33 10 43
other nonsyndromic 29 27 56
Total nonsyndromic 404 85.6 711 87.3 1115 86.7
Apert 14 22 36
Crouzon/Pfeiffer 30/7 28/20 58/27
Saethre Chotzen 10 18 28
Other syndromic 7 15 22
Total syndromic 68 14.4 103 12.7 171 13.3
Mathijssen The Journal of Craniofacial Surgery  Volume 26, Number 6, September 2015those in the general population. Prematurity was more often seen in
the study group than in the general population.
None of the 30 included patients had craniofacial dysmorphias.
In 4 of the 30 patients another anomaly was diagnosed (nevoid basal
cell carcinoma syndrome, defects of the cardiovascular system and
of the urinary tract. DNA testing was performed in 8 patients, in 1 of
whom a FGFR2 mutation was found.
Zeiger36 investigated genetic and environmental factors associ-
ated with a higher risk of scaphocephaly in a group of 42 children
from craniofacial clinics in the Baltimore-Washington area. In 24 of
the 36 Caucasian children, DNA-testing was performed of specific
exons of the FGFR1, 2, and 3 genes and of exon 1 of the TWIST
gene. Pathogenic mutations were not found.
McGillivray37 identified an FGFR2-mutation in a patient with
familial scaphocephaly. Seto (2007)38 identified a TWIST box
mutation in a patient with a sagittal suture synostosis. The sameCopyright © 2015 Mutaz B. Habal, MD. Unautho
TABLE 4. The Major Features of the Most Common Craniosynostosis Syndromes
Apert Crouzon Pfeiffer
Synostosis coronal
suture
þ þ þ
Proptosis þ þ
Ptosis þ
Hypertelorism þ þ
Cleft palate þ
Deformity of the
auricles
Deformity of the hand Complete syndactyly of
dig 2–3–4, sometimes
with 5 and or 1
Broad thumbs Partial
cutaneous
syndactyly dig 2–3
Deformity of the foot Complete syndactyly
of all toes
Broad great toes; Partial
cutaneous
syndactyly dig 2–3–4
Malformations of the
internal organs
10% congenital heart
defect; 10% urogenital
malformation
1742mutation occurred in the patient’s nonafflicted father. The signifi-
cance of this mutation is not clear.
Trigonocephaly
Of a series of 1713 patients admitted between 1976 and 1996 in
Paris, Lajeunie published an analysis of 237 patients with a
trigonocephaly.39 The nonsyndromic type occurred in 184 of the
237 patients (77.6%). Fifty-three (22.4%) of the patients had 1 or
more other malformations next to the trigonocephaly. Thirteen of
these 53 had a known syndrome; the diagnosis in the other 40
patients was unknown.
Also in the group of trigonocephaly patients theman:woman ratio
was skewed, that is, 3.3: 1. The proportion of patients with a positive
family history was 5.6%. The proportion of twins in this series was 3
times higher than in the general population, andwas higher than in the
group of patients with a scaphocephaly (6.8% versus 4.2%).33rized reproduction of this article is prohibited.
Muenke
Saethre-
Chotzen Carpenter
Craniofrontonasal
dysplasia
þ þ þ þ
þ
þ þ þ
Small auricles
with prominent
auricular crura
Partial cutaneous
syndactyly
dig 2–3
Brachydactyly,
clinodactyly, partial
syndactyly,
camptodactyly
Longitudinal grooves
of the nails
Broad great toe in
hallux valgus;
Mild brachydactyly;
Partial cutaneous
syndactyly dig 3–4
Duplicated great toe Broad great toe;
Longitudinal grooves
of the nails
50% congenital heart
defect, urogenital
malformation
(hypogenitalism)
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TABLE 5. Genes Involved in Syndromic Craniosynostosis
Clinical diagnosis Genes to be Investigated
Apert FGFR2
Crouzon FGFR2
Crouzon with acanthosis nigricans FGFR3
Pfeiffer FGFR2 (FGFR1)
Carpenter RAB23
Muenke FGFR3 (TWIST1)
Saethre-Chotzen TWIST1 (FGFR3)
Craniofrontonasal dysplasia EFNB1
The Journal of Craniofacial Surgery  Volume 26, Number 6, September 2015 Diagnoses of CraniosynostosisAzimi40 investigated 25 patients with trigonocephaly (diagnosed
between 1996 and 2001). In 16 patients it was an isolated anomaly,
2 patients in addition had a craniosynostosis of the sagittal suture
without associated anomalies. The trigonocephaly was part of a
syndrome in 7 patients (28%), in 2 of whom a chromosome
abnormality was detected and Jacobsen syndrome could be diag-
nosed. Regarding the other 5 patients, in 1 the diagnosis of Say-
Meyer trigonocephaly was made, in 1 I-cell disease and in another
one Opitz-C syndrome. A diagnosis could not be made in 2 patients.
In 2 of the syndromic patients FGFR2 and FGFR3 analysis was
performed, which yielded no abnormalities.
In 1 of 9 patients with a seemingly nonsyndromic trigonoce-
phaly a mutation in the FGFR2 gene was found.41 This patient later
developed features characteristic of the Crouzon-syndrome and the
diagnosis was revised. Kress42 found a FGFR1 mutation in 1 of 10
nonsyndromic trigonocephaly patients, who had or did not develop
other dysmorphias. In 2002, Kan34 reported that in none of 17
patients with trigonocephaly a FGFR2 mutation was found in a
comprehensive screening of the whole gene.34 Jehee43 analyzed the
frequencies of occurrence of micro deletions of chromosome 9p and
chromosome 11q in a cohort of 76 nonconsanguineous trigonoce-
phaly patients (44 from Sao Paolo, 15 from Oxford, and 20 from
Baltimore). The patients were classified into groups, a group of 40
patients with an isolated trigonocephaly and a group of 36 patients
with associated abnormalities. A striking finding was that the
condition was nonsyndromic in 71% of the English/American
patients, but was syndromic in 63% of the Brazilian patients.
In the nonsyndromic group no 9p- or 11q-deletions were found.
In 7 of the 36 syndromic trigonocephaly patients a 9p- or
11q-deletion was found. Four of these deletions were not detectable
with conventional cytogenetic analysis.
In a case-report, Van der Meulen (2006)44 describes a trigono-
cephaly in a patient with Muenke syndrome.
Plagiocephaly, Brachycephaly, Oxycephaly
In these types of craniosynostosis the coronal suture is involved;
unilaterally in plagiocephaly, bilaterally in brachycephaly and
oxycephaly. In oxycephaly there is also a craniosynostosis of the
sagittal suture.
Mulliken45 performed molecular diagnostics in patients with a
bilateral coronal suture synostosis, of whom 38 had been diagnosed
with Apert, Crouzon, or Pfeiffer syndrome and 19 had no specific
diagnosis. In all 38 syndromic patients, a mutation was identified in
FGFR2 (N¼ 33) or FGFR3 (N¼ 5). In 14 of the other 19 patients a
mutation was found, either in FGFR2 (N¼ 4) or in FGFR3 (N¼ 10).
In 2004, Mulliken46 reported results of molecular genetic diag-
nostics in 47 patients with a unilateral coronal suture synostosis.
This was a prospective study in children admitted between 1997 and
2000. Theman:woman ratio was 1:2. DNA testing of the FGFR-
genes and the TWIST gene was performed in all 47 patients. In 8
patients a mutation was found in 1 of these genes (N¼ 3 in FGFR3,
N¼ 2 in FGFR2, and N¼ 3 in TWIST). One patient was clinically
diagnosed with craniofrontonasal dysplasia. The 47 patients were
physically examined on inner canthal distance (ICD), among other
things; ICD> 2SD was defined as hypertelorism. Also the parents
of the children were examined. Of the 47 children, 13 showed
hypertelorism or had a parent with characteristics of craniosynos-
tosis. All above anomalies were found in these 13 children. In the
children with a unilateral coronal suture synostosis in whom no
hypertelorism was established, no mutation in FGFR1, 2, 3, or
TWIST was found.
The known craniosynostosis syndromes, Apert syndrome, Crou-
zon syndrome, Pfeiffer syndrome, Muenke syndrome, Saethre-
Chotzen syndrome, Carpenter syndrome, and craniofrontonasalCopyright © 2015 Mutaz B. Habal, MD. Unautho
# 2015 Mutaz B. Habal, MDdysplasia (CFND), are characterized by craniosynostosis of one
or both coronal sutures next to other birth defects. A proportion of
patients with these syndromes show pathogenic mutations of known
genes (Table 5).47–51
In a comprehensive screening of the FGFR2 gene in patients
who were proven negative for a mutation in FGFR1 or 3 or TWIST,
the large majority of mutations were located on exon IIIa or IIIc. In
addition, mutations were found in 7 new exons.34
In patients with a syndromic craniosynostosis, genetic diagnos-
tics is performed on the guidance of the syndrome diagnosis.
Mutations are most frequent in FGFR2, followed by FGFR3 and
TWIST, and least frequent in FGFR1 and EFNB1.52,53
In Rotterdam, DNA testing of the FGFR1, 2, 3, and TWIST
genes was performed during several years in all patients with a
craniosynostosis, except those with an isolated scaphocephaly.
FGFR1 mutations were not identified.54 Routine screening of the
FGFR1 gene does not seem to be useful, therefore, and should be
performed only in patients with a specific phenotype.
Morriss-Kay53 reported a prospective study in 214 patients born
between 1993 and 2005. Analysis of FGFR1, FGFR2, FGFR3,
TWIST1 and EFNB1 was performed as well as cytogenetic analysis.
In 60 of the 214 patients a specific molecular diagnosis was made;
in 4 patients this was a chromosomal abnormality, in 56 patients a
mutation in FGFR2, FGFR3, TWIST, or EFNB1. The patients with
the FGFR2, FGFR3 and TWIST1 mutations all had a craniosynos-
tosis of 1 or both coronal sutures
Wilkie52 tested 217 patients in a diagnostic setting as from 2002.
Submittingmaterial of patients with a nonsyndromic scaphocephaly
or trigonocephaly was strongly discouraged. In 59 of the 217
patients a pathogenic mutation was found, in 55 patients in FGFR2,
FGFR3, or TWIST.
In 80% of the patients with a clinical diagnosis of Crouzon or
Pfeiffer syndrome this diagnosis is confirmed by molecular test-
ing.54 Clinically diagnosed Apert syndrome is confirmed by mol-
ecular testing in almost all patients. Two specific mutations in
FGFR2 were found in approximately 98% of patients with Apert
syndrome.52 In more than 80% of a group of patients with the
phenotype of Saethre-Chotzen syndrome a mutation was found in
the FGFR3 or the TWIST gene.55
If conventional molecular genetic diagnostics does not reveal
mutations in one of the known craniosynostosis genes, additional
diagnostics is warranted in patient of syndromic craniosynostosis.
Genetics diagnostics was performed with different techniques in the
screening of 45 patients with a syndromic craniosynostosis without
known mutation.56 New causal abnormalities were found in 19
patients.
ConclusionsLevel 1rized reIt has been demonstrated that the Apert, Crouzon, and
Pfeiffer syndromes are caused by mutations in the FGFR2 gen,
except in Crouzon patients with acanthosis nigricans
(FGFR3 mutation)production of this article is prohibited.
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1744A2 Oldridge, 199757A2 Meyers, 199558Level 1 It has been demonstrated that the Saethre-Chotzen syndrome is
caused by mutations and deletions in the TWIST1 geneA2 Johnson, 199859A2 Chun, 200255Level 1 It has been demonstrated that the Muenke syndrome is caused by
the P250R mutation in FGFR3A2 Muenke, 199749A2 Chun, 200255B Kress, 200660B Mulliken, 199945Level 1 It has been demonstrated that craniofrontonasal dysplasia
(CFND) is caused by mutations in het EFNB1 geneA2 Twigg, 200451A2 Wallis, 200861Level 2 It is likely that almost no genetic abnormalities are found in
nonsyndromic trigonocephaly and scaphocephaly. DNA
testing is indicated in patients with other birth defects or
dysmorphias next to the craniosynostosis of the sagittal
suture or metopic suture or in case of a positive
family history.B Kan, 200234B Wilkie, 200752B Morriss-Kay, 200553B Zeiger, 200236C McGillivray, 200537C Jehee, 200543C Tartaglia, 199941C Kress, 200042Level 2 There are indications that FGFR2, FGFR3 and TWIST1
mutations are almost exclusively detected in patients with
craniosynostosis of the coronal sutures.B, Mulliken, 199945B Morriss-Kay, 200553B Wilkie, 200752Level 3 There are indications that in no more than 25% of patients with
a craniosynostosis a specific molecular diagnosis could be made
after analysis of the coding regions of FGFR1, FGFR2,
FGFR3, TWIST1, and EFNB1B Wilkie, 200752B Morriss-Kay, 200553Level 3 There are indications that in familial scaphocephaly an FGFR2
mutation can be foundC McGillivray, 200537Level 3 There are indications that in patients with syndromic trigonocephaly
or complex nonclassifiable craniosynostosis additional diagnostics
can lead to an etiologic diagnosisC Shimojima, 200962C Barbaro, 200963C Jehee, 200543Level 3 There are indications that in a proportion of patients with
unexplained syndromic craniosynostosis a cause can be
established with the use of new molecular genetic techniquesC Jehee, 200856Considerations
The Crouzon and Pfeiffer syndromes cannot be easily distin-
guished clinically and genetically, but such distinction is not
relevant to choice of treatment. The first choice for the genetic
diagnostics is analysis of the FGFR2 gene.
Patients should be invited to contact the clinical geneticist again
after reaching the age of 18 years to discuss the wish to have
children and receive counseling if desired.
Recommendations
After referral of a child to a craniofacial team, the clinical
geneticist of the team should be consulted. To distinguish betweenht © 2015 Mutaz B. Habal, MD. Unauthononsyndromic and syndromic craniosynostosis a clinical geneticist
experienced in the fields of hereditary and congenital abnormalities/
dysmorphias should perform a complete physical examination in
each child. In addition, the family history regarding the occurrence
of skull deformities and other birth defects should be documented.
If multiple dysmorphias/visible congenital abnormalities are
observed, further diagnostics in the first weeks of life is indicated
(including, among other things, cardiologic examination, renal
ultrasound, and examination by pediatric neurologist).
Molecular genetic diagnostics is not offered in patients with
nonsyndromic scaphocephaly and nonsyndromic trigonocephaly.
If these types of craniosynostosis occur in relatives, molecular
genetic diagnostics is performed depending on the family history
and preferably after consultation with a tertiary craniofacial center.
If a syndrome diagnosis has been made clinically, genetic
diagnostics can be requested syndrome specifically:Clinical diagnosisrized reproduction of this article
# 2015 MGenes to be investigatedApert FGFR2Crouzon FGFR2Crouzon with acanthosis nigricans FGFR3Pfeiffer FGFR2 (FGFR1)Carpenter RAB23Muenke FGFR3 (TWIST1)Saethre-Chotzen TWIST1 (FGFR3)More advanced diagnostics is indicated in the patient of a
syndromic craniosynostosis without clinical diagnosis (¼ a non-
classifiable craniosynostosis) or a clinical diagnosis that could not
be confirmed genetically.
4. PERIOPERATIVE CARE
Basic Question
What organizational conditions should be minimally present for
adequate and safe perioperative care for patients with a craniosy-
nostosis?
Introduction
Correction of craniosynostosis in childhood can cause relatively
much blood loss. The risk of blood loss is higher in older patients
and in corrective surgery of syndromic craniosynostosis. Next to the
surgical and anesthesiologic challenges, we should take into
account that syndromic patients may be associated with comorbid-
ity. This is why optimal organizational conditions should be in
place, before, during, and after the intervention. This chapter deals
with the specific risks involved in correction of nonsyndromic and
syndromic craniosynostosis and recommendations are given to
perform surgery as safely as possible.
Summary of the Literature
General
The ‘‘Richtlijn Kwalificering Chirurgie bij Kinderen’’ makes
clear that the anesthesiologic goals in complex care such as
craniofacial surgery can only be realized in specialized pediatric
centers.64
Preoperative Preparation
All members of the multidisciplinary team should be aware of
possible comorbidity, that is, mostly in case of a syndromic
craniosynostosis with compromised airway with or without
OSAS. It is recommended to set the threshold for postponing the
intervention low in case of a recent upper airway infection in is prohibited.
utaz B. Habal, MD
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airway infection is believed to be more strongly associated with
complications.
One of the big problems (or complication) in the surgical
correction of craniosynostosis is the occasional massive blood
loss of 20% to 500% of the circulating volume, which may occur
during the operation in a relatively short period and in patients with
age-related circulating volume.66
The following factors may predict large blood loss: syndromic
craniosynostosis, pansynostosis, age <18 months, and duration of
the procedure.67
A number of methods have been proposed to reduce both the
blood loss and the need of homologous (allogeneic) blood transfu-
sion (in view of the risk of blood-transferable infection, immuno-
logic reactions, coagulopaty, and transfusion-related acute lung
injury (TRALI), but most studies are not randomized double blind
and have a B-C Level. These methods can be classified into
different categories and are applied pre-, per- or postoperatively.
In the polyclinic (preoperative) period: OCo
# 201ptimalization of hematological conditions preoperatively,
by administering erythopoietin (EPO) plus Fe supplement: A
review concludes that multicenter studies are needed to
determine the optimal dosing of EPO.68 Different dosages
have been described, that is, 600–200–100 U/kg once to
thrice a week, but all during 3 weeks preceding the operation.
Also the timing of administration, the optimal dosing of Fe,
and cost-effectiveness must be determined. The use of EPO
was also successfully combined with other methods in a
number of B-C studies.69–73 A disadvantage of this method
for the child is that blood must be drawn several times. Preoperative blood sampling for autologous transfusion
during the operation: Opinions differ on this technique. It
has been used as part of a ‘‘no allogenic blood transfusion’’
protocol, but other authors think it is not indicated in these
very young patients as only small volumes can be drawn.
Furthermore, the procedure is not child friendly as the
newborns and infants must be anesthetized. Preoperative selection of the extent of surgical procedure on
the basis of age, accounting for the percentage of Hbf, which
at 4 months has been decreased to 16% of total Hb. Preoperative surgical planning with the use of three-
dimensional models seems to reduce operation time and
thus also blood loss. Still, according to a C study, duration of
the procedure is not decisive for the blood loss.74
75,76 Less invasive surgical procedures.Immediately before surgery the presence of blood products and
availability of a pediatric intensive care unit (PICU) bed for the
postoperative period should be confirmed in case significant blood
loss related to the child’s circulating capacity should occur. A clear
plan must have been made anticipating problems with intubation.
The use of pre- and postoperative checklists and the time-out
procedure (TOP) before start of surgery importantly add to safety
of the entire perioperative process.
Peroperative Management
Monitoring
Invasive monitoring is recommended in open procedures with
expected severe blood loss. Invasive monitoring involves the use of
a central venous line and an arterial line next to conventional
monitoring (capnography, ECG, pulse oxymeter, FiO2, tempera-
ture, and urine output) and precordial Doppler. The major goals of
invasive monitoring are timely recognition of serious problems thatpyright © 2015 Mutaz B. Habal, MD. Unautho
5 Mutaz B. Habal, MDmay occur in open craniosynostosis surgery, such as hypohydration,
hypotension, and electrolyte disturbances, as well as being able to
check effectiveness of treatment of these problems.
Positioning
Venous cerebral congestion by hyperflexion of rotation of the
head must be avoided.
Usually, the patient is placed in a moderate anti-Trendelenburg
position to reduce blood loss (cave air embolism, see below under
Complications). Notably, in children with exorbitism the eyes
should be well protected with eye cream, and pressure on the eyes
must be avoided (especially in prone position).
Single administration of an antibiotic, after the induction, before
start of surgery is standard procedure.76
Maintenance of Anesthesia
Most recommendations are aimed at a balanced technique that
provides for cardiovascular stability with the use of opioids and
volatile agents next to relaxants. The use of remifentanil infusion
(0.25–0.5mcg/kg/min) is recommended as well.77–79 If remifen-
tanil is used for maintenance of anesthesia is it recommended to
administer a bolus of morphine or piritramide before the end of the
procedure so as to start postoperative pain management.
Measurement/Compensation Blood Loss Intraoperatively
An additional problem is that measurement of the lost volume
intraoperatively is impeded by surgical technique and type of
patient. Few studies have been performed to optimize blood loss
measurement and findings are mostly not conclusive. Next to the
above-mentioned preoperative approaches to reduce blood loss and/
or to prevent allogeneic blood transfusion, several measures can be
taken peroperatively: Irizenfiltration of the skin with vasoconstrictors before the
incision is much used but its effectiveness is disputed because
of the greater degree of bleeding with treatment of the
periostium and bone. Controlled hypotension is rarely used because it has no clear
benefits and can be disadvantageous in case of ICP and also in
the anti-Trendelenburg position. The acute normovolemic hemodilution (ANH) technique is
used before the surgical intervention after the child is brought
under anesthesia. It involves removal of whole blood via the
arterial or central line which is replaced with colloids 1:1 or
with crystalloids 1:3 according to precise calculations and
formulas. Most healthy children tolerate a mild hemodilution
(Htc 25%–30%). According to a B study, this technique in
itself is not sufficient to reduce or avoid homologous blood
transfusion in this type of surgery.80 Perioperative (intra- and postoperative) blood ‘‘recollection’’ is
not routinely used in this type of surgery in view of the small
collected volumes, the sometimes acute blood loss, and its cost-
effectiveness. Fearon81 reported that 59 of 60 children needed a
transfusion, of which only 30% received an allogeneic
transfusion with the use of the cell-saver device. Duncan82
found no difference in allogeneic transfusion rate when a cell
saver was used and when not. With the development of small
reservoirs (50 ml) this method seems to be more promising and
in C studies it has been associated with a considerable reduction
of the homologous blood transfusion rate.
83 Intraoperative antifibrinolytics.
 Aprotinin: is no longer used after serious complications in
cardiac surgery. Tranexamic acidin: its use in itself is
controversial, but is has been applied in combination with
other methods.d reproduction of this article is prohibited.
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reduce bleeding and/or to prevent or reduce the use of homologous
blood has shown sufficient effects.80 A review by Di Rocco68
confirms this conclusion. The transfusion strategies are usually
based on intraoperative acceptation of Hb values approximately
7 g/dl (4mmol/l) and Ht <30.84
Guidelines for the application of blood products are in place in
every hospital as established by the local transfusion committees,
and in conformity with the CBO Guideline Blood transfusion
2004.85 The latter guideline does not contain specific recommen-
dations for very young children.
Complications
The best known complications are inherent to the surgical
technique and/or a result of massive blood transfusion. VCo
1746enous air embolism (VAE) and the subsequent cardiovas-
cular collapse can be prevented by a precise technique and by
rapid application of adequate monitoring (precordial Doppler,
capnography, echocardiography, transcutaneous O2–CO2
monitoring, esophageal stethoscope, and venous central
line). Although Faberowski86 reports an incidence of
82.6% shown with Doppler in a small series of craniosynos-
tosis patients with a mean 90% blood loss, Tobias87 describes
an incidence of 8% with the use of Doppler in strip
craniotomies. Meyer88 reports a 2.6% incidence in children
undergoing craniosynostosis surgery who were monitored
with end-tidal CO2 only. The hemodynamic consequences of
VAE are generally insubstantial, provided the patients are
well monitored and measures are taken upon signs of VAE. As a result a massive blood loss the patient may develop
relevant consumption coagulopathy and dilutional coagulo-
pathy characterized, in principle, by depletion of soluble
clotting factors.83 As cryoprecipitate is not available every-
where and fresh frozen plasma (FFP) has limited effectiveness
to compensate for fibrinogen deficiency, it is recommended at
C level to timely use fibrinogen concentrate based on
thromboelastography.89 Temperature monitoring is crucial
for the prevention and treatment of clotting disorders. Massive blood transfusion can result in development of
TRALI.90 Airway management in syndromic children (Apert, Crouzon/
Pfeiffer) is sometimes complicated by hypoplasia of the
midface and exophthalmos that may impede hood ventilation,
although direct laryngoscopy and intubation normally are
possible. The situation changes when these children undergo
a distraction osteotomy procedure and need to be intubated
acutely in case of respiratory insufficiency, or when the
distraction materials are being removed. Evidence from the C
level studies is conflicting on this issue. One of the 2 studies
recommends immediate fiberoptic intubation, whereas the
other study claims that the distractors exert minimal effect in
the anesthesiologic conditions when certain factors must be
taken into account (the right screwdrivers and cutting pliers
must always be available) and that removal of the vertical bar
allows for direct laryngoscopy.91 Roche92 describes problems
with intubation at the time when distractors are removed as a
result of trismus that had not yet occurred when the distractors
were placed. The possibility of cerebral salt wasting syndrome should be
considered when a patient develops hyponatremia after
craniosynostosis surgery.93 Then, a differential diagnosis with
syndrome of inappropriate antidiuretic hormone secretion
(SIADH) should be made right away as the treatment
modalities for these 2 are quite different.pyright © 2015 Mutaz B. Habal, MD. UnauthoCriteria for extubation at the end of the procedure, before
transport to the ICU, are the following: rapid recovery of spon-
taneous and stable breathing, hemodynamic stability, normother-
mia, short to medium operation time with relatively little blood loss,
and no continuous large blood loss through the surgical drains.
Postoperative Management
Pediatric Intensive Care Unit (PICU)
In principle all studies recommend ICU admission after open
craniosynostosis surgery to continue volume management there
and, if necessary, start artificial respiration.
Bleeding may continue in the postoperative period via the
drains, and the cardiovascular status next to Htc/Hb must be
monitored carefully. Most studies on postoperative transfusion
management report a tendency to overtransfusion.74,94
Pain Treatment
There is scarce literature on postoperative pain treatment after
craniosynostosis surgery. In Rotterdam 2 double blind, placebo-
controlled studies have investigated pain treatment in the first 24
hours after cranial correction for craniosynostosis.95,96 Specific
literature on pain treatment after facial surgery, such as Le Fort
III or monobloc, is completely lacking.
Van der Marel95 treated 20 children with oral paracetamol and
20 with rectal paracetamol. The pain scores in the oral group were
higher, but this effect disappeared with exclusion of the patients
who had vomited after oral administration. Despite the fact that
22.5% did not reach a 10 to 20mg/L plasma level, the pain score
exceeded 4 in fewer than 7.5%. Rectal administration of parace-
tamol was recommended.
Prins96 describes 12 children who received intravenous paraceta-
mol and 14 children who received rectal paracetamol. Effectiveness
was assessed with the VAS score and COMFORT-B score. A stat-
istically significant difference for the COMFORT-B score was found,
to the effect that it was more often higher in the rectal paracetamol
group. This is indicative of more discomfort, possibly caused by more
pain, and intravenous administration was recommended.
In the European literature, the use of paracetamol and NSAIDs is
recommended (if the blood loss is not significant) with or without
codeine phosphate (British literature).
The American literature places a focus on treatment with
morphine next to paracetamol and NSAIDs.
All textbooks emphasize, and this also appears from our own
practice, is that the pain scores are surprisingly low.
In extubated patients oversedation must always be avoided.
In patients operated on for nonsyndromic craniosynostosis,
invasive monitoring can usually be discontinued the following day.
ConclusionsLevel 1rized reIt has been demonstrated that postoperative pain in the first 24 hours
can be adequately treated with administration of paracetamol.A2 Van der Marel, 200195A2 Prins, 200896Level 2 A number of preoperative measures (erythropoietin plus Fe, blood
sampling for autologous transfusion) reduce both the blood loss
and the need of blood transfusion.B Helfaer, 199869A2 Fearon, 200272B Meneghini, 200373Level 3 It seems likely that craniofacial syndromes, pansynostosis, age
<18 months and duration of the operation are predictors of
massive blood loss.C Meyer, 199394B White 200967production of this article is prohibited.
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# 2015 MuNone of the perioperative strategies (skin infiltration, anti-
Trendelenburg position, hemodilution, and antifibrinolitics) to
reduce bleeding and/or to avoid or diminish the use of
homologous blood has shown satisfactory effects.B Hans, 200080C Di Rocco, 200468Level 3 Overtransfusion in the postoperative course does regularly occur.C Kearney, 198974C Meyer, 199394Considerations
Despite the proven effectiveness of erythropoietin and blood
drawing for autologous transfusion, the use of these strategies is
discouraged as they involve high costs and require repeated veni-
puncture, which is not child friendly.
Introduction of less invasive interventions is associated with less
blood loss. As these, however, are very young children with a smaller
circulating capacity, blood loss relatively is still significant. In
selected cases admission to a medium care unit could be considered
(defined as a monitored bed providing for artificial respiration).
Recommendations
The anesthesiologic goals in craniofacial surgery can only be
realized in specialized pediatric centers, where multidisciplinary
perioperative care is provided by a team composed of plastic
surgeon, neurosurgeon, maxillofacial surgeon, pediatrician,
pediatric anesthesiologist, pediatric intensivist, and specialized
pediatric nurses with experience and means to manage and monitor
this type of patients and where a sufficient number of children is
operated on to keep the experience of the team at a high level.
Administration of EPO preceding the intervention, as well
as collecting autologous blood for autotransfusion are advised
against.
Postoperatively a bed in a PICUmust be available. In less drastic
interventions medium care may perhaps suffice, although 1 should
be aware that these are mostly very young children with a smaller
circulating capacity, in whom even slight postoperative blood loss
must be monitored carefully.
Invasive monitoring is recommended in the case of open pro-
cedures with expected severe bleeding.
Overtransfusion in the postoperative phase should be prevented
by adhering to the guideline on transfusion management.
Extubation at the end of the operation, before transport to the
ICU, is possible in case of rapid recovery of spontaneous and stable
breathing, hemodynamic stability, normothermia, short to medium
operation time with relatively little blood loss, and no continuous
large blood loss through the surgical drains.
The analgesic of choice for postoperative pain treatment is
paracetamol. If this is not sufficient, an NSAID can be added even
though this could increase the risk of postoperative bleeding.
5. SURGICAL TREATMENT OF
NONSYNDROMIC CRANIOSYNOSTOSIS
Basic Questions1. What are the indications for surgery in the different types of
nonsyndromic craniosynostosis?2. What treatment is most indicated for the different types of
nonsyndromic craniosynostosis?3. At what developmental stage is surgical treatment preferably
performed?ght © 2015 Mutaz B. Habal, MD. Unautho
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Nonsyndromic craniosynostosis can present in varying severity
of the deformity of the skull. Surgical treatment seems indicated on
the basis of:1. trizhe associated risk of ICP (see also chapter on ICP)2. the prevention or restriction of associated neuropathology3. the morphologic abnormality (with both esthetic and psycho-
logic consequences)The variability in both the severity of the morphologic abnorm-
ality and in the occurrence of increased ICP may occasionally
result in less strict operative indication on the basis of these
parameters.
Many different surgical techniques have been described for the
treatment of nonsyndromic craniosynostosis but the functional
results of these techniques have not always been shown convin-
cingly. In addition, the timing of surgery is debated.
For patients with a synostosis of multiple cranial sutures in
whom a syndromic diagnosis cannot (yet) be made, the method of
treatment of syndromic craniosynostosis is recommended. This
chapter will place a focus on craniosynostosis of the sagittal suture
(scaphocephaly), metopic suture (trigonocephaly), unilateral cor-
onal suture (frontal plagiocephaly), and lambdoidal suture (pachy-
cephaly).
Summary of the Literature
Indications for Surgery
The indications for treatment of craniosynostosis are the risk of
ICP and the morphologic abnormality of the skull and face. As
mentioned in chapter 8, the risk of increased ICP in scaphocephaly
is 12%, in trigonocephaly 9%, and in plagiocephaly 10%. The
estimated risk in bilateral coronal suture synostosis is 37%.
The chapter on cognition and behavior provides evidence of
absence of a relation between cognitive functions in children with a
nonsyndromic craniosynostosis and surgical treatment or not,
severity of the deformity, or age at operation. The prevention or
treatment of the associated neuropathology is therefore no indica-
tion for surgery.
The morphology can vary from very mild to an evidently
abnormal skull shape.97
In sagittal suture synostosis, compensatory growth of the other
cranial sutures results in increasing deformity in the course of time,
so that, for example, the frontal bossing in scaphocephaly can
intensify after birth.98,99 Sagittal suture synostosis is characterized
by highly variable expression, however, ranging from a ridge over
the suture in combination with a slightly narrower skull to mid-
parietal saddle-like bone formation with severe frontal bossing and
a pointed and prominent back of the head.
Barritt100 evaluated a series of 44 children with scaphocephaly,
of whom 34 did not undergo surgery. This was common policy in
this clinic at the time for children presenting with this condition at
an age older than 6 months. In these 34 children, the deformity in
any patient did not seem to improve in the first 10 years. In 14
children, the cranial index (CI) decreased (69> 65), in 7 the CI
increased (64> 68) and in 7 it did not change.
The presentation of trigonocephaly also varies from very mild to
severe. Its mildest form is characterized only by a bony ridge as a
result of premature fusion of the metopic suture. In follow-up,
cosmetic worsening is only rarely seen. The other end of the
spectrum is characterized by a wedge-shaped forehead with hypo-
telorism and supraorbital retrusion on the basis of decreased growth
of the forehead widthwise.101ed reproduction of this article is prohibited.
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notably in facial asymmetry.102 In a study from Paris, 16% of the
children who were operated on after the first year of life developed
increased ICP (see chapter 8).103
Unilateral synostosis of a lambdoidal suture causes increasing
asymmetry of the back of the head and particularly also of the face.
Increased ICP does not seem to be prominent in this type of
synostosis, although reliable research on this issue is lacking
(see chapter 8).
2. Surgical Treatment of Nonsyndromic
Craniosynostosis
Since the first operative intervention for craniosynostosis, many
surgical techniques for the various types of craniosynostosis have
been described. A broad distinction is made between osteoclastic
techniques and remodeling techniques. In the first group bone is
removed, enabling the developing and expanding brain to change
the shape of the skull, in part because the adverse impulse to the
growth direction of the skull also is removed. From this technique
evolved the remodeling techniques, because it was suspected that
one cannot only rely on the self-correcting capability of the skull
and the brain. These techniques are aimed at directly achieving the
desired skull shape by a kind of reconstruction.
Randomized comparisons of the different surgical techniques
have never been performed. For the different types of nonsyndromic
craniosynostosis we will provide a review of the literature regarding
the different techniques in these 2 groups, but also pay attention to
the new developments in the past 10 years in a separate section.
2.1 Scaphocephaly
Strip Craniectomy
Ingraham104 described a technique using bilateral parasagittal
strip craniectomies, in which the fused suture was not resected.
To prevent the problem of premature reossification of the skull bones
he applied a layer of plastic to the bone rims. Successful treatment
required early intervention, however, preferably in the first 2 months
of life. The results of this technique were confirmed by other
authors.105–107 Anderson and Geiger105 attempted to prevent pre-
mature reossification with the use of chemical coagulation of the
dura, but failed to demonstrate the advantages of this technique.
Albright108 presented a sagittal strip craniectomy with biparietal
wedge osteotomies. The same procedure was performed by Mar-
ucci109 in 89 patients, but they noticed that 7 of the 89 patients later
developed a cosmetically unsatisfactory vertex bulge, which they
interpreted as a sign of possibly raised ICP or a new synostosis. Also
Florisson110 reported that some patients with scaphocephaly again
showed signs of raised ICP postoperatively.
A variant to this technique is wide resection of the sagittal suture
(4 cm) in combination with a bone-strip resection along the coronal
and lambdoid sutures, as described by Christophis.111 The average
CI improved from 66 to 76.
Amm112 presented a technique, in which the usual 2.5 to 3 cm
wide strip craniectomy of the sagittal suture, combined with lateral
strip osteotomies, is expanded with weakening with a burr of the
occipital bone, allowing the skull to hinge occipitally. They expli-
citly try tomake use of gravital force by keeping the infant strictly in
supine position during sleep for a period of 3 weeks. Using this
technique an average improvement of the CI of 8.1 (4.8–16) points
was achieved.
All in all, many of the described techniques represent only slight
modifications of previously presented techniques and not real
conceptual changes.
Postoperative infections are rare (0%).108 Duration of hospital-
ization ranges from 1 to 6 days postoperatively.108,111,112 Here, too,Copyright © 2015 Mutaz B. Habal, MD. Unautho
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rather than morbidity or impact of the operation.
Cranial Remodeling; the p Procedure Strips Are Resected
De p procedure is a technique in which strips are resected at
either side of the synostotic sagittal suture bone, while in addition a
bone strip is resected anteriorly to the coronal suture. The sagittal
suture itself is not resected, and the temporoparietal bone is bent
outwards. In this technique, the anteroposterior diameter of the skull
is dynamically shortened by attaching the bone strip in the middle of
the skull, which is shortened, to the frontal bone. Thus, it is in fact
also a compression technique, which might be associated with an
increase in ICP.
Gewalli113 with the use of a modified p procedure shortened the
anteroposterior diameter in 26 children by a mean of 16mm, and
concluded from neuropsychologic assessment that this had not
adversely affected mental development. Only a global development
quotient, however, was tested in very young patients, without
inclusion of a control group, which raises great doubt on the
reliability of this finding.
In older children or in children with a more pronounced dys-
morphology (notably frontal bossing), a more extensive calvarial
reconstruction is needed, with resection and reconstruction of the
frontobiparietal complex.114 Heller et al performed this intervention
in 24 children with mean age 23 months (range 3 to 96 months) and
thus achieved normal CI postoperatively in all children (mean 78
versus 68 preoperatively). The authors concluded that in this
population this more extensive procedure had no adverse effect
on postoperative growth rate of the skull or on intracranial
volume.114
New Developments
Lauritzen115 reported in 2008 on the first 100 operations in
which distraction was used to correct craniosynostosis. This method
is eminently suitable for scaphocephaly in view of the uni-
directional growth delay widthwise.
The results are not worse, but also not better than those of the
current techniques and the small numbers preclude valid compari-
son. Also regarding the newer surgical techniques, randomized or
comparative studies have not been published.
2.2 Trigonocephaly
Also in view of the complex three-dimensional dysmorphology
seen in metopic synostosis, treatment by suturectomy solely is
considered insufficient.116–120 In the past 30 years, therefore the
emphasis was on reconstruction of the entire forehead, including the
upper parts of the orbits.121 The question whether this should also
include specific correction of the hypotelorism is subject of debate.
Posnick122 analyzed the growth process on the basis of CT data in
10 patients and concluded that correction of the hypotelorism had
remained insufficient. Selber120 found that the use of interpositional
bone grafts in a series of 68 metopic children led to a decrease in the
development of temporal dents. In a population of 92 trigonoce-
phaly children in which no bone graft was used, Van der Meulen,101
however, observed an automatic growth correction of the hypote-
lorism on x-ray, on account of which the use of an interpositional
bone graft was judged to be unnecessary. From a photographic
evaluation of 45 patients, Hilling123 concluded that a satisfactory
esthetic outcome on the long term was largely dependent on a good
initial reconstruction.
2.3 Frontal Plagiocephaly
A distinction is made between unilateral and bilateral frontal
advancement techniques. Some surgeons prefer the unilateralrized reproduction of this article is prohibited.
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reference for the degree of advancement,124 whereas others main-
tain that adequate advancement with good symmetry is only
possible if the entire frontal bone and both orbital margins have
been dissected.121
New Developments
Barone and Jimenez125 report since the late 1990s on endoscopic
strip craniectomy of the affected suture. The benefits mainly lie in
low morbidity, short hospitalization, and little need of blood
transfusions in comparison with the classic fronto-orbital advance-
ment technique. The cosmetic outcome is reported as good, but it
not adequately quantified.
Stelnicki126 in the early years of this century started to use the
strip craniectomy technique, but concluded that after endoscopic
intervention often no full symmetry is reached and that the forehead
unilaterally is still receding 3 or 4mm. For this reason, the technique
was adapted to an endoscopic unilateral fronto-orbital advancement
technique. This was applied in 10 patients, who did not develop any
complications, did not need blood transfusions, and could be
discharged home after 2 days. The cosmetic outcome was assessed
to be similar to that of fronto-orbital advancement.126
2.4 Posterior Plagiocephaly
The number of publications on lambdoid suture synostosis is
very limited, probably because of the very low prevalence. Uni-
lateral lambdoid suture synostosis causes only relatively little
volumetric restriction. The morphologic changes consist of an
asymmetry of the face and an asymmetric basal occipital region.
New Techniques, Distraction
Kim127 reports a study comparing distraction versus remodeling
surgery. Among the patients were 3 children with brachycephaly
treated with the distraction method and 4 with remodeling. The
distraction method led to satisfactory calvarial expansion and an
esthetically pleasing outcome. Advantages of distraction are the
significantly shorter operation time, less bleeding, shorter stay at the
neonatal intensive care unit (NICU), and better skull shape. A
disadvantage of the distraction method is that children must have
reached the age of 6 months.128 Furthermore, a second operation is
needed to remove the distraction materials, there is a risk of
infection and dislocation of the material, and total hospitalization
is relatively long. The authors are of the opinion that these down-
sides do not outweigh the benefits of distraction.
3. Evaluation of the Outcome of Surgery
Most children with a craniosynostosis are operated on in the first
year of life. A direct evaluation of surgical outcomes is possible, but a
final evaluation is not possible until the child has fully grown at adult
age. As a surgeon’s career spans perhaps 25 year, and at most 30
years, the surgeon canonly at an advance career stage assess the result
of his or her ownwork. Yet he or she will be able to see the definitive
results of his/her predecessors. There may be a tendency to ascribe a
poor result to a wrongly performed surgical technique, without
questioning the technique itself. Furthermore, knowledge about
the natural course of the condition with and without surgical inter-
vention is usually lacking. This shortcoming undoubtedly is
coresponsible for the fact that we see regular shifts in type of
intervention in the course of decades and that paradigms change.
One and the same research groupmay recommend a certain approach
in the 1 decade and disassociate oneself from it in the next decade.129
Only few solid objective results with such a long follow-up are
available, whereas comparative studies of different surgical tech-
niques (with or without randomization) have not at all beenCopyright © 2015 Mutaz B. Habal, MD. Unautho
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because all craniosynostoses, including the syndromic types, are
pooled.
One way to assess the outcome of surgery is looking at the
operative morbidity and mortality. Most series are too small,
however, to yield significant data. Anyway, the mortality is very
low for all procedures, from 0% to 1%.129
Morbidity is reflected in the complications that may occur and
length of hospitalization. Although the first is a relatively objective
score, the second is certainly not. Length of hospitalization strongly
depends on the treating physicians, but also on the healthcare
system itself. To illustrate this, for similar procedures the average
length of hospitalization in North America is significantly shorter
than in Europe. The patients are simply discharged home earlier,
which possibly is enabled by a better outpatient care system.
Generally, hospitalization after minimally invasive interventions
is 1 or 2 days; for more complex interventions 2 to 7 days.129
As postoperative infections are very rare, only large series can
yield significant data. In series of 248 patients who underwent
surgery for unisutural craniosynostosis only 2 (0.4%) developed a
postoperative infection.129 In an older series of Whitaker the
infection rate was 3.7% in 164 patients; however, a distinction
between syndromic and nonsyndromic craniosynostosis was not
made.130 Still it seems that infections particularly occur in the
syndromic patients.
Severe complications, such as brain lesions, also occur spor-
adically: 0% to1%.129 In a series of 107 patients, Sloan131 found a
3.7% complications rate, almost all of which were mild, and in a
series of Whitaker the rate was 8%,130 but this was largely on
account of the syndromic craniosynostoses. In general, the com-
plications rates in the nonsyndromic craniosynostoses are signifi-
cantly lower than in the syndromic craniosynostoses, 3.5% and
39%, respectively, in the same series reported by Sloan.131 In
nonsyndromic multisutural craniosynostoses the rate is higher than
in monosutural craniosynostoses.131
The use ofmetal plates and screws has been customary in a certain
period. Meanwhile, it has become evident that application of this
material in young children may lead to intracranial translocation of
the plates and screws,with the screwends penetrating the dura.132–134
Risk factors for translocation seem to be longer plates, placement in
the temporal region, young age, and syndromic craniosynostosis.133
Hardly anything is known about the consequences of this compli-
cation. In the past few years, resorbable plates and screwdevices have
been applied for specific indications in craniosynostosis surgery. The
reported rate of complications is low: infection 8/1883 patients135 and
5/146 patients;136 delayed foreign-body reaction in 12/1883
patients,135 and postoperative resorbable device failure with loss
of bony position in 5/1883 patients.135
The outcome of surgery can also be expressed by need for
secondary revision surgery. This is rarely needed. Fearon129 reports
5 patients in 248 patients (2%) and Sloan131 reports a 7.2% rate of
unscheduled reoperations in 250 patients.
Scaphocephaly
Amm112 routinely uses three-dimensional surface analysis soft-
ware to analyze CT-scans. Computerized tomography scanning,
however, is a source of radiation exposure. Still it enables to assess
the outcome in a relatively reliable and objective manner, and this
yielded a mean 8.1 points improvement in CI.
Marucci109 noticed a cosmetically unsatisfactory vertex bulge
after minor surgery in 7 of 89 patients.
Trigonocephaly
At follow-up in the course of years after reconstruction of
trigonocephaly, the lateral sides of the forehead often appear torized reproduction of this article is prohibited.
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which however seldom are cosmetically unsatisfactory to the
degree that revision surgery is justified.101
Hilling123 evaluated the result of bifronto-orbital advancement
in trigonocephaly from photographs of the patients pre- and post-
operatively and after follow-up by a panel of independent assessors
with the aid of a scoring form. They concluded that the cosmetic
result generally was good to very good, but also that the severity of
the deformity does not influence the eventual outcome. In addition,
they established that the obtained result is stable during time and
independent of the age at operation (6 to 15 months). Temporal
depressions are ultimately the most frequent abnormalities at
follow-up and cosmetically usually only little unfavorable.
Van der Meulen101 performed standard x-rays of the skull before
and after operation and in the course of time and noted that although
in fronto-orbital advancement, the hypotelorism had not been
actively corrected, autocorrection still occurred during time.
Frontal Plagiocephaly
Assessment of the result of the various techniques applied in
frontal plagiocephaly is highly subjective. Objective outcome
measures are lacking and assessment therefore mainly consists
of an evaluation of the achieved facial symmetry. In a series of
19 patients with longer follow-up, Anderson established that the
result of identical procedures was highly variable, from moderate to
very good, but that these results still were considered ‘‘acceptable’’.
Two of those patients underwent corrective ophthalmological
surgery for strabismus as a result of a malformed orbit, whereas
a third patient had rejected the same proposed intervention.124
Although reasonably satisfied with the result, Anderson’s group
still converted to bifrontal advancement in this abnormality.
The earlier mentioned panel assessment of photographs by
Hilling123 in trigonocephaly, was also applied by the same research-
ers in 59 patients with frontal plagiocephaly.102 The conclusions are
more or less the same: the result is usually good, moreover stable
during time, irrespective of the initial situation and irrespective of
patient’s age at operation. Also in this deformity, the temporal
depression is the most striking finding at follow-up.102 This raises
the suspicion that occurrence of a temporal depression at the longer
term after bifronto-orbital advancement is not so much a con-
sequence of the primary condition but rather of the applied surgical
technique. Direct evidence for this supposition, however, is lacking.
For that matter, this research group also concludes that the fre-
quency of temporal depressions decreases with increasing experi-
ence of the surgeon.
Sloan131 established that in almost 45% of the patients with a
frontal plagiocephaly insufficient symmetry had been obtained after
correction and thus an unsatisfactory outcome with the necessity of
reoperation in 7% of patients.
Lo137 specifically assessed the orbital morphology (both of bone
and soft tissue) after surgical intervention and evaluated this by
means of CT-scans. They noted that the orbital morphology had
genuinely improved, but also that complete symmetry had not been
obtained. Furthermore, outgrowth, however, was normalized.
3. Timing of Surgery
The timing of surgery differs worldwide and is dependent,
among other things, on the surgical technique used.24 An important
factor is prevention of relapse. In patients with boat-shaped head, it
was observed that the initially improved CI index had slightly
decreased 1 year after correction, whereas in fronto-orbital
advancements, the frontolateral skull will again slightly recede
(a part reversal to the primary deformity). This in general does
not cause cosmetic problems, the more so because some surgeons inCopyright © 2015 Mutaz B. Habal, MD. Unautho
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until the age of 15 to 18 months for major, exclusively cosmetically
correcting interventions, particularly because this delay is believed
to lower the risk of relapse and thus the need of reoperation.
Thompson138 proposes that nonsyndromic craniosynostosis ideally
is corrected within the first year of life, with scaphocephaly as a
possible exception, corrected with early modified strip craniect-
omy.
The largest series is reported by Marchac,139 nearly 1000
patients with all types of craniosynostoses were operated on in
Paris. It is suggested to correct brachycephaly at the age of 2 to 4
months (often syndromic patients with raised ICP) and the other
conditions at the age of 6 to 12 months. The reason why is not
argued, however. Amm112 prefers correction of scaphocephaly at
the age of 6 to12 months, without clear argumentation.
Fearon, 140 evaluating 16 children with trigonocephaly,
established that the younger the child, the more spontaneous
improvement of the hypotelorism after surgery, even though the
hypotelorism itself was not surgically corrected. In 1996, they
concluded that surgery at the age of 3 months would be ideal
for good development of the orbits. Thirteen years later, however,
the same research group concludes that the younger the child,
the larger the growth inhibition of the skull after operative
intervention. Their timing then is 4 months for the scaphocephalic
child (to prevent progression of the frontal bossing) and 9 months
for monosutural craniosynostoses requiring advancement (so
that in any case the frontal band is strong enough, but the dural
capacity of bone regeneration also is still sufficient to close all
holes).129
Also for frontal plagiocephaly, there is no consensus on the
timing of surgery. Although minimal invasive surgical techniques
need to be performed at young age, ages of 6 months to from 15 to
18 months are recommended for major reconstruction. Here, too,
the most convincing argument for late surgery at the age of
18 months is a possibly lower chance of later relapse. Another
approach to prevent relapse is ‘‘overcorrection’’ in the primary
reconstruction, so that the final outcome after relapse still represents
a ‘‘normal’’ situation into which the child has grown.129 Several
surgeons opt for early correction, however, for example before the
age of 6 months, although this is not always motivated.124,140
4.7. ConclusionsLevel 2rized reIt seems likely that surgical intervention lowers the risk of
increased ICP and improves cosmesis.B Arnaud, 1995141B Mathijssen, 2006103B Renier, 1982142C Hilling, 2006a102C Hilling, 2006b123Level 2 It seems likely that there is increased risk of preoperatively
raised ICP if surgery is performed after the first year of lifeB Arnaud, 1995141B Mathijssen, 2006103B Renier, 1982142Level 3 It seems likely that in some mild types of craniosynostosis, such as
palpable bone ridge during the metopic suture without bitemporal
narrowing or partial synostosis of the sagittal suture, the natural
course is favorable to the extent that operation is not indicated.C Barritt, 1981100C Van Veelen-Vincent, 201097Level 3 It seems likely that the risk of relapse is somewhat larger after
a limited early intervention than after a late complete skull
remodeling.B Fearon, 2009129production of this article is prohibited.
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# 2015 MuIt seems likely that only resection of the synostotic suture
(strip craniectomy) provides unsatisfactory result.C Anderson, 1981116C Delashaw, 1986117C Friede 1990118C Aryan, 2005119C Selber, 2007120Level 3 It seems likely that there is no difference between the different
techniques (strip with helmet or springs, extended strip and
complete skull remodeling) with regard to the morphologic result
andCI. Probably there is a difference with regard to operation
time and blood loss.C Amm, 2005112C Barone, 1999125C Christophis, 2001111C Lauritzen, 2008115Level 3 It seems likely that an extended strip craniectomy does not always
create sufficient intracranial volume.C Florisson, 2010110C Marucci, 2008109Level 3 It is probably the case that the orbital deformity does not normalize
after resection of the synostotic suture only.C Aryan, 2005119C Selber, 2007120C Stelnicki, 2009126Level 3 It is probably the case that the use of metal plates and screw devices
in cranial remodeling in very young children leads to intracranial
migration.C Fearon, 1995132C Goldberg 1995133C Persing, 1996134Considerations
Although the risk of relapse seems to be somewhat increased
after an early limited intervention, the risk is probably small. This
should be weighed against the burden of a late complete cranial
remodeling with longer operation time and more bleeding. This
guideline therefore does not pronounce on a preference for early or
late surgery. Still, in view of the results of Renier regarding the
outcome of surgery after the first year of life, it is recommended to
perform the intervention in the first year of life.
The novel techniques, such as the endoscopic strip craniectomy
and the spring-assisted craniectomy, seem safe and effective. There
is some concern in the field about the use of the remodeling helmet
after endoscopic strip craniectomy. In patients with a NSOP
this helmet exerts a restrictive influence on skull growth. This is
notably an undesirable effect in craniosynostosis. It would be
prudent, therefore, to systematically monitor patients treated in
this way on restricted skull growth and signs of raised intracranial
pressure. Considering the findings from the study of Marucci,109
this holds true as much for patients treated with extended strip
craniectomy.
Recommendations
Surgical correction is in principle not indicated for mild types of
craniosynostosis, such as the metopic ridge and the partial synos-
tosis of the sagittal suture, with few morphologic abnormalities. In
all other types, operative correction of the deformity is indicated
both on functional and cosmetic grounds.
Cranial remodeling in nonsyndromic craniosynostosis should
take place in the first year of life.
Strip craniectomy for nonsyndromic craniosynostosis without
additional measures is advised against.
The choice between the other techniques for scaphocephaly (ie,
extended strip craniectomy, complete cranial remodeling, and stripght © 2015 Mutaz B. Habal, MD. Unautho
taz B. Habal, MDcraniectomy combined with helmet or springs) is based on age of
presentation and severity of the abnormality.
In case of orbital involvement, correction should include remo-
deling of the supraorbital margin (ie, trigonocephaly, frontal pla-
giocephaly, and brachycephaly).
The use of metal plates and screw devices in cranial remodeling
in very young children is strongly discouraged.
6. SURGICAL TREATMENT OF SYNDROMIC
CRANIOSYNOSTOSIS—THE CRANIAL VAULT
Basic Question
What type of cranial vault expansion is at what moment
indicated as first treatment of the various types of syndromic
craniosynostoses?
Introduction
Points of attention are the following:1. Irizn the different international centers either occipital expansion
or fronto-orbital advancement is performed as first cranial vault
expansion.2. Timing of the first cranial vault expansion may differ; it is often
performed by protocol when the child reaches a certain age, but
in some centers not until when signs of increased ICP are noted.
It is not clear whether this has any effect on functional results
and/or number of operations performed.3. The group of complex craniosynostoses (clinical suspicion of
syndromic craniosynostosis without proven genetic abnorm-
ality, often with multiple sutural synostosis) is managed in the
same way as the syndromic craniosynostoses, as these patients
often experience similar problems regarding cognition and
increased ICP.Summary of the Literature
Cranial Vault Expansion: Frontal or Occipital?
In the mid-1990s, a number of articles were published reporting
the experiences of various large centers, in which in particular the
frontal cranial vault expansion was propagated.- From Paris, it was reported that in syndromic patients with
brachycephaly a fronto-orbital intervention was performed at the
age of 2 to 4 months in which the forehead together with the
supraorbital margin was dissected and only basically was
reattached (‘‘floating forehead’’) to obtain a larger cranial
volume. At later referral, a more extensive fronto-orbital
advancement was performed (using tongue in groove).139- McCarthy et al described a comparable procedure in a group of
76 patients with a craniofacial syndrome. All underwent a
primary fronto-orbital advancement within 18 months (mean
6.1).143 In 28 patients a second procedure proved necessary
(mean 28 months) and in 5 third procedure. The authors propose
fronto-orbital advancement by protocol at the age of 6 to
9 months.In a retrospective review of 167 patients with a syndromic
craniosynostosis, De Jong54 describes that a second intracranial
intervention was needed in 14% with Apert syndrome, 22% with
Crouzon/Pfeiffer, 5% with Muenke, and 15%with Saethre-Chotzen
syndrome. In more than half of these patients the indication was
increased ICP. In 1 patient a third cranial vault expansion was
performed.ed reproduction of this article is prohibited.
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another option for patients with Apert of Crouzon/Pfeiffer syn-
drome: occipital cranial vault expansion. The benefits of a primary
frontal expansion for a young child were considered too short
lasting; it would have only a minimal effect on the remainder of
the facial deformity and a next intervention for a facial correction
(Le Fort III, monobloc or facial bipartition) would therefore be
unnecessarily compromised.138,144
As a result of a consensus meeting, Bruce22 proposed to post-
pone surgery of the midface in patients with the Apert and Crouzon/
Pfeiffer syndromes as long as possible, with posterior decompres-
sion as first option.
From Birmingham a similar plea was made, also for patients
with other diagnoses than Apert and Crouzon/Pfeiffer syndromes
who develop no or only mild midface hypoplasia: on signs of
increased ICP is increased, a posterior decompression should be
performed first, allowing for an anterior intervention to be post-
poned (and sometimes declared to be even unnecessary even-
tually).145 Furthermore, later timing of the frontal procedure
would often remove the need of a frontal reoperation. Exception:
severe exorbitism posing a threat to vision, for which fronto-orbital
advancement should indeed be the first procedure.
In 2000 also Paris appears to have converted from frontal to
occipital approach of faciocraniosynostosis (Apert and Crouzon/
Pfeiffer syndromes). The classic management includes initial
anterior skull remodeling and facial advancement as a second step.
Since evolution of these complex faciocraniosynostoses results in
turricephalic aspect or recurrences more often than nonsydromic
craniosynostosis, another approach can be used, consisting in an
initial posterior vault expansion.121 Fronto-orbital advancement is
recommended, however, for the syndromic craniosynostosis in
which retrusion of the orbital bar is the main feature (Saethre-
Chotzen and Muenke syndromes).
Honnebier146 reports that nearly half of the patients with
Muenke syndrome required a second fronto-orbital correction to
correct retrusion of the supraorbital margin following an initial
fronto-orbital advancement at the age of 6 to 9 months. Vir-
tually100% will require an extracranial intervention to correct
the temporal impressions. The authors do not provide a recom-
mendation to adjust the timing of the initial intracranial intervention
to this result.
The Rotterdam craniofacial team recommends occipital remodel-
ing between 6 and 9 months for Apert and Crouzon/Pfeiffer syn-
dromes except for patientswith severeOSAS or severe exorbitism, in
whom a monobloc with distraction is performed. Fronto-orbital
advancement is recommended for the Muenke and Saethre-Chotzen
syndromes, at 9 to 12 months for Muenke syndrome and at 6 to 12
months for Saethre-Chotzen syndrome. The difference in timing is
based on the low risk of increased ICP in Muenke syndrome.54
The team from Dallas provides arguments for parietal widening
at very young age (8 to 16 weeks) in severe presentation of the
Pfeiffer syndrome.147 They renounce frontal correction because the
bone is too soft for a fronto-orbital advancement. Occipital correc-
tion is not performed because they prefer to combine this with
expansion of the foramen magnum in case of a symptomatic Chiari.
For the milder types, they perform fronto-orbital advancement at
the age of 9 to 15 months. As it is clear from the literature that a
Chiari in Crouzon/Pfeiffer is often asymptomatic, solid underpin-
ning of this reasoning seems to be lacking. Their strategy seems to
be based on setting a low threshold for placement of a tracheostoma
and not considering a monobloc procedure until the age of 3 or
4 years in such a situation.
In summary: now in 2009 posterior decompression is usually
considered the first choice for children with Apert or Crouzon/
Pfeiffer syndrome. Jeevan148 in 2008 issued a warning relating toCopyright © 2015 Mutaz B. Habal, MD. Unautho
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Fronto-orbital advancement is recommended for the syndromic
types without midface hypoplasia.
In 2007,144 Arnaud by means of a series of 36 children intro-
duced ‘‘frontofacial monobloc with distraction’’ into the debate:
this intervention may be essential in a very young child already
demonstrating serious exorbitism and/or severe upper airway insuf-
ficiency, as it is associated with considerably lower morbidity and
mortality than the ‘‘classic monobloc’’ as described by Marchac in
1996. Serious complications in 36 monoblocs with distraction were
death by acute tonsillar herniation postoperatively in 1 patient and
septic osteonecrosis of the frontal bone in 1 patient. Earlier oper-
ations preceding the monobloc increased the morbidity.144
Kamoshima149 describes the results of this intervention in 3
children as follows: ‘‘excellent functional and cosmetic outcome,
with no remarkable complication.’’ Fitzgerald O’Conner described
10 syndromic craniosynostosis patients who underwent monobloc
distraction.150 The CT scans (pre- and postsurgery) demonstrated
adequate advancement of the bony orbits, including forward
advancement of the eyeball.Timing: Standard or Not Until Signs of
Increased ICP?
Parisian studies on mental development in syndromic cranio-
synostosis patients report higher IQ in patients operated on in the
first year of life. This was found for patients with Apert syn-
drome,121 Crouzon syndrome,121 and Muenke syndrome with
bicoronal synostosis,151 but not for patients with Muenke syndrome
with a unilateral coronal suture synostosis (see chapter 16).103 On
the other hand, unilateral coronal suture synostosis (nonsyndromic
and Muenke syndrome) was associated with higher risk of raised
ICP in children operated on after the age of 12 months.
From analysis of the treatment protocols of the craniofacial
centers participating in the International Society for Craniofacial
Surgery it appeared there was consensus to perform the initial
cranial vault expansion within the first year of life.24
The London team is the only 1 with a different approach. They
screened patients with Apert or Crouzon/Pfeiffer syndrome with the
use of VEPs (visual evoked potentials) at ages 3, 6, 9, 12, and 18
months and next at ages 3, 4, 6, and 10 years. Cranial modeling is
performed as soon as the VEPs show signs of delays in optic nerve
conduction.Of the 24 apert patients treated according to this protocol,
20 developed increased ICP.152 The youngest patient showing
increased ICP was 1 month old and the eldest 4 years and 5 months.
Metal plates and screw devices have been commonly used during
a certain period. Later it became evident that application of this
material in young children may lead to intracranial translocation of
the plates and screws,with the screwends penetrating the dura.132–134
Risk factors for translocation seem to be longer plates, placement in
the temporal region, young age, and syndromic craniosynostosis.133
Hardly anything is known about the consequences of this compli-
cation. In the past few years resorbable plates and screw devices have
been applied for specific indications in craniosynostosis surgery. The
reported rate of complications is low: infection 8/1883 patients135 and
5/146 patients,136 delayed foreign-body reaction in 12/1883
patients,135 and postoperative resorbable device failure with loss
of bony position in 5/1883 patients.135
ConclusionsLevel 3rizedIt seems likely that posterior decompression is the first choice
of cranial vault expansion in the Apert and Crouzon/Pfeiffer
syndromes because this results in fewer risks associated with
a monobloc or Le Fort III procedure carried out at a later stages. reproduction of this article is prohibited.
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# 2015In the Saethre-Chotzen and Muenke syndromes a fronto-orbital
advancement is the first choice of cranial vault expansion because this
will normalize the profile, upon which a monobloc or Le Fort III
procedure is hardly ever indicated.C Thompson, 1994138C Bruce, 199622C Sgouros, 1996145C Renier, 2000121C Arnaud, 2007144C Honnebier, 2008146C De Jong, 200954Level 3 It seems likely that a monobloc-advancement is an adequate
treatment of severe exorbitism and/or severeOSAS.C Arnaud, 2007144C Fitzgerald O’Connor, 2009150Level 3 It seems likely that patients with a syndromic craniosynostosis in
whom the cranial vault expansion is performed within the first year
of life have better mental outcome.B Arnaud, 2002151C Renier, 2000121C Mathijssen, 200724Level 3 It is probably the case that the use of metal plates and screw devices
in cranial remodeling in very young children leads to intracranial
migration.C Fearon, 1995132C Goldberg 1995133C Persing, 1996134Considerations
It is believed that occipital cranial vault expansion results in
a larger intracranial volume than does a fronto-orbital advance-
ment. Leaving the fronto-orbital region untouched in the first
operation leads to lower risk of complications of a monobloc
procedure performed at a later stage. Furthermore, by emphasiz-
ing the midface hypoplasia, a fronto-orbital advancement in
Apert or Crouzon/Pfeiffer syndrome reinforces the facial dysba-
lance.
The question arises whether intensive ophthalmologic
screening for increased ICP as well as the practice of performing
cranial vault expansion not until results are abnormal should be
protocolized. The high frequency of hospital visits and tests
places a burden on patients, parents, and the members of the
craniofacial team. In addition, there is a risk of false-negative
VEP results, which does not seem to outweigh the lower number
of patients who will not be operated on for the indication of
increased ICP.
Recommendations
The initial cranial vault expansion in Apert or Crouzon/Pfeiffer
syndrome is an occipital expansion; in Saethre-Chotzen or Muenke
syndrome a fronto-orbital advancement.
If the patient also shows exorbitism with a threat to vision and/or
severe OSAS, a monobloc-advancement with distraction should be
considered as initial intervention (see chapters 7 and 12).
The initial cranial vault expansion in syndromic craniosynos-
tosis is performed within the first year of life.
In patients with Apert, Crouzon/Pfeiffer, or Saethre-Chotzen
syndrome it is recommended to perform the operation approxi-
mately at the age of 6 to 9 months, or earlier on evidence of
increased ICP.
In patients with Muenke syndrome is recommended to perform
the operation between the ages of 9 and 12 months.
The use of metal plates and screw devices in very young children
is strongly discouraged.right © 2015 Mutaz B. Habal, MD. Unautho
Mutaz B. Habal, MD7. SURGICAL TREATMENT OF SYNDROMIC
CRANIOSYNOSTOSIS—THE FACE
Basic Questions1. Wrizhat treatment is most indicated for maxillary hypoplasia
(sagittal, vertical and transversal), including exorbitism?2. At what developmental stage is this treatment preferably
performed?3. At what moment and in which way should associated
hypertelorism be treated?The focus of this document is on maxillary hypoplasia in
syndromic craniosynostosis patients; the exorbitism is a con-
sequence of this hypoplasia and is therefore not separately inves-
tigated. Furthermore, (correction of) hypertelorism is evaluated as
part of the monobloc operation.
Introduction
The Apert, Crouzon, and Pfeiffer syndromes are associated with
hypoplasia of the maxilla, exorbitism, and hypertelorism. Indica-
tions for correction vary from acute vision impairment or respir-
atory problems to a relatively esthetic/psychologic problem.
Various techniques are available to correct these deformities,
and their timing greatly influences the eventual outcome.
Summary Literature
Syndromic craniosynostosis can be associated with skeletal
hypoplasia of the midface, notably in the Apert and Crouzon/
Pfeiffer syndromes. This benign hypoplasia can be present in 3
dimensions (sagittal, vertical, and transversal) and may result in
restricted airway at the level of the nasopharynx (possible resulting
in OSAS); exorbitism; malocclusion; and esthetic/psychosocial
problems.
Although aspects of OSAS will be discussed in the ‘‘Aftercare’’
section of this guideline, the next section deals with the choice of
surgical technique to correct the hypoplastic midface as well as the
timing of surgery.
Corrections of the sagittal and vertical dimensions are discussed
first, followed by those of the transversal dimensions.
Sagittal-Vertical
Timing of the Surgical Correction and (Postoperative) Growth
As investigated by Posnick in 1997, the face grows in 2 distinct
periods. Craniofacial growth in the first 6 or 7 years is determined
by growth of the brain, eyes, and the nasal cartilages.153 The second
period starts after the seventh year, in which growth consists of bony
surface apposition and deposition, development of the processus
alveolaris and enlargement of the nasal cavities and paranasal
sinuses. Analysis of CT-scans of nonsyndromic healthy patients
shows that growth of the orbits and the nasal bone is largest between
the third and fourth years, so that at the age of 5 years already 93%
of the eventual dimensions is reached. This observation is likely to
be important for the timing of corrective surgery. Although some
authors suggest that further growth could be restricted by surgery,
others report (very) slow unchanged growth after surgery in syn-
dromic craniosynostosis patients (see below).
Bachmayer (1986)154 determined growth of the midface in 19
surgically treated syndromic craniosynostosis patients (Apert,
Crouzon, and Pfeiffer syndrome) aged from 6 to 15 years. Post-
operative growth of the maxilla in sagittal direction was less thaned reproduction of this article is prohibited.
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was 1.3mm per year and thus comparable with the growth in a
healthy control group and schisis patients. Meazzini155 concluded
that the sagittal growth in untreated syndromic craniosynostosis
patients was negligible, and if minimally present would not be
adversely influenced by an operation. Kreiborg analyzed 8 patients
with Crouzon or Apert syndrome on preoperative growth, stability
of the Le Fort III osteotomy, and postoperative growth.156 Some
vertical growth was supposed to occur, irrespective of surgical
intervention, and as a result of remodeling and appositional growth
rather than sutural growth. During 10 years’ follow-up (after Le Fort
III osteotomy), no vertical or sagittal growth of the maxilla was
observable.
Fearon157 compared postoperative growth of the midface after
conventional osteotomy (N¼ 10) with that after a distraction
operation (N¼ 12). Neither group showed postoperative horizontal
and vertical growth. Fearon states that the disturbed maxillary
growth in the syndromic craniosynostosis patients is intrinsically
associated with the syndrome, and that this would not so much be
the effect of an operation.
Correction of the Hypoplastic Midface: the Le Fort III
Osteotomy
In syndromic craniosynostosis patients, notably those with
Crouzon/Pfeiffer syndrome or Apert syndrome, the hypoplasia of
the midface consists of a hypoplasia of the maxilla, nasal bone, and
zygomatic bone bilaterally including the bony orbits. The choice of
treatment is primarily aimed at correction of these underdeveloped
anatomic structures. The Le Fort III osteotomy, as originally
described by Gillies and Harrison in 1950158 but further developed
by Tessier in 1967159 (including the variations Tessier described for
the lateral orbital margin) is designed to correct all these elements
by a single forward advancement. Usually by means of an approach
from cranial, the entire midface (including the maxilla, nose bone,
and caudal part of the bony orbits bilaterally) is wholly detached
from the skull base and moved forward. Hollier160 described for the
Le Fort III osteotomy a minimally invasive approach via local
incisions (intraorally, upper, and lower eyelid).
Furthermore, a few publications are available on monobloc
distractions (frontal bone including the Le Fort III part) in young
patients, in whom osteotomy is not performed at all. 161,162 After
surgical placement of the bone-borne distraction device, distraction
is started. Liu et al163 described 4 patients (aged between 6 and
12 years) in whom a Le Fort III ‘‘sutural’’ distraction was performed
(distraction without osteotomy), resulting in a mean 8mm advance-
ment. Pellerin et al reported on 4 syndromic craniosynostosis
patients (all younger than 24 months) in whom midface advance-
ment was obtained by means of a transfacial pin (K-wire) through
both zygomatic bones connected percutaneously with an internal
temporally fixed distractor bilaterally.161 All distractions are
reported to have been successful.
Variants of the Le Fort III Osteotomy
In 1969, Obwegeser164 presented several variants, including the
combination of a Le Fort III and Le Fort I osteotomy in conjunction,
and the ‘‘butterfly’’ (Le Fort III osteotomywithout the nasal bone). In
2006, these osteotomic variants were again described by Kobus,165
although with application of external frame distraction. Ueki et al
(2005)166 reported on a Crouzon patient (15 year of age) in whom
distraction with external frame of the midface and surgically assisted
rapid maxillary expansion (SARME) was performed in conjunction.
The osteotomy of the midface can be performed according to the
design of Kuffner, a ‘‘high’’ Le Fort I up to and including the
infraorbital margin and up to the zygomatic arc bilaterally.Copyright © 2015 Mutaz B. Habal, MD. Unautho
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Orthognatic Surgery
The Le Fort III procedure is primarily aimed at correction of the
hypoplasia of the nasal bone, orbits, and zygomatic bones. The
occlusion is of secondary importance here. Also because open
bite is frequently present, additional orthognatic surgery to correct
the malocclusion is often required. This is naturally preceded by a
thorough (cephalometric) analysis in consultation with the ortho-
dontist (including orthodontic treatment) (see this section of the
guideline). It is recommended to plan the surgical intervention
aimed at correction of the malocclusion after age 18 years in all
patients. If a Le Fort III osteotomy after age 18 years is indicated
(and the distance to be bridged is limited), this can be combined
with a Le Fort I osteotomy.
Additional Periorbital Surgery
Patients with syndromic craniosynostosis (notably those with
Apert syndrome) often show down slanting of the palpabral fissures
(in which the lateral portion of the eye slit is lower than the medial
portion), which results in a characteristic syndromic appearance.
Several operative techniques are available to move the position of
the lateral canthus to cranial, thus normalizing the down slanting.167
These procedures can be performed at the time of the distraction, at
the time of possible orthognatic surgery, or separately. Occasion-
ally, patients are satisfied with their facial appearance, or this
surgical step is not at all indicated, and then further cosmetic
interventions to the face are withheld.
The ventral movement of the midface, including the peri-orbital
bony margin, is aimed at correction of the exorbitism, among other
things. Nevertheless, after correction of the periorbital bony
skeleton a soft tissue shortage of the lower eyelid may persist.
Although all kinds of methods have been applied, such as local skin
flaps, free skin transplants, and commercially available fillers, the
Coleman lipofilling technique is increasingly used.168,169 After
harvesting fat in places where this is abundantly available (such
as abdomen, trochanter, and knee) the fat is centrifuged and next
injected in the lower eyelid. It may be necessary to repeat this
procedure several times to eventually obtain a good result.
Conventional Osteotomy or Distraction?
Application of distraction in the Le Fort III advancement is
repeatedly underpinned with the argument that it allows for moving
the hypoplastic midface over a larger distance to ventral (and
possibly also to caudal) than with conventional osteotomy. This
would lower the chance of needing a second intervention at later age
after a first intervention during the child’s growth phase. Further-
more, distraction could prevent a number of disadvantages of
conventional osteotomy, such as intermaxillary fixation and the
additional harvesting of autologous bone transplants with risk of
comorbidity.
Tables 6 and 7 present data of the Le Fort III osteotomy and
distraction, respectively, including numbers of patients, distance
achieved, age at time of operation, and relapse (if mentioned in the
publication).
Fearon157 retrospectively analyzed 22 syndromic craniosynos-
tosis patients who had undergone a Le Fort III advancement. Of
these 22 patients (mean age 7.5 years), 10 had undergone conven-
tional osteotomy and 12 distraction (2 with internal distractors and
10 with an external frame). The average advancement achieved in
the osteotomy group for point A was 5.1mm and for Nasion
7.7mm; in the distraction group for point A 16.0mm and for
Nasion 7.0mm. Asymmetry was observed with the use of internal
distractors but not with the use of an external frame. The 2 groups
did not differ with regard to operation time, need of transfusions,rized reproduction of this article is prohibited.
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TABLE 6. Conventional Le Fort III Osteotomy
N Advancement Mean Age Long Term
Ousterhout199 21 8.6 17 f/u 5 Stable
Kaban197 2 10 9.8 Stable
Bachmayer196 9 12.4 7.1 Relapse 9.4% horizontal
5.5% vertic.
Kreiborg156 8 10.9 10 Stable
David188 32 Horizontal 7.6 16.6 Relapse?
Vertical 8.0
McCarthy198 12 10 5.1 Stable
Fearon157 10 6 Stable
Meazzini155 17 6–14 7.3 Stable
Phillips171 14 14.1 6.6 Stable
The Journal of Craniofacial Surgery  Volume 26, Number 6, September 2015 Diagnoses of Craniosynostosislength of hospitalization (including ICU stay), and general com-
plications. Fearon157 recommends distraction as it allows for brid-
ging a larger distance.
Iannetti et al170 reported on 15 syndromic craniosynostosis
patients, in 5 of whom Le Fort III osteotomy achieved an average
8.6mm advancement and in 10 of whom Le Fort III distraction with
internal distractors achieved a distance of 13.9mm. Long-term
results are not reported. Technical problems with the distractors
are not mentioned. The authors recommend the conventional Le
Fort III osteotomy if the distance to be bridged is less than 10mm.
Meazzini et al155 retrospectively analyzed the results of Le Fort
III osteotomy in 17 syndromic craniosynostosis patients. Surgery
was performed at a mean age of 7.3 years. Stability was assessed by
means of cephalometry and judged as good with relapse to 3mm
after advancement of 6 to 14mm (average advancement was not
mentioned).
Phillips et al171 compared the results of their Le Fort III
osteotomies in 14 syndromic craniosynostosis patients (mean age
6.6 years) with those in the literature for Le Fort III distraction
techniques. Conventional Le Fort III osteotomy obtained a mean
advancement of 14.1mm at a mean 33 months’ follow-up.
Le Fort III Distraction: Internal or External Distractors, or
Combination?
Distraction of the detached midface (using Le Fort III osteot-
omy) can be performed with 2 types of distractors: internal and
internal distractors. A combination of internal (push) and internal
(pull) distractors has been reported as well.Copyright © 2015 Mutaz B. Habal, MD. Unautho
TABLE 7. Le Fort III Distraction
N Advancement Mean Age
Chin173 9 20 8.2
Satoh174 20 14–20 9.6
Meling175 7 23 11
Holems176 7 18 11
Gosain177 7 15 7
Kubler179 6 16 6
Cedars178 14 18 4–12
Fearon181 41 18 8
Shetye182 15 16 5.9
Mu184 8 9 not mentioned
Malagon185 5 10 8
Lima186 11 10 9
# 2015 Mutaz B. Habal, MD1. Iriznternal distractors. The internal distractors are placed
subcutaneously in the temporal region with the ‘‘push section’’
at the site of the lateral orbital margin/zygoma part and at the
site of the temporal cranial bone. The rod is either distracted
transcutaneously in dorsal direction above the ear or via the
cheek in ventral direction. Among others, Molina has
contributed to the development of these internal distractors.2. External distractors. The external distractor consists of an
externally placed external frame that is attached to with 6 to 8
pins to cranial vault bone. The detached midface is fastened to
the frame with the use of a ‘‘tooth-borne’’ device and/or ‘‘bone-
borne’’ microplates. Polley and Figueroa172 in 1997 introduced
an external frame, the ‘‘rigid external distraction’’ (RED)
device. Subsequently variations of the RED-frame have become
available.3. Combination van internal and external distractors (push–pull).
This method is called the push–pull method and makes use of
both types of distractors. After the Le Fort III osteotomy
internal and internal distractors are placed. An optimal vector is
aimed for with the external distractor, and after having reached
the intended position it can be removed. The internal distractor
stabilizes the advanced midface and the external frame can be
removed earlier after active distraction is stopped. This method
would allow for more symmetrical advancement of the
zygomatic arches, better advancement of the face on both
occlusal and orbital level, and lastly for better advancement of
the central part of the midface.Re: Le Fort III Distraction With Internal Distractors1. Chin and Toth
173 described 9 patients (mean age 8.2 years; 8
syndromic craniosynostosis and one with schisis) who under-
went Le Fort III internal distraction. The internal distractors are
distracted ventrally via the cheeks bilaterally. The mean
midface advancement reached was 20 mm.
174
2. Satoh et al described 20 syndromic craniosynostosis patients
with mean age at surgery 9.6 years. A 14 to 20 mm distraction
length was obtained. In 14 patients, a zygoma–zygoma internal
distractor was used and in 6 patients zygoma-skull device. In
the latter method (6 patients), the distractor is attached dorsally
to the skull and the distraction rod is distracted percutaneously.
In 3 of the 6 patients it was observed, however, that the
convergent vector of the internal distractors exerted great strain
on the zygomatico-maxillary suture, resulting in the Le Fort II
portion being left behind. In these patients, conversion toed reproduction of this article is prohibited.
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17distraction with an external frame was necessary. Subsequently,
the authors used a type of internal distractors that are distracted
ventrally at the zygomatic arches and are placed in parallel with
the use of a perioperatively applied reference rod. The authors
prefer this type (zygoma-zygoma) of internal distractor. Slight
asymmetry was noticed in 2/14 patients.
175
3. Meling described 7 patients with mean age 11 years in whom
a mean distraction length of 23 mm was obtained, with in 1 case
problems related to the internal distractor, and in 1 case
deviation of the nose. All other cases were judged successfully.
Data on stability and/or vector were not described.
176
4. Holmes described 7 consecutive syndromic craniosynostosis
patients who underwent a Le Fort III osteotomy with internal
distraction (mean linear distraction 18.1 mm, mean age 11
years). In 1 case a mechanical problem related to the internal
distractor was observed. The authors report less advancement of
the midface (Le Fort II complex) with the use of internal
distractors. The bony zygomatico-maxillary junction in young
patients is often too thin to transmit the vector 1 to 1. The
authors have changed their policy; in the future they will apply
he push–pull method.Gosain177 described 7 syndromic craniosynostosis patients
(mean age 7 years, mean distraction 14.8mm) in whom the Le
Fort distraction with internal distractors was performed. In 5 cases a
fracture occurred and/or weak zygomatico-maxillary junction and
in 2 cases the internal distractors were replaced with an external
frame.
Cedars178 described 14 patients (13 syndromic craniosynostosis
patients and one with schisis) who underwent Le Fort III distraction
(internal). The mean distraction length obtained was 18mm as
determined by counting the number of rotations during the active
distraction. In 1 patient the distraction caused asymmetry of the
face; in 2 patients infection developed of the skin around the
insertion site of the internal distractor, which resolved after removal
of the internal distractor.
Re: Le Fort III Distraction With External Distractors (External
Frame)1. Fearon
157 retrospectively analyzed 22 syndromic craniosynos-
tosis patients who had undergone a Le Fort III advancement. Of
these 22 patients (mean age 7.5 years), 10 had undergone
conventional osteotomy and 12 distraction (2 with internal
distractors and 10 with an external frame). The average
advancement achieved in the osteotomy group for point A was
5.1 mm and for Nasion 7.7 mm; in the distraction group for
point A 16.0 mm and for Nasion 7.0 mm. Asymmetry was
observed with the use of internal distractors. This was not the
case for the patients who underwent external distraction.
179
2. Kubler described in 6 patients (mean age: 6 years) fronto-
orbital advancement by means of an osteotomy in combination
with a Le Fort III distraction with external frame, with good
results. The mean advancement of the Le Fort III portion was
15.8 mm.
180
3. Mavili described Le Fort III distraction with external frame
in 4 syndromic craniosynostosis patients (age range: 5.2–12
years). The frame was fixed with an intraoral splint and with 2
infraorbital steel wires. In all patients the distraction was
successful. There were no problems with the external frame.
Information is lacking about the distance obtained as well as
stability.
181
4. Fearon analyzed Le Fort III advancement in 51 syndromic
craniosynostosis patients (mean age 8 years), 41 of whomopyright © 2015 Mutaz B. Habal, MD. Unauthoriz
56underwent distraction with external frame. In the distraction
group the mean obtained advancement was 18 mm. Cephalo-
metric assessment after 1 year did not show any relapse.
Furthermore, there was no growth of the maxilla after the Le Fort
III operation. Problems with the external frame were not reported.
The auteurs pose that the lack of growth is rather related to the
syndrome and not so much a consequence of the operation.
182
5. Shetye analyzed 15 syndromic craniosynostosis patients who
underwent internal distraction with the Rigid External
Distraction (RED) device. Fixation of the frame was by means
of an occlusal splint and bone anchors at the site of the
zygomatic arch and the maxilla. Point A had advanced 15.9 mm
sagittally along the x-axis and moved downward 1.1 mm along
the y-axis. These results were stable at cephalometric
assessment after 1 year. Five patients developed a skin infection
at the insertion site of the external pin, which in all patients
could be managed successfully. In 2 patients there was
traumatic dislocation of the frame. In 1 patient the external
frame had to be repositioned under general anesthesia.
183
6. Nout analyzed 21 patients undergoing a Le Fort I and III
external distraction. Most of the problems encountered were
related to the external pin: loosening of the pin, infection of the
skin around the pin, and in 3 patients there was traumatic
dislocation of the frame, albeit without any effect on the final
outcome.
184
7. Mu analyzed Le Fort III internal distraction (RED II device)
in 8 syndromic craniosynostosis patients. In all patients the
distraction, at mean 9 mm anteriorly and 1.5 mm caudally, was
successful; in 1 patient a skin infection at the insertion site of
the external pin was seen; in 1 patient a seroma. This
publication is in the Chinese language, only the information in
the English-language abstract is reported here. Malagon185
described 5 syndromic craniosynostosis patients (mean age at
operation 8 year) in whom a Le Fort III with halo frame was
performed. The maxilla was advanced over 10 mm. Problems
with the frame are not reported. In all patients the distraction
was successful.
186
8. Lima described 11 syndromic craniosynostosis patients (mean
age at operation 9 years) who underwent Le Fort III distraction
with RED device. The mean obtained length was 10.3 mm
horizontally and 2.4 mm vertically. Cephalometric assessment
after 1 year showed less than 1 mm relapse in horizontal direction.
Vertical face growth after 1 year was 2.9 mm.Push–Pull Method
Schulten187 described 10 syndromic craniosynostosis patients
(mean age 11 years), in whom the central midface using Le Fort III
with push–pull distraction was advanced a mean of 12mm. After
the distraction period all devices were removed under anesthesia. It
is not reported how the advanced segment was fixed during the
consolidation phase. Push–pull distraction permits equal movement
at both the upper and lower facial levels, advancement of the central
midface, and symmetric movement. This method also provides a
backup in case 1 device malfunctions.
Complications in Le Fort III Osteotomy/Distraction
Various complications have been reported in relation to the Le
Fort III osteotomy and in relation to the application of internal and
external distractors.
Complications of the Le Fort III Osteotomy. David188
reported the following complications in 32 Le Fort III and
monobloc osteotomies: blindness (1), frontal osteomyelitis (2),ed reproduction of this article is prohibited.
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periorbital abscess (1), wound infection (1), velopharyngeal insuf-
ficiency (4), diplopia (1), and facial nerve palsy (1).
Matsumoto189 described a 9-year-old patient with Crouzon
syndrome in whom a Le Fort III distraction is complicated by
intracranial bleeding because of a skull base fracture. As a result,
the patient died. Lanigan et al reported a skull base fracture in a
nonsyndromic patient associated with the pterygomaxillary dys-
junction (as part of the Le Fort osteotomy) resulting in unilateral
blindness.190
Nout191 described a lethal course in a 10-year-old patient with
Apert syndrome in whom a Le Fort III osteotomy was performed
immediately followed by placement of internal and external dis-
tractors. Anisocoria was noticed at the end of the intervention.
Computed tomographic-angiography revealed a dissection of the
internal carotid artery. Computed tomographic-angiography is
therefore recommended in the preoperative planning of the Le Fort
III distraction: in the first place to gain more insight into the
thickness and configuration of the bone structures and intracranial
structures in relation to the planning of the osteotomy lines and the
placement of the distractors and secondly, to identify possible
abnormalities of the arteries and veins.
Complications of Internal Distractors.
Mechanical problems in relation to internal distractors have
been mentioned above.
Complications Van External Distractors.
The majority of the problems related to the external frame appear to
be because of the percutaneous pins with which the frame is
attached to the cranial vault. Skin infections and loosening pins
are well-known problems reported in the orthopedic and neurosur-
gic literature. The data on incidences and recommendations on, for
example, required torque, cannot be extrapolated one-to-one to
syndromic craniosynostosis patients. These patients often have
undergone earlier remodeling of the cranial vault. Thickness and
strength of the cranial vault are not similar (less strength and lack of
continuity in some places).
Nout183 analyzed 21 patients (including 19 syndromic cranio-
synostosis patients) undergoing a Le Fort I and III external dis-
traction. Most of the problems encountered were related to the
external pin: loosening of the pin, infection of the skin around the
pin, and in 3 patients there was traumatic dislocation of the frame,
albeit without any effect on the final outcome.1. AC
# 2number of case reports describe intracranial migration of an
internal pin.192–195 In all patients this had no permanent
consequences with full recovery of the patient.Timing of the Surgical Correction and
(Postoperative) Growth
Although the number of cephalometric studies of maxillary
growth in surgically treated and nonsurgically treated syndromic
craniosynostosis patients is small, the results point at a clear picture.
If there were to be any vertical and sagittal growth of the maxilla at
all, it would be negligibly small or near-enough null: Bachmayer,196
Meazzini,155 Kreiborg,156 Fearon,157 and Fearon.181 The methodo-
logical quality of these findings can only be classified as Level 3
and 4.
Le Fort III Osteotomy or Distraction?
The publications on Le Fort III distraction consistently mention
the following arguments, among other things, to prefer thisopyright © 2015 Mutaz B. Habal, MD. Unautho
015 Mutaz B. Habal, MDprocedure during the conventional Le Fort III osteotomy: shorter
operation with less blood loss, less pain, and shorter hospitalization,
including ICU stay. But solid evidence is not provided in those
studies. Yet the studies make clear that distraction permits to obtain
a larger distance during which the detached portion can be
advanced.
The publications on Le Fort III osteotomies demonstrate that the
mean obtained midface advancement is approximately 9 to 10mm
(range 6–14mm). The publications on Le Fort III distraction
demonstrate that the mean obtained midface advancement is
approximately 17mm (range 9–23mm). The methodological qual-
ity of these findings can only be classified as Level 3 and 4.
This would therefore also enable better functional and esthetic
outcomes. Although in the Le Fort III distraction, in contrast to the
conventional Le Fort III osteotomy, intermaxillary fixation and
bone transplants are not needed, complications related to the
internal and internal distractors may still occur. These are usually
mild; in exceptional patients serious complications are described,
often directly related to the pins of the external frame.
Lastly, it should be mentioned that a Le Fort III and a Le Fort I
osteotomy technically can be combined in 1 operation, with which
eventually the tooth-borne segment of the jaw can be moved over a
larger distance.
Distraction With Internal of External Distractors?
The body of literature on the Le Fort III distraction includes
more publications with more patients who have undergone a
procedure with external frame than with internal distractors. At
the same time, it is striking that recent publications tend to focus on
the application of an external frame rather than the application of
internal distractors.
It is not easy to summarize the results of the distractions with
internal distractors. Individual publications report reasonable
results, but at the same time in Satoh,174 the internal distractors
are eventually replaced with an external frame in 3/20 patients,
whereas in Meling,175 problems are reported in 2/7 patients. In
Holmes,176 we find a policy change on account of poor results with
internal distractors in 7 patients in favor of the push–pull technique,
in Cedars178 the internal distractors were removed prematurely in
2/14 patients, and lastly in Gosain177 the internal distractors were
replaced with an external frame in 2/7 patients. Quite often this
replacement is necessitated by a mechanical problem of the internal
distractor.
The following publications on the Le Fort III distraction with
external frame do not report any problems: Fearon157 22 patients;
Mavili180 4 patients; Fearon181 41 patients; Malagon185 5 patients;
and Lima186 11 patients.
The following publications reported minor problems with the
frame only:
Shetye182 pin-related skin infection in 5/15 patients and trau-
matic dislocation of the frame in 2/15; Nout183 loosening of pins in
43% of the patients and traumatic dislocation of the in 3/21 patients,
albeit without clinical consequences; and Mu184 observed skin
infection in 1/8 patients and seroma in 1/8.
The push–pull method is reported in only 1 publication, but
Schulten is enthusiastic on the basis of outcomes in 10 patients.187
ConclusionsLevel 3rized Maxillary growth in surgically and nonsurgically treated Apert,
Crouzon, and Pfeiffer patients seems negligibly small.B Fearon, 2001157B Fearon, 2005181C Bachmayer, 1986154reproduction of this article is prohibited.
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1758C Meazzini, 2005155C Kreiborg, 1986156Level 3 It seems likely that the mean advancement of the midface obtained with
distraction is larger than that obtained with conventional osteotomy.
In Le Fort III distraction an external frame is preferred for its ease of
placement and removal and optimum vector control. Any distractor
(internal and external) related complications tend to be minor.Le Fort III osteotomy:B Fearon, 2001157C Bachmayer, 1986196C David, 1990188C Kaban, 1986197C Kreiborg, 1986156C McCarthy, 1990198C Meazzini, 2005155C Ousterhout, 1986199C Phillips, 2006171Le Fort III distraction:B Fearon, 2005181C Cedars, 1999178C Chin, 1997173C Gosain, 2002177C Holmes, 2002176C Kubler, 2004179C Lima, 2009186C Malagon, 2008185C Meling, 2006175C Mu, 2007184C Satoh, 2006174C Shetye, 2006182C Nout, 2010191Level 3 CT-angiography is recommended in the preoperative planning of
the Le Fort III distraction. In the first place to gain more insight into
the thickness and configuration of the bone structures and
intracranial structures in relation to the planning of the
osteotomy lines and the placement of the distractors. Secondly,
to identify possible abnormalities of the arteries and veins.C Nout, 2010191Considerations:
Indications for midface advancement in OSAS and weighing up
the pros and cons of a permanent or temporary tracheal cannula are
dealt with in the chapter on OSAS.
One should be aware that there is no maxillary growth after a Le
Fort III distraction at young age, so that a second Le Fort III (or
mono-bloc) operation from the age of 18 years may be necessary.
Additional orthognatic surgery (also from age 18 years) may be
indicated to correct the malocclusion, including open bite (see
chapter 14).
Operations that change the appearance considerably, such as a
Le Fort III advancement in 12 to 17-year-old patients could give rise
to psychosocial problems, which may already have been present
because of the abnormal appearance.
Fronto-orbital advancement as the initial surgical intervention
affects the facial profile and thus also influences the planning of the
Le Fort III advancement (see chapter 6).
An external frame puts a considerable psychosocial burden on
the patient and his/her family, those who activate the distractor. This
may be a consideration to opt for an internal distractor instead.
Furthermore, low mental development in syndromic craniosynos-
tosis patients may be reason to opt for an internal distractor. The
application of the internal distractor can be combined with a facial
mask to optimize the vector of the Le Fort III distraction (see
chapter 14).right © 2015 Mutaz B. Habal, MD. UnauthoRecommendations
The Le Fort III distraction in Apert and Crouzon/Pfeiffer
patients to correct the maxillary hypoplasia (including exorbitism)
is typically performed between the ages of 8 and 12 years, or from
the age of 18 years. In case of severe OSAS and/or severe
exorbitism posing a threat to vision it may be performed at younger
age (see chapter on OSAS). In young children (6 years) a
monobloc distraction is preferred, dependent on previous surgeries.
In view of the higher risk of psychosocial problems or unrealistic
expectations in 12 to 18 year olds, the Le Fort III distraction is
preferably not performed at these ages (see chapters 17 and 18).
After the Le Fort III, occlusion must be monitored. Orthognatic
surgery is recommended in the patient of malocclusion (eg, Le Fort
I, bilateral sagittal split osteotomy). This type of surgery is per-
formed after age 18 years (see chapter 14).
Computed tomographic-angiography deserves to be considered
in the preoperative planning of the Le Fort III distraction.
In Le Fort III distraction an external frame is recommended in
view of its ease of placement and removal and the possibility of
optimum vector control.
If internal distractors show mechanical problems they should be
replaced with an external distractor.
Monobloc Osteotomy/Distraction and
Hypertelorism
The monobloc frontofacial osteotomy is a combination of a
transcranial advancement of the frontal bone and an extracranial Le
Fort III advancement in 1 operation and in 1 piece. This surgical
intervention is indicated in syndromic craniosynostosis patients to
correct the hypoplastic midface with possibly associated functional
problems and elevated ICP at a relatively too small cranial volume.
It was described in 1978 by Ortiz-Monasterio et al.200
The body of good literature on the results of monobloc osteo-
tomies is evidently much smaller than that regarding the Le Fort III
advancement. Data on complications of the conventional monobloc
operation were not available in Pubmed and fort his reason we
searched the publications of the first congresses of the International
Society for Craniofacial Surgery. Only very few surgeons applied
the conventional monobloc in the earlier days, and results including
complications were presented at these meetings only. Exclusion of
these publications would result in a bias with considerable under-
estimation of the complications of this procedure.
Hypertelorism in Syndromic
Craniosynostosis Patients
Apart from midface hypoplasia, hypertelorism is a well-known
phenomenon in syndromic craniosynostosis patients. Although it
seldom leads to functional problems, the position of the bony orbits
can esthetically be unappealing to such an extent that correction is
indicated. In 1979, Van der Meulen described the ‘‘median faciot-
omy’’ for correction of the midline cleft with hypertelorism.201 By
vertical splitting of the monobloc segment in the midline and
removing a wedge from the midline of the midface he was able
to rotate the 2 halves of the midface toward each other, thus
reducing the distance between the orbits. Tessier202 later refined
this technique and named it facial bipartition. This refined tech-
nique can be combined with forward advancement: ‘‘facial biparti-
tion osteotomy with advancement’’, in which advancement can be
performed with distraction as well.
Orbital hypertelorism may also be treated with orbital box
osteotomy. This procedure cannot be performed until the teeth
have erupted permanently, usually from approximately the age of
14 years. Orbital box osteotomy is well suited to be combined withrized reproduction of this article is prohibited.
# 2015 Mutaz B. Habal, MD
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lateral canthus should be paid attention to in the orbital box
osteotomy and the ‘‘facial bipartition’’.167,203 Although some sur-
geons do not detach the canthi and prefer to leave these in situ at the
bone, other surgeons purposefully detach the canthi to reattach them
later to the bone. The latter method would permit better correction
of the positions of the canthi.
Moreira Gonzalez reported good results after facial bipartition in
14 syndromic craniosynostosis patients, combined with advance-
ment using osteotomy in 3 patients. Postoperative problems were
the following: liquor leakage (2), infections (2).204 Problems with
diplopia are not reported.
Urrego205 reported a surgical technique aimed at reducing the
remaining telecanthus in this intervention. In 12 patients, a mean
39% reduction of interbrow distance was noted.
Posnick206 analyzed pre- and postoperative CT scans of 7
syndromic craniosynostosis patients undergoing facial bipartition
osteotomy. Also after 1 year the results showed stable improvement
but no complete normalization.
Risks and Complications of Monobloc/Facial Bipartition (With
and Without Distraction)
The literature consistently points to the same risks, compli-
cations and problems around monobloc osteotomies: presence of a
ventriculoperitoneal shunt, need of extensive bone grafts for the
sake of stabilization, pressure on the soft tissues and cranial flap,
and extradural retrofrontal dead space created by the advancement
and which directly connects with the nasal cavity and the ethmoid.
Occurrence of the latter complication could perhaps be reduced by
closing the connection between this dead space and (para-) nasal
cavity with galea frontalis flap or periosteal flap.
Aspects of relapse and revision of monobloc in relation to the
indication of monobloc for OSAS are addressed in the relevant
chapter.
Osteotomy
Posnick described 23 syndromic craniosynostosis patients, 10
undergoing monobloc advancement, 7 facial bipartition advance-
ment, and 6 facial bipartition solely (all osteotomy, no distrac-
tion).207 All showed a retrofrontal dead space after the intervention,
which in 10 patients had disappeared after 6 weeks and in all within
1 year. The presence of a ventriculoperitoneal shunt did not
influence the risk of complications. One patient showed evidence
of a late (after 3 months) CSF leakage via a skin fistula with necrosis
of the frontal bone.
Timing of the Monobloc-Distraction in Relation to
Orbital Growth
Bentley208 preoperatively analyzed the volumes of the bony
orbits in 50 syndromic craniosynostosis patients and compared the
outcomes with those of a normal group. Volumes in the syndromic
craniosynostosis patients were smaller shortly after birth but tended
to reach normal values at 6 to 8 months of age and had completely
normalized at 13 months of age. This would imply that surgical
intervention should be delayed until the age of 6 to 8 months, thus
maximizing the effects of accelerated normal orbital growth.
Position of the Eye Globe After Monobloc
Distraction
Fitzgerald O’ Conner150 analyzed in 10 syndromic craniosy-
nostosis patients the position of the eyeball after monobloc dis-
traction. At an osseous distraction distance of 12.9mm (upper face)
and 14.2mm (lower face) the globe moved 5.3mm (left eye) andCopyright © 2015 Mutaz B. Habal, MD. Unautho
# 2015 Mutaz B. Habal, MD6.3mm (right eye). Globe advancement was approximately 2/5 of
the distraction distance, without evidence of optic nerve damage
and impaired vision.
Distraction
As was done above for the Le Fort III distractions, the following
section describes the application of internal and internal distractors
in monobloc distractions.
Monobloc Distraction With External Distractors1. Wrizitherow209 reported 20 syndromic craniosynostosis patients
undergoing monobloc distraction with halo external frame;
mean advancement: 16.4 mm, mean age 7.8 years. Cerebrosp-
inal fluid leakage was noted in 8 patients (the leakage stopped in
5 patients; 3 underwent a revision operation using a lumbar
drain)
210
2. Witherow evaluated relapse after monobloc distraction with
external frame in 21 syndromic craniosynostosis patients (mean
age 8.3 years, probably largely the same patients as mentioned
under point 1). The midface was distracted to an average of
16.4 mm. Relapse was seen only in 3 of all patients during 14.8
months’ follow-up period.
211
3. Ponniah studied the pre- and postoperative CT scans of 10
syndromic craniosynostosis patients undergoing monobloc
distraction (7) and facial bipartition distraction, both using
an external frame. In particular, the facial bipartition distraction
differentially advanced the central part of the face more than the
lateral areas.Monobloc Distraction With Internal Distractors1. Cohen
212 described 5 syndromic craniosynostosis patients, in 3
of whom monobloc distraction was performed and in 2 a facial
bipartition, in all patients using internal distractors (age
between 9 months and 5 years). The distraction distance
ranged from 22 to 30 mm. Device infection developed in 1
patient.
213
2. Arnaud described 20 syndromic craniosynostosis patients
who underwent monobloc distraction using internal distractors
(mean age: 3.2 years). Cerebrospinal fluid leakage occurred in 3
patients. Device infection developed in 2 patients requiring
removal of the distractor. Septic frontal necrosis occurred in 1
patient 2 months after completion of distraction, necessitating
removal of the forehead flap.
144
3. Arnaud studied 36 syndromic craniosynostosis patients
undergoing monobloc distraction using internal distractors
(mean age: 5.2 years). Distraction was uneventful in 28
patients; 7 required revision surgery because distractors
stagnated. One patient died from acute brain tonsillar herniation
before distraction was begun. Furthermore, loss of dead frontal
bone in 1 patient.
214
4. Bradley described 13 syndromic craniosynostosis patients
(mean age 8.3 years) who underwent facial bipartition,
including monobloc distraction using internal devices. Stable
results were obtained and no complications were reported (no
liquor leakage, meningitis, or frontal bone loss).
150
5. Fitzgerald O’Connor described 10 syndromic craniosynos-
tosis patients undergoing monobloc distraction (upper face
distraction distance 12.9 mm and lower face 14.2 mm). From
CT scans (pre- and post-) a mean forward movement of 5.3 mmed reproduction of this article is prohibited.
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17for the left globe and 6.3 mm for the right globe was established.
Although there was no evidence of optic nerve stress with
possible functional limitations, the long-term development
should be closely monitored.Complications in Monobloc Osteotomies/Distractions
David (1990)188 reported the following complications in 32 Le
Fort III and monobloc osteotomies: blindness (1), frontal osteo-
myelitis (2), CSF leakage (2), extradural abscess (1), periorbital
abscess (1), wound infection (1), velopharyngeal insufficiency (4),
diplopia (1), and facial nerve palsy (1).
Vyas215 reported a left carotid-cavernous fistula as a compli-
cation in monobloc distraction in a patient with Apert syndrome.
The fistula was successfully embolized. After 1 year there was
still partial vision loss in the left eye, but there were no other
sequelae.
Witherow described in 20 syndromic craniosynostosis patients
the following complications after monobloc distraction: CSF leak-
age (8, in 5/8 it stopped spontaneously, 3/8 required lumbar
drainage in combination with endoscopic repair of the tensor fascia
latae muscle with Tissuecoll), hypernasality (5), loss of frontal
dead/avital bone (1), temporary tracheotomy (2), fracture of the
zygomatic bone (1), trismus which spontaneously had resolved after
6 months (5), and cornea ulceration (2).209
Complications in Monobloc Osteotomy/Distraction
The literature (case reports and no series larger than N¼ 4)
consistently points to the same risks, complications, and
problems around the monobloc osteotomies (including the
variants): presence of a ventriculoperitoneal shunt; need of exten-
sive bone grafts; pressure on the soft tissues and cranial flap;
and extradural retrofrontal dead space created by the advancement
and, which directly connects with the nasal cavity and the
ethmoid.
On the other hand, Posnick et al207 described monobloc osteot-
omy in 23 syndromic craniosynostosis patients, of whom 1 showed
late CSF leakage via a skin fistula with necrosis of the frontal bone.
In all patients, the retrofrontal dead space had disappeared after 1
year. The presence of a ventriculoperitoneal shunt did not influence
the risk of complications.
This is the only series of appreciable size in which this was
analyzed retrospectively.
Benhaim provide an overview of monobloc fronto-facial
advancements performed in University of California, Los Angeles
(UCLA) in the predistraction period from 1988 to 1996.216 In total
26 patients were operated; mean operation time was more than 8
hours, mean blood loss 1700 cc. The following complications were
noted: liquor leakage (27%), SIADH (15%), pneumonia (12%),
epilepsy (8%), meningitis (4%), hypoxic injury (4%), pseudome-
ningocele (4%), oronasal fistula (4%), partial flap necrosis (4%),
and abscesses (4%). This was already a considerable improvement
compared with the results from the 1979 to 1988 period as a
consequence of adaptations of the operative technique.
Wolfe reports the results of a classic monobloc in 44 patients.217
The complications consisted of death (2%), liquor leakage (2%),
violent infections (osteitis, temporal, and epidural abscesses, 9%)
resulting in loss of the frontal bone in 7%. The created frontofacial
dead space was mentioned as the major cause for these infections.
Marchac218 reported their lethal complications after craniofacial
surgery. Twenty of the 1397 patients undergoing intracranial
operations died (1.4%). And even 6 of the 18 patients in whom
a monobloc was performed died.opyright © 2015 Mutaz B. Habal, MD. Unautho
60Timing
Regarding the timing of monobloc distraction in relation to
growth of the orbits, Bentley et al (2002)208 concluded from CT-
analysis in 50 syndromic craniosynostosis patients and control
group that this should be delayed to minimally the age of 6 to 8
months to allow for optimal orbital growth.
Monobloc Distraction: Osteotomy or Distraction?
Internal or Internal Distractors?
Regarding the choice of operation technique—distraction versus
osteotomy—the literature unanimously makes clear that distraction
allows for movement of the bone segment over a larger distance.
Witherow209 described 20 syndromic craniosynostosis patients and
Ponniah211 described 10 patients undergoing monobloc distraction
with external frame. No major problems and complications were
reported. Most of the publications, encompassing the large majority
of patients, describe monobloc distraction with the use of internal
distractors.
Position of the Eye Globe After Monobloc
Distraction
Fitzgerald O’Connor150 concluded from CT-analysis in 10
syndromic craniosynostosis patients undergoing monobloc distrac-
tion that globe advancement was approximately 2/5 of the distrac-
tion distance, without evidence of optic nerve damage and impaired
vision. This is the only report on this issue.
ConclusionsLevel 3rized rIt is likely that monobloc distraction can be performed in a predictable
way with either type of distractors (internal and external) with
eventually fewer complications than with conventional
monobloc osteotomy.C Benhaim, 1997216C Marchac, 1995218C Wolff, 1995217C Witherow, 2008209C Ponniah, 2007211C Cohen, 1999212C Arnaud, 2007144C Bradley, 2008214C Fitzgerald O’Conner, 2009150Level 3 Regarding the timing of the monobloc operation there are indications
that it is worth waiting until minimally the age of 6 to 8 months to
allow for optimal growth of the orbits.C Bentley, 2002208Considerations
Regarding the indication for midface/monobloc advancement in
OSAS and the considerations on the pros and cons of a permanent
temporary tracheal cannula, please refer to the chapter on OSAS.
As there is no maxillary growth after an early monobloc, a
second monobloc (or Le Fort III) operation after the age of 18 may
be necessary.
Operations that change the appearance considerably, such as a
monobloc in 12 to 17-year-old patients could give rise to psycho-
social problems, which may already have been present because of
the abnormal appearance (see chapter 17).
An external frame puts a considerable psychosocial burden on
the patient and his/her family, those who activate the distractor. This
may be a consideration to opt for an internal distractor instead.
Furthermore, low mental development in these syndromic cranio-
synostosis patients may be reason to opt for an internal distractor.eproduction of this article is prohibited.
# 2015 Mutaz B. Habal, MD
The Journal of Craniofacial Surgery  Volume 26, Number 6, September 2015 Diagnoses of CraniosynostosisAs syndromic craniosynostosis patients, notably those with
Apert or Pfeiffer/Crouzon syndrome, often show V-shape in the
maxilla including the open bite, facial bipartition is preferred
because this does not only correct the hypertelorism but also
restores this V shape to a normal occlusal line. Regarding the
timing of this intervention the same argument as in the midface/
monobloc operations is proposed: at the age of 4 to 5 years by far the
largest part of the osseous orbits has been fully developed.
Although orbital box osteotomy compromises vascularization of
the margins that were detached with osteotomy (which could result
in resorption and undesirable decrease in volume), this effect will be
less with the facial bipartition. The orbital box osteotomy can be
performed from approximately at the age of 14 years. After all, the
caudal part of the osteotomy (under the infraorbital margin) requires
sufficient space between the infraorbital nerve and the apical
boundaries of the dentition. The orbital box osteotomy can be well
combined with orthognatic surgery.
Recommendations
The monobloc distraction in syndromic craniosynostosis
patients is indicated in severe exorbitism (ocular globe luxation
and/or corneal injury) with1. sC
# 2evere OSAS at the time of protocolized initial cranial vault
expansion2. severe OSAS in combination with elevated ICP.In case of severe OSAS, age (and therefore timing) does not play
a role. In very young children (<2 years) tracheal cannula place-
ment may bridge the waiting time (see chapter on OSAS).
Monobloc distraction is preferred in view of the lower percen-
tage of serious complications in comparison with the conventional
monobloc osteotomy.
In view of the higher risk of psychosocial problems or unrealistic
expectations in 12 to 18 year olds, a monobloc is preferably not
performed at this age (see chapters 17 and 18).
Hypertelorism is preferably corrected from the age of 4 or 5
years by means of the facial bipartition technique. The orbital box
osteotomy technique can be performed after the upper teeth have
erupted permanently (from approximately the age of 14 years) and
can be well combined with additional orthognatic surgery.
Computed tomographic-angiography is recommended in the
preoperative planning of the monobloc distraction (with or without
facial bipartition).
After the monobloc procedure, monitoring of occlusion is
warranted. Orthognatic surgery is recommended if malocclusion
should occur (eg, Le Fort I, bilateral sagittal split osteotomy).
This surgery should be delayed until after the age of 18 years
(see chapter 14).
Transversal Correction
The sagittal and vertical dimensions have already been
addressed in the sections on the Le Fort III and monobloc osteot-
omy/distraction. The transversal correction is discussed below. The
available literature on this topic is even more limited and mostly
concerns small case series.
Transversal maxillary hypoplasia in adolescence and adulthood
is seen in non-syndromic and syndromic patients, including schisis
patients. This type of hypoplasia leads to transversal malocclusion.
In skeletally immature patients, the maxilla can be expanded
orthodontically. In skeletally mature patients, however, a uni- or
bilateral transversal hypoplasia can solely be correctedwith the use of
SARME. This procedure is a combination of surgical andopyright © 2015 Mutaz B. Habal, MD. Unautho
015 Mutaz B. Habal, MDorthodontical techniques that offers room in the maxillary arch for
orthodontically correct arrangement of the teeth. In addition, SARME
substantially enlarges the maxillary apical (dentoalveolar) base and
the palatal arch, which allows good movement of the tongue in
swallowing. An additional favorable effect is a subjective improve-
ment in nasal breathing as a result of the expansion of the narrowest
passage in the nose (nasal valve) and of the nasal cavity volume.219
The scientific background for the timing of this treatment is
addressed below. In the absence of recent studies on this subject,
however, we had to resort to literature from before 1980.
Growth at the sutures takes place by deposition of new bone at
the suture borders by the adjacent cellular layer. By the end of fetal
life this cellular layer will become thinner, which indicates slower
growth rate and reduction of the number of fibers in the inter-
mediary cellular layer, which separates the capsular layers. In a
study of human sutures from birth to 18 years of age, Latham and
Burston220 concluded that after some 2 to 3 years the sutures
primarily are functioning as sites where the separate bone plates
meet, but that remodeling is a continuous process. The cranial
sutures will fuse before the complete eruption of the third molars.
Shortly hereafter the facial sutures will fuse, and the sutures that
connect the skull and the face are the last to fuse.221 Regarding the
facial sutures, Sicher222 concluded from anatomic studies that
fusion in humans on average starts by the middle of the fourth
decade, at the posterior part of the median palatal suture, but that
some facial sutures, including the frontozygomatic suture, remain
open to later age.
A conflicting view is presented by Persson,223 who found
evidence of osseous fusion of the median palatal suture at age
17 years. Latham and Burston,220 however, did not find evidence of
synostosis in the same suture at age 18 years. An ‘‘overall view’’ is
presented by Scott224 who believes that in spite of the fact that most
of the facial sutures seem to be open on the surface, they show a
certain degree of fusion somewhat deeper. The available literature
clearly is not unambiguous and conclusive on this subject.
In clinical practice, however, transversal orthodontical expan-
sion is successful until the age of approximately 14 to 15 years,
depending on the patient’s sex. After this age it is virtually
impossible to achieve orthodontic expansion.225–227 In general it
is believed that that the fusion of the midpalatal suture impedes
expansion.225–227
The above applies to the nonsyndromic situation. The literature
contains 2 studies dealing with maxillary sutures, maxillary trans-
versal growth, and SARME in the syndromic situation.
Koudstaal et al228 describe the application of a bone-borne
distractor device for the expansion of the maxilla in 8 syndromic
and 5 non-syndromic patients. They conclude that this type of
distractor is suitable for surgical expansion of the maxilla in both
nonsyndromic and syndromic patients. Notably the small dimen-
sions of the device make it suited for application in the extremely
narrow upper jaws seen in syndromic craniosynostosis patients.
The literature does not contain publications on the effects of
SARME on further growth of the maxilla, neither in nonsyndromic
nor in syndromic patient groups.
Only very few publications are available on the indications,
timing, and the effects of SARME in syndromic craniosynostosis
patients. The information is based on literature data of nonsyn-
dromic patients.
In summary, the patient’s age determines the indicated
therapy for transversal maxillary hypoplasia, either orthodontical
expansion or SARME. As soon as the diagnosis of transversal
maxillary hypoplasia is made and treatment can reasonably be
started in view of the dental and mental situation, orthodontic
expansion is indicated before the age of 14 to 15 years, SARME
at older age.rized reproduction of this article is prohibited.
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1762It seems likely that the SARME procedure can be performed from
the age of 14 to 15 years.C Koudstaal, 2006228Considerations
The experts are of the opinion that in syndromic craniosynos-
tosis patients the maxilla may be extremely narrow, in which
situation a tooth-borne distractor in the SARME procedure tech-
nically is not feasible. In that case, the application of the bone-borne
distractor is indicated. One should be aware that the palatal mucosa
may be very thick in syndromic craniosynostosis patients. This may
impede placement of some types of bone-borne distractors.
Recommendations
If a SARME procedure is performed in syndromic craniosynos-
tosis patients, a tooth-borne distractor is preferred over a bone-
borne distractor. But in case of an extremely narrow maxilla and
insufficient space for a tooth-borne distractor (Hyrax), a bone-borne
distractor is indicated. The thick palatal mucosa impedes the
placement of a bone-borne distractor. A SARME procedure is
performed from the age of 14 to 15 years.
8. INCREASED INTRACRANIAL PRESSURE
Basic Questions1. What is the prevalence of ICP in the various types of
nonsyndromic and syndromic craniosynostosis, before and after
skull remodeling?2. What screening (nature and frequency) is needed to timely
identify increased ICP?3. How can increased ICP be prevented or treated?Introduction
The risk of increased ICP varies widely between the types of
craniosynostosis, and the syndromic type carries a much higher risk
than the nonsyndromic type. The risk in the nonsyndromic group,
however, is much less recognized and therefore possibly under
diagnosed. It is important to detect and treat increased ICP at an
early stage. High ICP may lead to, for example, irreversible loss of
vision.229 It is not clear what method is best suited to establish
increased ICP, what thresholds should be set, and at what frequency
it should be applied to identify problems at an early stage.
Summary of the Literature
Prevalence
I. Nonsyndromic Craniosynostosis. Until 1996, genetic diag-
nostics was not possible and therefore the distinction between
syndromic and nonsyndromic was not always evidenced. In the
older literature about ICP it is often unclear whether this really
concerns nonsyndromic craniosynostosis. Especially, cases of uni-
lateral or bilateral coronal suture synostosis may well be of a
syndromic type.Most of the publications on ICP in craniosynostosis
patients derive from 2 centers (Paris and London) and patient
populations may overlap. Most studies only address increased
ICP preceding a cranial vault expansion. Reliable data on the
prevalence of increased ICP following cranial vault expansion
are rare. There are no data at all on ICP in patients with a lambdoidht © 2015 Mutaz B. Habal, MD. Unauthosuture synostosis, most likely because of the very low prevalence of
this type of synostosis.
The following publications are from the Parisian center, and
patient populations may overlap:
Renier (1982) preoperatively performed invasive ICP measure-
ments in 49 nonsyndromic patients, that is, 23 with scaphocephaly,
9 with plagiocephaly, 5 with trigonocephaly and 7 with brachyce-
phaly. Increased ICP (>15mm Hg) was measured in 3, 2, 0, and 3
patients, respectively; borderline ICP (11–15mmHg) in 4, 4, 1, and
2 patients, respectively and normal ICP (10mmHg) in 16, 3, 4,
and 2 patients, respectively.142 In 23 patients (both isolated and
syndromic) the ICP measurement was repeated postoperatively: in
all 23 the ICP had decreased over a number of weeks. Regarding the
relation between ICP and age, ICP peaked at 6 years. In 17 patients,
clinical suspicion of increased ICP years after the operation was
confirmed with an invasive measurement. The diagnoses, however,
are not mentioned.
Gault230 defined increased ICP as >15mm Hg, irrespective of
age, which widely ranged in the study population. Intracranial
pressure was measured invasively preceding cranial vault expan-
sion. Increased ICP was established in 1 of the 2 patients with
brachycephaly, in none of the 4 patients with trigonocephaly, in
none of the 3 patients with plagiocephaly, and in 2 of the 44 patients
with scaphocephaly.
Arnaud141 preoperatively measured ICP invasively in 142 chil-
dren with scaphocephaly. Intracranial pressure exceeded 15mm Hg
in 19 children, of whom 12 were older than 1 year, which was
statistically significantly different.
Renier121 provides an overview of more than 2137 patients with
craniosynostosis. Invasive preoperative ICP measurements
revealed prevalences of 13.8% in scaphocephaly (246 measure-
ments), 7.7% in trigonocephaly (39 measurements), 12.7% in
plagiocephaly (63 measurements), and 31.3% in brachycephaly
(32 measurements).
Mathijssen103 reported invasive preoperative ICP measurements
in plagiocephaly; ICP was>15mmHg in 8 of the 50 patients. These
8 children were all older than 1 year (statistically significant).
Also the craniofacial team in London published a considerable
number of publications on this issue:
Thompson231 performed invasive preoperative ICP measure-
ments in 37 patients with plagiocephaly, 25 with scaphocephaly and
12 was trigonocephaly. Increased ICP (>15mm Hg) was estab-
lished in 3, 6, and 4 patients, respectively.
Thompson232 preoperatively measured ICP invasively in 72
nonsyndromic patients: 18 children with scaphocephaly, 35 with
plagiocephaly, 10 with brachycephaly and 9 with trigonocephaly.
Intracranial pressure was increased (>15mm Hg) in 13 children: 3
with scaphocephaly, 2 with plagiocephaly, 5 with brachycephaly,
and 3 with trigonocephaly. Borderline ICP (10–15mm Hg) was
measured in 7, 13, 2, 5, and 3 patients, respectively. Here, too, it is
not certain if the brachycephaly was really nonsyndromic. If
increased ICP was defined on the basis of plateau waves rather
than just mean ICP, the number of patients with increased ICP
would have been somewhat higher.
Shipster233 reports increased ICP (>15mm Hg), measured
invasively, in 4 of 11 scaphocephaly patients. It is not clear why
ICP was measured in these 11 patients and whether there may have
been selection bias. Thompson234 is referred to, and probably the
populations overlap. For this reason this publication is not included
in Table 8.
The other studies are from Camperdown, Australia,235
Rome,236–237 and the United States, that is, Chicago,238 and Seat-
tle.239
Whittle235 included 5 nonsyndromic craniosynostosis patients: 4
with scaphocephaly and 1 with plagiocephaly. Preoperativerized reproduction of this article is prohibited.
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scaphocephaly and in the 1 with plagiocephaly. The indications for
ICP measurements were radiologic signs of mild hydrocephalus,
loss of vision, headache or behavior change, and are therefore a
source of bias. For this reason this publication is not included in
Table 8.
Tamburrini236 reports invasive preoperative ICP measurements
in 5 nonsyndromic craniosynostosis patients: 3 with scaphocephaly
and 2 with brachycephaly. All 5 had normal ICP levels (15mm
Hg).
Tamburrini (2005)237 reports invasive preoperative ICP
measurements in 7 nonsyndromic craniosynostosis patients: 3 with
scaphocephaly and 4 with brachycephaly. Of the latter 4 patients, 2
had an anterior brachycephaly and 2 a posterior brachycephaly. The
question is whether the 2 with posterior brachycephaly really
showed synostosis. The 2 patients with a bicoronal synostosis
had increased ICP. Possibly these were indeed cases of syndromic
craniosynostosis. Probably these are the same patients as described
in the 2004 publication. In view of the very small numbers and the
dubious diagnoses this study is not included in Table 8.
Foster238 investigated the occurrence of resynostosis after
primary skull remodeling in 13 patients with trigonocephaly, 30
with scaphocephaly, 22 with plagiocephaly, 1 with unilateral
lambdoid suture synostosis and 9 with brachycephaly. The resy-
nostosis rates were 7.7% (1), 3.3% (1), 0, 0, 0, respectively. In 1
patient with scaphocephaly increased ICPwas established by means
of lumbar puncture before second cranial vault expansion. As the
occurrence of resynostosis was subjected to selection, these rates do
not reflect the real prevalence in the total population of patients with
a nonsyndromic craniosynostosis.
Scott describes 36 patients older than 2 years at the time of
primary cranial vault expansion. A total of 17 patients showed
preoperative symptoms consistent with increased ICP, and 10 had
already earlier undergone cranial surgery elsewhere.239 The study
group consisted of 5 patients with scaphocephaly, 2 with brachy-
cephaly, 1 with trigonocephaly, 3 with multiple suture synostosis, 3
with Crouzon, 1 with Saethre-Chotzen, 1 with Muenke, and 1 with
Shprintzen. In 10 patients, CT findings suggested increased ICP or
papilledema. Symptoms resolved in most patients. This series is left
out of consideration in view of the heterogeneity of the study
population (syndromic/nonsyndromic; earlier operation or not)
and the indistinct criteria for increased ICP.
Marucci109 describes 81 patients with scaphocephaly who
underwent limited cranial surgery before 6 months of age. Seven
patients developed a progressive vertex bulge at the site of theCopyright © 2015 Mutaz B. Habal, MD. Unautho
TABLE 8. Prevalence of Increased Intracranial Pressure (ICP) in Nonsyndromic
Craniosynostosis Before Skull Remodeling
Number of Patients
With Increased ICP/
Number of Patients
Measured (%) Scapho Trigono Plagio Brachy Lambdoid
Renier142 3/23 (13) 0/5 (0) 2/9 (22) 3/7 (43)
Gault230 2/44 (5) 0/4 (0) 0/3 (0) 1/2 (50)
Arnaud141 19/142 (13)
Thompson231 6/25 (24) 4/12 (33) 3/37 (8)
Thompson232 3/18 (17) 3/9 (33) 2/35 (6) 5/10 (50)
Renier121 34/246 (14) 3/39 (8) 8/63 (13) 10/32 (31)
Mathijssen103 8/50 (16)
Florisson110 7/103 (7) 3/71 (4) 0/28 (0) 0/3 (0)
Total 74/601 (12) 13/140 (9) 23/225 (10) 19/51 (37) 0/3 (0)
ICP, increased intracranial pressure.
# 2015 Mutaz B. Habal, MDformer anterior fontanel within an average of 8 months postopera-
tively. Five patients underwent invasive ICP measurement, and ICP
was elevated in 4 of them. Five patients had progressive synostosis
and 2 were positive for FGFR2 mutations (of whom 1 was known
with hypochondroplasia). Intracranial pressure was measured in 3
of the 5 eventually true nonsyndromic scaphocephaly patients, and
was found to be raised in 1.
Florisson110 describes a retrospective study of 205 consecutive
patients with a non-syndromic unisutural craniosynostosis, treated
between January 2003 and June 2007, and in whom preoperatively 1
or 2 fundoscopies were performed by protocol. This revealed
papilledema notably in the patients with scaphocephaly and to a
lesser degree in those with trigonocephaly; the youngest patient was
3 months old.
A review from 2004 on the basis of 5 studies with a total of 503
patients with scaphocephaly, trigonocephaly, or plagiocephaly
reports a 4% to 14% increased ICP range, with increased ICP
defined as ICP >15mm Hg.240
In summary, the risk of increased ICP seems to be 12% in
scaphocephaly, 9% in trigonocephaly, and 10% in plagiocephaly.
The range is larger for trigonocephaly (0%–33%) as a smaller
number of patients was investigated. The estimated risk for the
group of bilateral coronal suture synostosis patients is 37%. In the
majority of the studies it is not clear, however, whether this really
concerns nonsyndromic synostosis.
Risk of increased ICP following skull remodeling is explicitly
mentioned only in a retrospective study from Rotterdam in 205
consecutive patients with a nonsyndromic craniosynostosis, treated
between January 2003 and June 2007.110 Postoperative fundoscopy
was performed if increased ICP had been present preoperatively, or
if clinical symptoms were noted, such as headache, behavioral
change, worsening of vision, deviating cranial circumference curve,
or copper beaten aspect on x-ray. Postoperative fundoscopy had
been performed in 46 patients (22% of initial population), of whom
3 patients with scaphocephaly (27, 39, and 46 months postopera-
tively) and 2 patients with trigonocephaly (1 persisting papilledema
already present preoperatively, and 1 patient developed papille-
dema 34 months postoperatively) appeared to have papilledema.
II. Syndromic Craniosynostosis.
Note 1: diagnoses mentioned in older articles (<1996) are not
genetically confirmed.
PM2: the distinction between the Crouzon and Pfeiffer syn-
dromes later appeared to be irrelevant on account of overlapping
genetic abnormalities in the FGFR2 syndrome.
Also regarding syndromic craniosynostosis, most of articles on
ICP are from Paris:
Renier142 performed invasive ICP measurements preoperatively
in syndromic patients, that is, 23 with oxycephaly, 6 with Apert, and
2 with Crouzon syndrome. Increased ICP (>15mm Hg) was
established in 10, 3, and 2 patients, respectively. Borderline ICP
(11–15mm Hg) was present in 9, 2, and 0 patients, respectively.
Normal ICP (10mm Hg) was found in 4, 1, and 0 children,
respectively. In 23 patients (nonsyndromic and syndromic) the
measurement was repeated postoperatively. Intracranial pressure
decreased in all 23 patients during a number of weeks. Regarding
the relation between ICP and age, ICP peaked at 6 years. Seventeen
patients were measured years after the operation on clinical suspi-
cion of increased ICP, which was confirmed with the measurement.
The diagnosis, however, is not mentioned.
Gault230 reported increased ICP on the basis of preoperative
invasive measurement in 4 of the 5 children with a complex
craniosynostosis, that is in 3 of the 4 with an oxycephaly, 2 of
the 3 with Crouzon syndrome, and in the only Apert patient.rized reproduction of this article is prohibited.
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craniosynostosis. Invasive preoperative ICP measurements resulted
in prevalences of 60% in oxycephaly (95 measurements), 47.1% in
multiple suture synostosis (17 measurements), 62.5% in Crouzon,
45% in Apert, and 29% in ‘‘other syndromes’’.
The following publications are from the center in London:
Thompson preoperatively measured ICP invasively in 53 syn-
dromic children, that is, 20 with Crouzon, 13 with Apert, 5 with
Pfeiffer, 14 with Saethre-Chotzen syndrome, 1 with a cloverleaf
skull, and 11 with multiple suture synostosis.232 Increased ICP
(>15mmHg) was found in 35 of them, that is, 13 Crouzon, 5 Apert,
3 Pfeiffer, 6 Saethre-Chotzen, 1 cloverleaf, and 7 multiple suture
synostosis patients. Borderline ICP (10–15mmHg) was found in 7,
7, 1, 6, and 0 patients, respectively. On the basis of plateau waves
rather than only mean ICP the number of patients with increased
ICP was even slightly higher.
Hayward241 described 24-hours ICP measurements in 11 symp-
tom-free children (5 with Pfeiffer, 2 with Crouzon, 2 with Apert, 1
with Antley-Bixler syndrome and 1 with osteopetrosis). Plateaus of
ICP were exclusively seen during active sleep with an increased
mean ICP in all 11 children. During quiet sleep, the mean ICP was
increased (>15mmHg) in 5 children, borderline (10–15mmHg) in
3, and normal in 3.
Marucci152 described 24 patients with Apert syndrome who
were operated upon not until there were signs of increased ICP,
which was the case in 83% at a mean age of 18 months (range 1
month to 4 years and 5 months). Of the patients who underwent
operation, 35% experienced a second episode of increased ICP at a
mean age of 3 years and 4 months (range 1 year and 11 months to
5 years and 9 months). The increased ICP was defined as presence
of papilledema, an abnormal VEP scan, an ICP measurement
>15mm Hg, or more than 3 plateaus in 24 hours.
Other articles are from Camperdown Australia,235 Toronto,242
Pittsburgh,243 Rome,236–237 Wu¨rzburg Germany,60 Boston
(Greene, 2008),244 Chicago,238 Rotterdam,245 and Oxford UK.246
Whittle235 included 8 patients with Crouzon syndrome, 1 with
Apert syndrome, and 6 with complex craniosynostosis, of whom 10Copyright © 2015 Mutaz B. Habal, MD. Unautho
TABLE 9. Prevalence of Increased Intracranial Pressure (ICP) in Syndromic Craniosy
Number of Patients With Increased ICP
Apert Crouzon Pfeiffer
Renier142 3/6 (50) 2/2 (100)
Gault230 1/1 (100) 2/3 (67)
Thompson232 5/13 (38) 13/20 (65)
Renier121 ? (45) ? (63)
Tamburrini236 5/5 (100) 3/4 (75)
Hayward241 2/2 (100) 2/2 (100)
Kress60
Greene244
Marucci152
Preop 20/24 (83)
Postop 7/20 (35)
De Jong54
Preop 2/22 (9) 24/45 (53) Cr/Pf
Postop 11/31 (35) 8/40 (20) Cr/Pf
Woods246
Postop 1 year
Postop 5 years
ICP, increased intracranial pressure. Many articles are from the same centers (Paris
preoperative measurements: few data on postoperative prevalence.
Operation not until increased ICP.
1764(7 Crouzon, 1 Apert, 3 complex craniosynostosis, respectively)
preoperatively showed increased ICP with invasive measurement.
Indications for measurement were radiologic signs of mild hydro-
cephalus, worsening of vision, headache or behavioral change, and
are thus subject to bias.
Siddiqi242 evaluated 107 syndromic children with the following
diagnoses: 52 Crouzon, 33 Apert, 8 Pfeiffer, 11 Saethre-Chotzen
syndrome, and 4 cloverleaf skulls. Six (6%) developed symptoms of
increased ICP after initial decompression (3 with Apert, 2 with
Saethre-Chotzen, and 1 with Pfeiffer syndrome), defined as papil-
ledema (N¼ 4), progressive macrocephaly (N¼ 1), and invasive
ICP measurement (N¼ 1). One patient required a third operation on
account of recurrent increased ICP. At follow-up 3 to 7 years later,
none of the 6 patients showed signs of increased ICP. In this series
routine screening of increased ICP was not performed, which is a
cause of strong bias. For this reason this study is not included in
Table 9.
Pollack243 described follow-up of 22 children with syndromic
craniosynostosis, most of whom were operated upon between the
ages of 6 to 18 months. Eight children developed recurrent
increased ICP, defined as papilledema (N¼ 3), progressive prop-
tosis (N¼ 1), or other clinical symptoms (N¼ 3). As most of the
children did not show any symptoms, routine ophthalmologic
examination is recommended.
Tamburrini236 described invasive ICP measurements in
16 syndromic children with the following diagnoses: 5 Apert, 4
Crouzon, 3 Pfeiffer syndrome, 2 turricephaly, and 2 oste-
opetrosis. Fourteen showed increased ICP (>15mm Hg), that is,
all except 1 child with Pfeiffer syndrome and 1 child with
osteopetrosis.
Tamburrini237 described invasive ICP measurements in 12
syndromic craniosynostosis patients, of whom 5 with Apert, 4 with
Crouzon, and 3 with Pfeiffer syndrome. Eleven of the 12 children
had increased ICP. Most likely these are the same patients as
described in the 2004 article.
Kress60 reported a 35% prevalence (24/68 patients) of increased
ICP in Saethre-Chotzen syndrome on the basis of papilledema orrized reproduction of this article is prohibited.
nostosis
/Number of Patients Measured (%)
Saethre-Chotzen Muenke Complex
10/23 (43)
7/9 (78)
3/5 (60) 6/14 (43) 8/12 (67)
65/112 (58)
3/3 (100) 2/2 (100)
5/5 (100)
24/68 (35) 0/42 (0)
30/39 (77)
5/26 (19) 1/28 (4)
4/24 (17) 2/38 (5)
9/26 (35)
8/19 (42)
or London) and patient populations therefore could overlap. Most studies concern
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ledema, whereas 2 had increased dural tension intraoperatively.
Greene244 selected 39 patients with complex craniosynostosis
(excluding bilateral coronal suture synostosis and pansynostosis). In
this group, the risk of increased ICP was 76.9%, defined as
papilledema, a deflecting cranial curve or extensive endocortical
erosion on CT scan.
Foster238 investigated the occurrence of resynostosis after
primary skull remodeling in 31 patients with multiple suture
synostosis, 2 with Apert, 4 with Crouzon, and 5 with Saethre-
Chotzen syndrome. Percentages of resynostosis were 12.9%
(N¼ 4), 0, 25% (N¼ 1), 0 (N¼ 0), and 20% (N¼ 1), respectively.
In 1 patient with Saethre-Chotzen syndrome and 2 with multiple
suture synostoses increased ICP was found with lumbar puncture
before the second cranial vault expansion.
Bannink245 described the prevalence, treatment outcome, and
risk factors for increased ICP in 33 Apert, 43 Crouzon, and 8
Pfeiffer syndrome patients. Papilledema was documented preopera-
tively in 25 of 66 (38%) patients and postoperatively in 30 of 70
patients (43%).Overall, 43 of the 84 (51%) patients (12 Apert, 31
Crouzon/Pfeiffer syndrome) showed papilledema at some moment.
Impressions on skull x-ray or clinical symptoms such as headache
or behavior changes were not correlated with the presence of
papilledema and consequently proved unreliable screening
methods. Complex craniosynostosis, the diagnosis Crouzon/Pfeif-
fer syndrome, exorbitism, and ventricular dilatation were found to
be risk factors for papilledema.
Honnebier146 did not find signs of increased ICP in any of 16
patients with Muenke syndrome, but does not report in which way
and how frequently this was investigated.
Woods246 evaluated 34 Saethre-Chotzen patients with geneti-
cally confirmed diagnosis. Nine of the 26 patients (35%) with at
least 1 year follow-up developed increased ICP, as well as 8 of the
19 patients (42%) with at least 5 years follow-up, for which
reoperation was needed. Increased ICP was defined as a baseline
of 20mm Hg or higher, or 4 or more B-waves. The indications for
ICP measurement were papilledema, a deflecting cranial curve,
headache or aggressive behavior, impressions on skull x-ray,
narrow ventricles, Chiari malformation, with effaced basal cisterns
and sulci spaces.
De Jong54 reported the prevalence of increased ICP, on the basis
of papilledema, per syndrome, with the population of patients with
Apert and Crouzon/Pfeiffer syndromes the same as the 1 described
by Bannink in 2008.245
The 2004 review of Bristol et al reports a 53% to 89% range of
increased ICP (>15mm Hg), based on 98 patients with syndromic
craniosynostosis.240
In summary, the prevalence of increased ICP in syndromic
craniosynostosis is considerably higher than that in nonsyndromic
craniosynostosis. Preoperatively the risk seems to be approximately
40% to 50% for Apert, 50% to 70% for Crouzon and Pfeiffer, 35% to
45% for Saethre-Chotzen, 0 for Muenke syndrome, and 50% to 80%
for complex craniosynostosis. Increased ICP after a previous skull
remodeling is a real danger and is estimated at 35% to 43% in Apert,
Crouzon, Pfeiffer, andSaethre-Chotzen syndromes.This hasnot been
investigated for complex synostosis. In Apert syndrome patients, the
mean age during the second episode of increased ICPwas 3 years and
4 months with a maximum of nearly 6 years.152 In Saethre-Chotzen
the second operation on account of increased ICP was performed at a
mean age of 3.4 years, with a maximum of 8.5 years.246
Screening
The different methods to determine the ICP consist of invasive
measurements during 1 night and minimally 12 hours (such as
epidural sensor or lumbar puncture), fundoscopy, VEP-scan, orCopyright © 2015 Mutaz B. Habal, MD. Unautho
# 2015 Mutaz B. Habal, MDCT-scan (endocortical erosion). Increased ICP is almost routinely
defined as a baseline above 15mm Hg during slow wave sleep or
more than 3 plateau waves. Eide247 compared the mean ICPwith the
number of peak ICPs above 20mm Hg and is of the opinion that the
mean ICP does not do justice to the full ICP measurement. The
number of ICPs peaking above 20mmHg that should be considered
abnormal cannot be ascertained. The definition of a plateau varies
by author: The minimal level ranges from 20 to 35mm Hg, the
duration from 5 to 20 minutes.
I. Nonsyndromic Craniosynostosis.
Tuite248 compared in 74 children with nonsyndromic craniosy-
nostosis the presence of signs of increased pressure on skull x-ray
with invasive ICP measurement. Children with increased ICP more
often showed diffuse impressions, diastasis of the sutures and
erosion of the sella tursica. The sensitivity was very low, however,
and therefore these are unreliable screening methods for increased
ICP.
Tuite249 compared 58 patients with nonsyndromic synostosis
and 55 patients with syndromic, 9 with multiple suture synostosis.
Papilledema was established in 15 patients: 11 with syndromic
synostosis, 2 with multisuture synostosis, 1 with trigonocephaly,
and 1 with plagiocephaly. On the basis of an invasive measurement,
41 patients had increased ICP, 13 of whom showed papilledema. In
children above the age of 8 years papilledema was specific and
sensitive. Sensitivity at lower age was only 22%. Consequently, in
this young group the absence of papilledema is no guarantee for
normal ICP, but on the other hand the presence of papilledema is an
evident sign of increased ICP.
Stavrou (1997)229 reported on 9 children, among whom 1 with
plagiocephaly, 1 with trigonocephaly and 1 with scaphocephaly,
age range 1 to 6 years, who showed lowering of vision as a
consequence of an increased ICP.
Tamburrini237 concludes in a review of the literature that
assessing the mean ICP during sleep in combination with plateau
waves is the most reliable method indicating increased ICP.
Eide250 demonstrated in patients with shunt failure, hydrocepha-
lus or craniosynostosis that there is no relation between ventricle
size on CT scan and increased ICP. Also the change in ventricle size
is no predictor of ICP changes.
Marucci109 described that a progressive vertex bulge at the site
of the former anterior fontanel in scaphocephaly patients after early
and limited skull remodeling may be a sign of increased ICP.
In conclusion, it is not known how often a deflecting cranial
circumference growth curve is related to an increased ICP and
consequently it is hard to tell how useful it would be to include this
parameter in the follow-up program. Radiologic findings such as
impressions, ventricle size, or changes therein are unreliable as a
screening method for increased ICP. Papilledema found with
fundoscopy is highly probably a sign of increased ICP,251 but its
absence does not exclude an increased ICP. The reliability of
fundoscopy seems to be age-related, although described in only
one study. A VEP scan could show signs of increased ICP or onset
of optical nerve injury at an early stage, before papilledema
develops,252 but this technique has not been proven with the use
of invasive ICP measurements. In addition, a high percentage of
abnormal VEP scans (24%) were reported in a population of
predominantly nonsyndromic craniosynostosis patients, which is
higher than the proportions reported in other studies using invasive
ICP measurements.
Invasive ICP measurement remains the gold standard, but
naturally has disadvantages such as the need of anesthesia, surgical
intervention with risk of complications, and admission to an
intensive or high care unit. Generally, the threshold is set at a
baseline ICP exceeding 15mm Hg or more than 3 plateau waves,rized reproduction of this article is prohibited.
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this threshold is unclear, but it is adhered to by nearly all experts.
II. Syndromic Craniosynostosis.
Fok253 and Gault254 demonstrated in syndromic children that the
intracranial volume is no reliable predictor for the ICP.
Gupta prospectively follows the optical nerve of 33 patients with
nonsyndromic and syndromic craniosynostosis with the use of VEP,
echographic thickness measurement and fluorescence angiogra-
phy.255 Notably, multiple suture synostosis and exorbitism corre-
lated with injury to the optical nerve as a result of papilledema. The
VEP scans of all 5 patients with optic atrophy showed a prolonged
latency period. Fluorescence angiography is useful to diagnose
onset papilledema. Optical nerve thickness measurements are use-
ful in the follow-up of papilledema. The added value of VEP scans
with respect to fundoscopy is not made clear.
Campbell256 presented a patient with Pfeiffer syndrome who
underwent skull remodeling on account of papilledema, after which
the papilledema resolved but vision gradually worsened. Invasive
measurement still evidenced increased ICP in spite of the absence of
papilledema. Unexplained lowering of vision may therefore be an
indication for invasive ICP measurement, because absence of
papilledema is no guarantee for normal ICP.
Tuite248 compared in 49 children with syndromic craniosynos-
tosis the presence of signs of increased pressure on skull x-ray with
invasive ICP measurement. Children with increased ICP more often
showed diffuse impressions, diastasis of the sutures and erosion of the
sella tursica. The sensitivity was very low, however, and therefore
these are unreliable methods for screening on increased ICP.
Tuite249 compared 58 patients with non-syndromic synostosis
and 55 patients with syndromic, 9 with multiple suture synostoses.
Papilledema was established in 15 patients: 11 with syndromic
synostosis, 2 with multisuture synostosis, 1 with trigonocephaly and
1 with plagiocephaly. On the basis of an invasive measurement 41
patients had increased ICP, 13 of whom showed papilledema. In
children above the age of 8 years papilledema was specific and
sensitive. Sensitivity at lower age was only 22%. Consequently, in
this young group the absence of papilledema is no guarantee for
normal ICP, but on the other hand the presence of papilledema is an
evident sign of increased ICP.
Pollack243 described 22 syndromic children who routinely
underwent ophthalmologic screening for increased ICP preopera-
tively and 6-month postoperatively. Papilledema was found pre-
operatively in 4 and postoperatively in 8 at a mean age of 16.5
months. Only 3 of these 8 showed clinical symptoms, which implies
that this is an unreliable screening method.
Stavrou229 reported on 9 children, among whom 4 with Crouzon
syndrome and 2 with complex craniosynostosis, age range 1 to 6
years, who showed lowering of vision as a consequence of increased
ICP.
Connoly257 described selected patients with multiple suture
synostosis and signs of increased ICP. Most of them had Crouzon
syndrome (confirmed by FGFR2mutation) and generally showed a
normal skull shape at birth with progressive synostosis. Increased
ICP presented in these patients approximately at the age of 5 years.
The authors recommended frequent screening using fundoscopy but
did not indicate frequency or age limit.
Hoefkens258 described 9 Crouzon syndrome children with post-
natal synostosis, of whom 9 showed impressions on skull x-ray, 7
developed a bregma at the anterior fontanel, and 4 papilledema.
Tamburrini237 concludes in a review of the literature
that assessing the mean ICP during sleep in combination
with plateau waves is the most reliable method indicating increased
ICP.Copyright © 2015 Mutaz B. Habal, MD. Unautho
1766Liasis259 compares 3 ophthalmologic methods, viz. vision,
fundoscopy, and VEP scan in 8 syndromic children. All 8 showed
a decrease in N80 to P100 amplitude preceding surgery and an
increase postoperatively. Fundoscopy showed no abnormalities in 3
patients, progressive bilateral swelling in 3, and unilateral swelling
in 2 patients. Vision worsened in 1, improved in 4, and fluctuated in
2 patients, preoperatively. Invasive measurement demonstrated
increased ICP in 3 of the 8 children, of whom 1 showed abnormal
fundus, 1 unilateral papilledema, and 1 unnatural paleness of the
papilla. The authors conclude that solely vision or fundoscopy is
insufficient and that VEP will timely detect vision abnormalities.
This article, however, provides only little evidence for this!
Marucci152 described 24 patients with Apert syndrome who
were operated upon not until there were signs of increased ICP,
which was the case in 83% at a mean age of 18 months (range 1
month to 4 years and 5 months). Of the patients who underwent
operation, 35% experienced a second episode of increased ICP at a
mean age of 3 years and 4 months (range 1 year and 11 months to 5
years and 9 months). The increased ICP was defined as presence of
papilledema, an abnormal VEP scan, an ICP measurement>15mm
Hg, or more than 3 plateaus in 24 hours.
Bannink245 demonstrated that the presence of papilledema is not
associated with clinical symptoms such as vomiting, headache,
vision, or behavior change.
Woods246 evaluated 34 Saethre-Chotzen patients with geneti-
cally confirmed diagnosis. The indications for ICP measurement
were papilledema, a deflecting cranial curve, headache or aggres-
sive behavior, impressions on skull x-ray, narrow ventricles, Chiari
malformation, with effaced basal cisterns, and sulci spaces. Of the 9
patients with increased ICP, 3 showed papilledema, 6 delayed skull
growth, 5 headache or aggressive behavior, and 8 signs of increased
pressure on CT. The eldest patient with increased ICP was 9 years
old.
In conclusion, clinical symptoms do not seem to be reliable
screening methods for increased ICP. Also in syndromic cranio-
synostosis radiologic findings are an unreliable screening method
for increased ICP. The finding of papilledema on fundoscopy is
highly probably a sign of increased ICP, but its absence does not
exclude increased ICP. The reliability of a fundoscopy seems to be
age related, although this is addressed in only 1 study. Visual
evoked potential as screening method is reported by only 1 center
and its reliability is therefore hard to assess. An invasive ICP
measurement remains the gold standard, but naturally has disad-
vantages, such as the need of anesthesia, surgical intervention with
risk of complications, and admission to an intensive or high care
unit. Generally, the threshold is set at a baseline ICP exceeding
15mm Hg or more than 3 plateau waves, irrespective of the age of
the patient. The scientific underpinning of this threshold is unclear,
but it is adhered to by nearly all experts.
Prevention and/or Treatment
Generally a cranial vault expansion is performed within the first
year of life. A number of studies have shown that the prevalence of
increased ICP increases if the operation is performed after the first
year of life. This has been demonstrated for scaphocephaly141 and
plagiocephaly.103
The London center pursues a policy by which a patient with
Apert syndrome is operated upon not until there were signs of
increased ICP.152 Of the 24 patients, 83% developed increased ICP
at a mean age of 18 months (range 1month to 4 years and 5months).
Of these patients, 35% experienced a second episode of increased
ICP at a mean age of 3 years and 4 months.
The percentage of recurrent increased ICP is not essentially
different from the percentages reported by teams performing arized reproduction of this article is prohibited.
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that an early cranial vault expansion is effective both preventively
(for approximately 3 years) and therapeutically. The London center
policy has the advantage that a small number of patients eventually
does not undergo skull remodeling, but is it disadvantageous in that
patients need to be screened for signs of increased ICP very
frequently, for which there is no watertight method.
If increased ICP is established again at follow-up after an initial
cranial vault expansion, treatment may consist either of a second
cranial vault expansion or VP-drain insertion. The choice depends,
among other things, on the presence of progressive ventriculome-
galy (see chapter on hydrocephalus). As there is a relation between
ICP and OSAS it is important to determine the presence and severity
of OSAS in case of confirmed increased ICP, as treatment can be
adjusted to this.260,261 Please refer to the chapter on OSAS.
ConclusionsLevel 2Copy
# 2015 MThe prevalence of preoperatively increased ICP in nonsyndromic
craniosynostosis is 12% (range 5%–24%) in scaphocephaly, 9%
(range 0%–33%) in trigonocephaly, 10% (range 0%–22%) in
plagiocephaly, and 37% (range 31%–50%) in bilateral coronal
suture synostosis.B Renier, 1982142B Gault, 1992230B Arnaud, 1995141B Thompson, 1995231B Thompson, 1995232B Mathijssen, 2006103C Florisson, 2010110C Renier, 2000121Level 2 The prevalence of preoperatively increased ICP in syndromic
craniosynostosis is 40%–50% in Apert, 50%–70% in Crouzon
and Pfeiffer, 35%–45% in Saethre-Chotzen syndrome,
50%–80% in complex craniosynostosis, and zero in Muenke
syndrome. Increased ICP after an earlier cranial vault
expansion is estimated at 35%–43% in Apert, Crouzon,
Pfeiffer, and Saethre-Chotzen syndromes.B Renier, 1982142B Gault, 1992230B Thompson, 1995232C Renier, 2000121C Tamburrini, 2004236C Hayward, 2005241C Kress, 200660C Greene, 2008244C Marucci, 2008152C Bannink, 2008245C Woods, 2009246Level 2 Clinical symptoms and radiologic findings are unreliable
screening methods for increased ICP. A progressive vertex
bulge at the site of the former anterior fontanel may indicate
increased ICP. Papilledema is an evident sign of increased ICP,
but its absence does not exclude increased ICP.B Tuite, 1996248B Tuite, 1996249B Eide, 2002247C Tamburrini, 2005237C Pollack, 1996243C Bannink, 2008245C Marucci, 2008152C Woods, 2009246Level 3 An invasive ICP measurement remains the gold standard, but is
associated with disadvantages and complications, and is not
recommended as routine screening method. Increased ICP is
defined as a baseline ICP >15mm Hg (measured at least 12 hours
during sleep) and/or minimally 3 plateau waves with
ICP >35mm Hg, during at least 20 minutes.right © 2015 Mutaz B. Habal, MD. Unautho
utaz B. Habal, MDrized rC Tamburrini, 2005237C Pollack, 1996243C Marucci, 2008152C Woods, 2009246Level 3 Patients with a nonsyndromic craniosynostosis seem to have a small
risk of developing increased ICP after initial cranial vault expansion,
which may result in lowering of vision.C Florisson, 2010110C Stavrou, 1997229C Marucci, 2008152Level 3 VEP scans may have added value in screening for increased ICP,
next to fundoscopy.C Gupta, 2003255C Liasis, 2006259Considerations
In spite of the fact that patients with a nonsyndromic cranio-
synostosis only have a relatively small risk of developing
increased ICP with risk of loss of vision, this is a contributing
reason to recommend operation, apart from the esthetic aspect.
Also if operation is decided against it is of importance to
frequently monitor the child for signs of increased ICP until
the age of 6 years (at least once a year). The craniofacial team in
Rotterdam has occasionally encountered papilledema in children
with nonsyndromic craniosynostosis after cranial vault expansion
until a maximum age of 6 years. At the time of this writing, there
are no studies providing scientific underpinning for the maximum
age until when increased ICP in nonsyndromic craniosynostosis
should be monitored.
Muenke syndrome seems to distinguish itself from the other
syndromic types of craniosynostosis by a slight risk of increased
ICP. For this reason, 1 may consider to perform skull remodeling
somewhat later than is common for syndromic craniosynostosis,
which strategy seems to reduce the risk of recurrence of the
deformity (see chapter 6).
Performing a cranial vault expansion by protocol in
syndromic craniosynostosis, notably in Crouzon, Pfeiffer, Apert,
and Saethre-Chotzen syndromes, seems justified in view of the
high risk of increased ICP. A wait-and-see policy, implying
surgical intervention only when increased ICP has been
demonstrated, requires very intensive ophthalmologic monitor-
ing, and does hardly reduce the indication for surgery. Moreover,
there are no noninvasive screening methods that are 100%
reliable.
Confirming papilledema by means of fundoscopy requires great
experience. Reliability of the fundoscopy is better guaranteed when
it is performed by an ophthalmologist with experience in this
procedure in children.
Decision making on invasive ICP measurement should weigh
the risks, burden for patient and parents, and deployment of
resources (operation time, ICU-admission, anesthesia, and costs)
against the added value of this measurement. Invasive ICP
measurement is worth considering if the ICP level is decisive
for performing an initial operation or reoperation, or in case of
unexplained lowering of vision without papilledema. The project
group is of the opinion that routine invasive ICP measurement is
not indicated.
In view of the great risk of (recurrent) increased ICP, among
other things, in syndromic craniosynostosis, treatment by a multi-
disciplinary team is recommended, in which one person is function-
ing as primary treating physician and is provided with all relevant
information by the other team members, such as test results that are
suggestive of increased ICP.eproduction of this article is prohibited.
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In nonsyndromic craniosynostosis, screening for increased ICP
is recommended, by means of fundoscopy before the initial skull
remodeling and in follow-up at the ages of 2 years and 4 years.
In syndromic craniosynostosis, screening for increased ICP is
required, by means of fundoscopy before the initial skull remodel-
ing and yearly until the age of 6 years. Muenke syndrome seems to
be an exception to this requirement, but in view of the limited
scientific underpinning the same recommendation is made.
Fundoscopy requires experience and is performed by an ophthal-
mologist, who will inform the primary treating physician of the
results.
The finding of papilledema should be followed by a CT of MRI
scan to assess changes in ventricle size (hydrocephalus). Other
pathology that could contribute to an increased ICP, such as OSAS,
is excluded. An invasive ICP measurement should be considered in
case of unexplained lowering of vision, progressive vertex bulge
without papilledema, or doubt about the degree of ICP increase in
the decision making on reoperation.
The treatment of increased ICP is governed by the causal factors
and should be geared to these.9. HYDROCEPHALUS
Basic Questions1. WC
17hat are the prevalence, the causes, and the consequences of
hydrocephalus in the different types of syndromic craniosy-
nostosis?2. What screening method (type and frequency) is indicated to
timely detect hydrocephalus?3. When is the treatment indicated and what is the appropriate
treatment for hydrocephalus?Introduction
Patients with a syndromic craniosynostosis may be at risk of
developing hydrocephalus, which risk seems to be syndrome
dependent. Specific screening methods are needed because cranio-
synostosis-related hydrocephalus develops gradually and the classic
signs of hydrocephalus are often absent. Treatment of hydrocepha-
lus is discussed in this chapter as well, as it should be specifically
geared to this patient population.
Hydrocephalus occurs in more than one third of patients with
syndromic craniosynostosis. It is very rare in nonsyndromic cra-
niosynostosis, with an incidence not exceeding that in the general
population.262–265
The cause of expanded brain ventricles in craniosynostosis is not
clear.
In clinical practice, it is hard to recognize hydrocephalus, as the
classic signs of hydrocephalus or ICP may be fully absent.
Patients in whom expanded brain ventricles occur without
increased pressure, as often seen in Apert syndrome, should be
distinguished from cases in which expanded brain ventricles do co-
occur withICP, such as seen in the Crouzon and Pfeiffer syndromes.
Shunt placement or cranial decompression is indicated in the latter
patients to prevent papilledema and blindness.
Summary of the Literature
The current literature probably does not provide information on
the real incidence. Because skull remodeling operations exert anopyright © 2015 Mutaz B. Habal, MD. Unautho
68effect on ventricle width, only serial measurements are believed to
be reliable. Serial measurements are reported in a few articles, but
only in small groups of patients.264–266 Furthermore, the classic
methods of measuring ventricle width are not useful if head shape
and ventricle shape are abnormal.267 Volumetric measurements of
the ventricular system or CSF/brain ratios, which would be more
accurate in these patients, have not yet been described so far.
Taking these limitations into account, the literature does make
clear that ventricle dilatation mainly occurs in syndromic cranio-
synostosis, that is, 30% to 70% in Crouzon and Pfeiffer syn-
dromes262–264 and 40% to 90% in Apert syndrome.263–265,268
Hydrocephalus is occasionally reported in rare craniofacial syn-
dromes such as Shprintzen-Goldberg syndrome.269 Hydrocephalus
is incidentally found in isolated craniosynostosis, yet always on the
basis of coincidental causes.262,263,270
It remains unclear why hydrocephalus should develop in cra-
niofacial malformations. Two mechanisms have been suggested:
high liquid pressure owing to impaired venous drainage; and too
small posterior cranial fossa with poor liquid drainage from the
fourth ventricle. Hydrocephalus often co-occurs with Chiari I
malformation. As Chiari I malformation develops earlier than
the hydrocephalus, it is plausible that the small posterior cranial
fossa should cause Chiari I malformation, which in turn may give
rise to hydrocephalus.270–273 The progression rate of hydrocephalus
also seems to be determined by the severity of the Chiari I
malformation.263
Indications for aqueduct stenosis are not found.273,274
Hydrocephalus also occurs, however, in the absence of Chiari I
malformation, or may persist after decompression of the Chiari I
malformation. In these patients, the hydrocephalus is perhaps the
result of impairment of fluid resorption associated with impaired
venous drainage.275,276 Angiography and CT-V can show the
presence of extensive venous collaterals in syndromic craniosy-
nostosis.148 The presence of these collaterals is suggestive of
impaired venous drainage. Cinalli262 reported jugular vein stenosis.
Hydrocephalus is defined as a progressive increase of ventricle
width, associated with signs of ICP. This should be distinguished
from ventriculomegaly without ICP.262,264,267,270 The cause of
ventriculomegaly is unknown as well. Brain maldevelopment has
been suggested, or either atrophy or adaptation of the ventricular
system to the abnormal head shape.264–267 The latter theory is also
supported by the finding of a wider subarachnoid space at the level
of the largest cranial deformation.
The clinical symptoms of hydrocephalus in craniosynostosis
may cause confusion. Often the classic symptoms are absent and is
only gradually developing papilledema seen.
The literature does not provide recommendations on the sys-
tematic screening for hydrocephalus. Collmann proposes a prag-
matic approach in which routine MRI and MR venography are
performed on the guidance of risk factors present, that is complex
syndromic craniosynostosis, notably the Crouzon and Pfeiffer
syndromes, lambdoid suture stenosis, crowded posterior fossa,
and Chiari I malformation.263 Patients showing tonsillar herniation
or increased ventricle width should be regularly monitored for signs
of high pressure, notably papilledema. Frequency of monitoring is
not mentioned.
Treatment is only indicated in case of increased ICP or
progressively increasing ventricle width. Shunt placement produces
an effect counter to the 1 intended in the treatment of craniosy-
nostosis, that is, cranial expansion. Order and timing of treatment
modalities have never been systematically investigated. Renier277
recommends performing cranial vault expansion first, and then to
proceed to shunt placement—provided this is clinically feasible.
Collmann draws the attention to the fact that ventricle width
increases after each cranial vault expansion, a phenomenon whichrized reproduction of this article is prohibited.
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ment is only indicated if increased ICP should persist and papille-
dema, in spite of adequate cranial vault expansion, should still be
present after several weeks.263,270,278 In view of possible dislocation
of bone fragments, Collmann263 recommends delaying shunt place-
ment to at least 2 months after the cranial vault expansion.
The following alternative treatment methods for hydrocephalus
are available: posterior cranial fossa decompression, Chiari I mal-
formation decompression, and third ventriculocisternostomy. Still,
posterior cranial fossa decompression does not always exert a
favorable effect on hydrocephalus. Renier277 labels it as a challen-
ging intervention which should be reserved for those patients when
symptoms of tonsillar herniation are evident. Ventriculocisternost-
omy is not mentioned in the literature for this indication. Lumbo-
peritoneal shunt presents a risk in case of tonsillar herniation.30,263
There are no studies on the best way to organize follow-up of
hydrocephalus. In view of the specific problems it would seem
advisable to consult a neurosurgeon as soon as the MRI/MR-A
shows indications for progressively increasing ventricle width and
in the case of persisting papilledema. The same holds true if a shunt
was placed indeed, as the diagnosis of anomalous drainage can be
misleading.
ConclusionsLevel 3Copyri
# 2015 MuThe incidence of ventriculomegaly is probably 30% to 70% in
Crouzon/Pfeiffer and 40% to 90% in Apert syndrome, but
progressively increasing ventricle width with high ICP is
more frequently seen in Crouzon/Pfeiffer syndrome than in
Apert syndrome.C Cinalli, 1998262C Noetzel, 1985C Cohen, 1990267C Renier, 1996277C Hanieh, 1993268C Collmann, 2005263Level 3 Hydrocephalus is probably caused by impaired venous drainage and
a too small posterior cranial fossa with Chiari I malformation and
impairment of fluid resorption as a consequence.B Cinalli, 1998262C Cinalli, 1995271C Sainte-rose, 1984276C Thompson, 1997273C Jeevan, 2008148C Francis, 1992272C Taylor, 2001275C Collmann, 2005263Level 3 It is probably the case that MRI and MR-V screening for
progressively increasing ventricle width is indicated in patients
showing risk factors and/or papilledema.B Cinalli, 1998262C Gosain, 1996278Level 3 In principle, shunting is counterproductive to cranial vault expansion.C Collmann, 2005263C Renier 2006277Considerations
Although there is no published evidence that shunting is coun-
terproductive to cranial vault expansion, this is nevertheless highly
likely. The consequence of this supposition is that cranial vault
expansion is to be preferred during shunting in case of dilated brain
ventricles with signs of increased pressure. Even if an initial cranial
vault expansion has already been performed it is worth considering
if a second cranial vault expansion is indicated or feasible: for
example in case of skull growth retardation, persisting small cranialght © 2015 Mutaz B. Habal, MD. Unautho
taz B. Habal, MDvolume, and insufficient or cosmetically less appealing initial
correction. Shunt placement should be considered only if the cranial
volume has proven to be sufficient.
Recommendations
Hydrocephalus should be differentiated from ventriculomegaly
using serial imaging.
Magnetic resonance image-scanning before the first cranial
correction is indicated for all patients with syndromic or complex
craniosynostosis. Ventriculomegaly is to be monitored using MRI-
scanning and sixth-monthly fundoscopy. Progressively increasing
ventricle width or papilledema is managed according to a multi-
disciplinary treatment plan.
Shunting is counterproductive to cranial vault expansion. This is
why in hydrocephalus, too, all efforts should be directed at treating
increased ICP by means of cranial vault expansion. Placement of
a shunt is indicated if high ICP should persist for a prolonged time
(2 months) after adequate cranial vault expansion.
10. CHIARI I MALFORMATION
Basic Questions1. Wrizhat is the prevalence of Chiari I malformation in the different
types of syndromic craniosynostosis?2. What screening method (type and frequency) is indicated to
timely detect Chiari I malformation?3. How to prevent or treat this associated pathology?Introduction
The risk of Chiari I malformation widely varies between the
different types of syndromic craniosynostosis. The prevalence,
causes, consequences, and need of preventive treatment are largely
unclear—and even the definition is not unambiguous. Chiari I
malformation is best demonstrated using MRI-scanning. The
optimal frequency of scanning for the different types of craniosy-
nostosis, however, is not known, and it is not clear what treatment is
indicated—and when.
Summary of the Literature
Prevalence
Cinalli271 reported a 72.7% prevalence of chronic tonsillar
herniation in 44 patients with Crouzon syndrome and a 1.9%
prevalence in 51 patients with Apert syndrome, demonstrated on
MRI scans. Ages varied from 3 months to 30 years. Tonsillar
herniation was defined as absence of the cerebellomedullary cistern,
asymmetry, and relocation of the brainstem or cerebellar tonsils
herniating more than 2mm under the line joining the basion to the
opisthion. Premature synostosis of the lambdoid sutures (within the
first 24 months of life) seems to be associated with tonsillar
herniation.
Thompson273 shows in 10 patients a relation between extent of
tonsillar herniation and level of intracranial pressure and volume of
the posterior cranial fossa. This volume was determined with a two-
dimensional method, however. All 4 patients with a hydrocephalus
also showed tonsillar herniation.
A review article by Cinalli279 reports the following prevalence
rates: 70% in Crouzon syndrome, 75% in oxycephaly, 50% in
Pfeiffer syndrome, 100% in cloverleaf skull, and rare in Aperted reproduction of this article is prohibited.
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syndromic craniosynostosis patients with hydrocephalus, 53% of
the children with a Chiari I malformation do not show hydrocepha-
lus. Chiari I malformation develops earlier than hydrocephalus and
therefore seems to be a prerequisite for the development of hydro-
cephalus. Nevertheless, another contributing factor is essential for
the development of hydrocephalus.
Fearon147 found a Chiari I malformation in 23 of 28 (82%)
patients with Pfeiffer syndrome. Eleven patients of this group were
genetically tested: 9 had a FGFR2 mutation, 1 a FGFR1 mutation,
and 1 none. There is a reason; therefore, to question the diagnosis of
Pfeiffer in this article, and it would certainly not seem useful to
distinguish it from Crouzon syndrome.
Screening
The review article of Cinalli279 recommends MRI-scanning in
the syndromic craniosynostosis group with a high risk of Chiari I
malformation, but preferred ages or frequencies are not mentioned.
Synostosis of the lambdoid sutures within the first 24 months of life
seems to be a risk factor for Chiari I malformation.
In an earlier study by Cinalli271 no more than 19% (6/44) of the
Crouzon patients with tonsillar herniation were symptomatic. In the
review article of Cinalli,279 more than one third of the patients had
developed symptoms of Chiari I malformation or syringomyelia at
later age. Symptoms included suboccipital pain, painful torticollis,
syringomyelia syndrome, respiratory arrest, life-threatening brain-
stem dysfunction, and axial hypotonia. Symptoms may develop
rapidly, especially in very young children: breathing problems
(central apneas), bilateral vocal cord paralysis, bulbar palsy, venti-
latory control problems, persisting cyanosis, and breath-holding
spells.
In a study by Fearon,147 10 of the 28 Pfeiffer patients underwent
operative decompression in Chiari I malformation on account of
swallowing and coordination problems, headache when coughing,
syrinx formation, and central apneas. Protocolled screening with
annual MRI until adulthood is recommended without further under-
pinning.
Prevention or Treatment
Cinalli274 describes an operative technique combining occipital
expansion with suboccipital decompression in 4 patients with
syndromic craniosynostosis and Chiari I malformation. In all 4
patients, however, the Chiari I malformation remained present. The
authors who commented on the article (J. Venes, M. Choux, T.H.
Milhorat, A.H. Menezes, and D.A. Bruce) mainly address the
question whether surgical correction is actually indicated in asymp-
tomatic Chiari I malformation. They suggest that occipital expan-
sion as primary surgical intervention could possibly prevent the
development of Chiari I malformation. No later studies have
confirmed or rejected this supposition.
Fearon280 describes 5 syndromic children with Chiari I malfor-
mation who underwent frontal advancement. Radiologic character-
istics on MRI improved in all 5, postoperatively. The presence of
Chiari I malformation is considered a relative indication for decom-
pression.
Cinalli279 prefers an occipital cranial vault expansion as primary
surgical procedure in patients at risk of Chiari I malformation. In
selected patients, occipital expansion to correct the occipital cranial
deformity and repair of the Chiari I malformation by suboccipital
decompression can be combined in 1 operation. If the Chiari I
malformation develops later, venous drainage must be evaluated
before occipital decompression is performed. The venous drainage
systemof the posterior fossamaybeabnormal in the sense that venous
drainage of the brains is dependent on collateral emissary veins.Copyright © 2015 Mutaz B. Habal, MD. Unautho
1770Jeevan148 reports this phenomenon in 9 of the 11 evaluated Crouzon/
Pfeiffer patients, in 4 of whom this appeared to be the major drainage
system for the brains. The authors recommend venographic studies as
part of the preoperative evaluation of occipital decompression for
Chiari I malformation. Al-Otibi281 and Sandberg282 describe that for
this reason occipital decompression was withheld in 3 patients with
Chiari I malformation (2 with Crouzon/Pfeiffer syndrome and 1 with
osteogenesis imperfecta). Thompson presents a patient with a clo-
verleaf skull syndrome in whom division of occipital emissary veins
during elevation of the skin flap led to an acute rise in ICP, resulting in
death of the patient.234
Martinez283 describes a complication of occipital decompres-
sion in a Crouzon patient with Chiari I malformation, that is, an
arteriovenous fistula over the mastoid region.
ConclusionsLevel 2rized The prevalence rate of Chiari I malformation in Crouzon/Pfeiffer
syndrome is 70% and is very low in Apert syndrome.B Cinalli, 1995271C Cinalli, 2005279Level 3 Chiari I malformation in syndromic craniosynostosis mostly seems
asymptomatic and can only be established using diagnostic
radiology, preferably MRI.C Cinalli, 2005279C Fearon, 2001280Level 3 Patients with Crouzon/Pfeiffer syndrome often show abnormal
intracranial-to-extracranial venous drainage on which the brains may
be dependent.C Jeevan, 2008148C Al-Otibi, 2007281C Sandberg, 2007282D Thompson, 1995234Level 3 There are indications that surgical treatment of asymptomatic Chiari I
malformation is not proven indicated or effective, but instead may be
associated with risk of complications.C Cinalli, 1998274D Martinez, 1996283D Thompson, 1995234Considerations
Reliable information on the prevalence of Chiari I malformation
in Saethre-Chotzen syndrome, Muenke syndrome or complex cra-
niosynostosis is not available. The working group asserts that
annual screening for symptoms and MRI-scanning at ages 0 and
4 years is indicated in these groups of patients, until a new
recommendation is justified based on evidence from scientific
publications.
The working group considers it appropriate that the responsible
physician should request a baseline-MRI at the first referral of
Crouzon/Pfeiffer patients, followed by a check-upMRI at the age of
4 years. As the literature describes a relation between premature
fusion of the lambdoid sutures and the development of Chiari I
malformation, and in view of the fact that this fusion typically takes
place approximately the second year of life, MRI-scanning at the
age of 2 years may be indicated. The consequences of Chiari I
malformation in this group of patients are not yet clear, and routine
scanning is therefore not yet recommended. From ongoing research
it appears that 80% of the MRI-scans in children with syndromic
craniosynostosis at the ages from 6 to 12 years show brain abnorm-
alities. This is notably the case in Chiari I malformation in Crouzon
patients.
Symptoms consistent with Chiari I malformation should be
assessed during the annual follow-up visits, and further examination
by the pediatric neurosurgeon is indicated upon suspicion of Chiari Ireproduction of this article is prohibited.
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TABLE 11. Prevalence of Astigmatism in NonSyndromic Craniosynostosis (in
Brackets; Numbers of Patients With Unilateral Versus Bilateral Astigmatism)
Coronal Sagittal Metopic
Gupta255 2/7 (1/1) 7/29 (2/5) 3/7 (0/3)
The Journal of Craniofacial Surgery  Volume 26, Number 6, September 2015 Diagnoses of Craniosynostosismalformation. The pediatric neurosurgeon informs the responsible
physician about the findings, which may be reason to adapt the
follow-up program.
Recommendations
Screening for the presence of Chiari I malformation in patients
with Crouzon/Pfeiffer syndrome by means of MRI-scanning is
strongly recommended, that is, at the ages of 0 and 4 years and
on clinical suspicion of asymptomatic Chiari I malformation.
Surgical treatment of Chiari I malformation is recommended
only when the patient shows symptoms. Otherwise, active follow-
up is indicated with annual evaluation by the pediatric neurosurgeon
or pediatric neurologist of neurologic signs or symptoms, and, on
indication, MRI-scanning and instructions to the parents.
If occipital decompression for Chiari I malformation is indi-
cated, absence or presence of abnormal occipital venous drainage
should be demonstrated preoperatively with CT-V of MR-V.
11. VISION, REFRACTION, AND MOTILITY
ABNORMALITIES
Basic Questions1. WC
TAB
Gup
Vasc
# 2hat is the prevalence of vision and motility abnormalities in
the different types of nonsyndromic and syndromic craniosy-
nostosis?2. What screening method is indicated to timely detect vision and
motility abnormalities?TABLE 12. Ocular Abnormalities in Apert Patients According to Type of FGFR2
Mutation
P253R (%) S252W (%)Introduction
Impaired vision in craniosynostosis is caused by optic atrophy
secondarily to papilledema in increased ICP, primary optic atrophy,
corneal abnormalities in lagophthalmos, or amblyopia secondarily
to strabismus or refractive errors. Early detection and management
of these abnormalities is essential to retain vision.
Papilledema is discussed above in the chapter on intracranial
pressure, and exorbitism and hypertelorism are discussed in the
chapter on facial deformities. These aspects are left out of con-
sideration in the current chapter.
Summary of the Literature
Nonsyndromic Craniosynostosis
Only 2 studies report on ocular abnormalities in the various
types of nonsyndromic craniosynostosis and both concern small
patient groups, as shown in Tables 10 and 11.255,284 The 29 patients
reported by Vasco284 had no refractive errors and all 29 had normal
vision 12 months postoperatively. The most frequent abnormality
found 12 months postoperatively was strabismus in patients with
unicoronal craniosynostosis.
Two other studies only report findings in patients with unicor-
onal craniosynostosis.
Tarczy-Hornoch describes 25 patients with unicoronal cranio-
synostosis, of whom 56% showed amblyogenic anisometropia, andopyright © 2015 Mutaz B. Habal, MD. Unautho
LE 10. Prevalence of Strabismus in NonSyndromic Craniosynostosis
Coronal Sagittal Metopic
ta255 2/7 1/30 0/8
o284 5/7 1/12 1/10
015 Mutaz B. Habal, MD79% of whom had the largest refractive errors in the eye contral-
ateral to the synostotic suture.285 The authors make a plea for
evaluation of refraction anomalies, also in the absence of strabis-
mus.
MacKinnon286 describes 37 patients with unicoronal craniosy-
nostosis who all showed strabismus, of whom 20mild, 10 moderate,
and 7 severe.
Syndromic Craniosynostosis
Of all syndromic types of craniosynostosis, the most detailed
and comprehensive ophthalmologic publications concern the Apert
syndrome. The few studies addressing the other syndromes are of
good quality and report few contradictory results.
Jadico287 compares ocular abnormalities in 18 patients with
Apert syndrome, that is, 11 with S252Wmutation and 7 with P253R
mutation (Table 12). The S252W mutation is associated with more
severe ocular abnormalities, with significant differences regarding
strabismus, astigmatism, and blocked tear duct.
Khong288 makes a similar comparison between 20 S252W
patients and 9 P253R patients (Table 13).
Khong289 reports ophthalmic findings in 61 patients with Apert
syndrome.290 The most frequent cause of visual impairment was
amblyopia (prevalence 35%), followed by corneal abnormalities
(8%) and optic atrophy (5%).
Visual acuity <6/12 in best eye 19%; <6/12 in minimally 1 eye
54%.
Strabismus 63%
Ametropia 69% (hypermetropic 42%, myopic 27%)
Anisometropia (0.75 dioptry) 50%
Gray291 found in 71 Crouzon patients that amblyopia was the
most common cause of visual impairment (21%).
Visual impairment in minimally 1 eye 35%
Ametropia 77% (hyperopic 2 D 57%; myopic 0.5 D 20%)
Keratopathy 15% without consequences for vision
Jadico292 compared 10 patients with a TWISTmutation (Saethre-
Chotzen syndrome) with 11 patients with P250R FGFR3 mutation
(Muenke syndrome) (Table 14).
De Jong54 reports the following proportions of refractive errors
per syndrome in 132 patients: Apert 22/29 (76%), Crouzon/Pfeifferrized reproduction of this article is prohibited.
Strabismus 85 91
Ptosis 71 73
Amblyopia 43 73
Blocked tear duct 14 100
Myopia 14 36
Hypermetropia 14 9
Astigmatism 14 82
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TABLE 13. Ocular Findings in Apert Patients According to Type of FGFR2
Mutation
P253R (%) S252W (%)
Visual acuity <6/12 in best eye 20 12.5
Visual acuity <6/12 in minimally 1 eye 60 12.5
Visual acuity <6/12 (per eye) 40 12.5
Optic disc pallor 16 29
Amblyopia 56 20
Corneal abnormality and keratopathy (per eye) 25 21
Strabismus (per eye) 47 39
TABLE 15. Prevalence of Strabismus Presented as Percentage (Esotropia/Exo-
tropia)
Apert Crouzon Pfeiffer Saethre-Chotzen Muenke
Khan293 82.9 66.7 94.7 53.4 –
(48.8/34.1) (20.0/46.7) (15.8/78.9) (29.3/24.1) –
Gray291 39
Jadico292 70 horizontal 55
60 vertical 36
Jadico287 85 P253R
91 S252W
Khong289 65 (36/19)
Lehman294 39 63 horizontal
De Jong54 93 63 37 39
Mathijssen The Journal of Craniofacial Surgery  Volume 26, Number 6, September 201516/41 (39%), Muenke 17/35 (49%), and Saethre-Chotzen 14/27
(52%).
Khan293 reports findings in 141 patients with syndromic cra-
niosynostosis, without distinguishing between the different types.
In 52% of the 226 eyes, visual acuity is 6/12 or worse (46% of right
eyes and 58.4% of left eyes). In 39.8% of 113 patients, visual acuity
is 6/12 or worse in the best eye; and in 64.6% visual acuity is 6/12 or
worse in minimally one eye.
A review by Lehman294 recommends frequent monitoring of
refractive errors and motility abnormalities to prevent amblyopia
and to preserve vision.
A number of case reports describe absence of ocular muscles in
Apert syndrome, notably the superior rectus muscle, although other
muscles may be absent as well. This abnormality has also been
described for Pfeiffer syndrome.295–297
Table 15 gives an overview on prevalence of strabismus and
Table 16 on prevalence of astigmatism.
ConclusionsLevel 2Copyright © 2
TABLE 14. Ocular Findin
Muenke Syndrome
Ptosis
Amblyopia
Horizontal strabismus
Vertical strabismus
Blocked tear duct
Astigmatism
Inferior oblique overaction
Hyperopia
Myopia
Nystagmus
Optic nerve abnormalities
1772Vision, refraction and motility abnormalities occur very
frequently in all types of syndromic craniosynostosis.B Jadico, 2006287B Jadico, 2006292B Khong, 2007288C Gray, 2005291C De Jong, 200954C Khan, 2003293C Khong, 2006289C Khong, 2006290C Lehman, 2006294Level 3 Strabismus and unilateral astigmatism in nonsyndromic
craniosynostosis are seen almost only in unicoronal
craniosynostosis.C Gupta, 2003255015 Mutaz B. Habal, MD. Unautho
gs in Patients With Saethre-Chotzen Syndrome and
TWIST (%) FGFR3 (%)
90 36
70 18
70 55
60 36
60 0
50 9
40 45
40 27
30 18
30 18
30 27rized reproduc
TABLE 16. Prevalence of
Eye/Left Eye)
Apert C
Khan293 52.4 4
(54.8/50.0) (
Jadico292
Jadico287 14 P253R
82 S252W
Khong289 42
>1.5D.C Vasco, 2008284C Tarczy-Hornoch, 2008285C MacKinnon, 2009286Recommendations
In view of a high incidence of vision, refraction and motility
abnormalities, orthoptic and ophthalmic evaluation is indicated for
nonsyndromic unicoronal craniosynostosis and all syndromic types
of craniosynostosis. Referral for evaluation is initiated at the first
consultation in the tertiary center.
Follow-up is arranged dependent on the results.
12. OBSTRUCTIVE SLEEP APNEA SYNDROME
Basic Questions1. What is the prevalence of OSAS in the different types of
syndromic craniosynostosis?2. What screening method (type and frequency) is indicated to
timely detect OSAS?3. How can OSAS be prevented or treated?Introduction
The OSAS is characterized by episodes of partial and (or)
complete upper airway obstruction during sleep state.298–300 These
may lead to hypercapnia, hypoxemia, and abnormal sleep
architecture. Dependent on the severity of the syndrome, vital
dysfunctions to even fatal pulmonary heart disease may occur.
The clinical symptoms are diverse and are distinguished into
those occurring in the night: troubled sleep, snoring, apneas,
bedwetting and perspiration, and those occurring in the day: drytion of this article is prohibited.
Astigmatism (>1D) Presented as Percentage (Right
rouzon Pfeiffer Saethre-Chotzen Muenke
3.4 44.8 30.2 –
40.0/46.7) (47.4/42.1) (28.6/31.7) –
50 9
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functioning, poor school performance, and behavioral disorders.
Disturbed growth may occur at the long term.
Children with craniosynostosis syndromes are among the risk
groups for OSAS.
Early identification is of great importance in view of the severe
consequences of OSAS, and considering that good treatment mod-
alities are available.
Question 1: What Is the Prevalence of OSAS in
the Different Types of Syndromic
Craniosynostosis?
Themost reliablemethod to determine the prevalence of OSAS is
polysomnography (PSG). Not all studies on the prevalence of OSAS
in craniosynostosis, however, use PSG; some apply another method,
such as history taking, questionnaire, or desaturation-index.
Ja¨rund301 retrospectively evaluated the clinical data of 73 patients
with Apert, Crouzon or Pfeiffer syndrome and found that OSAS had
been confirmed using PSG in 24%. Kakitsuba302 performed PSG in 6
patientswith a craniofacial synostosis and identifiedOSAS in 4 of them
(67%). In another study, Ja¨rund303 established a 61%OSASprevalence
with the use of pulse oximetry in children with craniofacial malfor-
mations in whom OSAS was suspected. Pijpers304 retrospectively
evaluated the occurrence of airway obstruction in 72 children with
Apert (N¼ 28), Crouzon (N¼ 30), or Pfeiffer syndrome (N¼ 14).
Children’smeanagewas9.3years (0–17years). Polysomnographyhad
been performed in only 11 children. Symptoms of airway obstruction
had been documented for 19 children (26%). Sirotnak305 conducted a
reviewof11 studies in childrenwithCrouzon syndromeandestablished
a 41% prevalence of airway obstruction. This review does not provide
details on the methods used to detect breathing problems. Fearon147
described a series of 28 patients with Pfeiffer syndrome. Tracheotomy
was performed in 17patients (61%)on account of respiratory problems,
which were in part ascribed to abnormalities of the trachea (stenosis).
De Jong54 recently reported on the prevalence of OSAS in a group of
167 patients with syndromic craniosynostosis. Obstructive sleep apnea
syndrome, diagnosed by means of an abnormal saturation profile, was
seen in 31% of the patients with Apert syndrome, in 27% of patients
with Crouzon/Pfeiffer syndrome, and in 5% of the patients with
Muenke or Saethre-Chotzen syndrome (7).
Although OSAS was diagnosed with different methods, we may
conclude that the prevalence of OSAS in syndromic craniosynos-
tosis is high.
Question 2: What Screening Method Is
Indicated to Timely Detect OSAS?
General Diagnostics of OSAS History
Informing after symptoms related to OSAS is of essential
value:Troubled sleep, snoring, apneas, skin discoloration, bedwet-
ting, perspiration; and in the daytime: as an expression of hypox-
emia , respectively , and a restless sleep pattern , with both periods
of arousal and also periods of deep sleep: dry mouth when waking
up in the morning, fatigue, impaired cognitive functioning, poor
school performance and behavioral disorders.
Brouillette306 developed a scoring system based on the follow-
ing nightly symptoms:a. Breathing problems?Copyright © 2015 Mutaz B. Ha
# 2015 Mutaz B. Habal, MD0¼ never, 1¼ sometimes,
2¼ often, 3¼ always(having to work hard to breathe)b. Sleep apneas? 0¼ no, 1¼ yes
(gasping for breath, pause in breathing,
or obstructed breathing such that the
chest moves up and down without inhaling air)bal, MD. Unauthoc. snoring?rized reproduction of this article0¼ never, 1¼ sometimes,
2¼ often, 3¼ alwaysThe OSAS score is calculated with the following formula: 1.42
aþ 1.41 bþ 0.71 c – 3.83
Obstructive sleep apnea syndrome is considered to be present at
a score >3.5. At the time of this writing this is the only scoring
system applied in children suspected of OSAS.
Parental observation of video images of the child’s breathing
pattern during sleep could help making the diagnosis.
Bannink,307 in a study in a large group of children with
syndromic craniosynostosis, showed that a negative answer to
the question ‘breathing problems during sleep?’ may be sufficient
to exclude moderate or severe OSAS.
Diagnostic Tests
Continuous saturation measurement during sleep in combination
with blood gas analysis may provide insight into the severity of the
OSAS.
Polysomnography is essential, however, to diagnose OSAS with
certainty, and to accurately determine its severity. Polysomnogra-
phy simultaneously registers oronasal airflow, thoracic movements,
abdominal movements, transcutaneous saturation, and heart rate.
Furthermore, the sleep stages can be monitored with neurophysio-
logic examination (EEG, EOG, and EMG).
Inspection of the upper airway by theENT-physician, if necessary
supplemented with endoscopy, is indicated in patients with severe
obstructive symptoms. Obstruction may be present at multiple
locations—in the nose, rhinopharynx, oropharynx, and hypophar-
ynx—but also in the larynx or trachea. Diagnoses are: narrow nose,
septum deviation, allergic or nonallergic rhinitis, choanal atresia,
adenoid hypertrophy, midface hypoplasia, abnormal skull base,
tonsillar hypertrophy,macroglossia, abnormal palate, retro- ormicro-
gnathia, laryngeal stenosis, fused tracheal rings. Once the obstruction
has been localized, more targeted treatment can be started.
Imaging diagnostics (CT/MRI) of the obstructed area could
provide further information.
To further map the consequences of severe OSAS, cardiologic
examination is indicated to evaluate right ventricular hypertrophy
or pulmonary hypertension.
Grading of Severity of OSAS
The use of an apnea-hypopnea index (AHI) and an oxygenation-
desaturation index (ODI) is recommended to grade nocturnal
respiratory problems.
Brouillette306 showed that an abnormal saturation measurement
on the basis of the ODI only had a 97% positive predictive value for
the diagnosis of OSAS in a group of healthy children >1 year with
OSAS as a consequence of adenotonsillar hypertrophy. Saturation
measurement is not reliable, however, to exclude OSAS (negative
predictive value 47%). It is not known whether this holds true also
for children with a syndromic craniosynostosis.
Polysomnography in addition permits to determine an arousal
index, in which the total number of events is expressed as a
respiratory disorder index. Traditionally, many studies in children
applied criteria of OSAS applicable to adults. There, however, is
growing evidence that mild nocturnal breathing problems and
snoring may have neuropsychologic consequences. A major differ-
ence between children and adults with OSAS is that children may
experience longer periods of partial airway obstruction during
sleep, often without arousals or desaturations, but still with
increased CO2 concentration or increased breathing effort (which
can be measured with an esophageal pressure measurement). Partial
upper airway obstruction leading to ‘‘upper airway resistance is prohibited.
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diagnose OSAS.
The morbidity from each separate respiratory parameter (ie,
AHI, intermittent hypoxia, hypercapnia, or sleep fragmentation by
arousals), however, is unknown.308
The various guidelines distinguish between mild, moderate, and
severe OSAS. Guilleminault309 provided amuch-used classification
of OSAS based on the sum total of the number of apneas and
hypopneas. Brietzke310 in a systematic review reported the cutoff
values used to classify OSAS. This review addressed the question
whether history taking and physical examination would permit to
adequately diagnose obstructive sleep apnea/hypopnea syndrome.
In 4 studies, an AHI of>1 per hour was used as cutoff value,311–314
in 2 studies an AHI of >5/hr,315,316 and in 1 study an AHI >15/
hr.317 One other study established severe OSAS on the basis of an
AHI >10/hr and/or desaturation <75%.
Next to cutoff values for the AHI, the following parameters
should be determined to achieve comprehensive grading of OSAS
distinguishing between mild, moderate, and severe: depth of desa-
turation, end tidal CO2 peak level, total period of sleep in which the
CO2 value is>50 cmHg, and number of arousals per hour. Table 17
presents an overview of the most-used definitions provided by
different authors.
Basically, OSAS in children with syndromic craniosynostosis is
diagnosed in the same way as in other children. The clinical history
may raise suspicion of OSAS. Many children with syndromic
craniosynostosis will be snoring, but this symptom is not discri-
minative for OSAS.
The golden standard is PSG, with level or number of channels
dependent on the availability of equipment and the aim of the
screening. The above-mentioned criteria for the diagnosis of OSAS
are applicable, in principle, to all diagnostic groups.
Gonsalez260 investigated the occurrence of OSAS in 13 chil-
dren with syndromic craniosynostosis with PSG using 5 channels:
arterial oxygen saturation, heart rate, thoracic movements,
abdominal movements, and ECG. Nasal flow was not measured.
OSAS was classified as mild, moderate, or severe on the basis of
the PSG profiles and clinical observation, that is, the degree of
respiratory efforts, snoring, and inspiratory recessions. On
the basis of these criteria, OSAS was diagnosed in 11 of the
13 children.
Hayward (2005)241 investigated the relation between OSAS and
increased ICP in 11 children with syndromic craniosynostosis.
Obstructive sleep apnea syndrome was diagnosed using the same
method as in the previous study by Gonzales,260 with in addition
measurement of the oro-nasal flow. The presence of OSAS was
established in all children.
Question 3: How Can OSAS Be Prevented or
Treated?
Treatment of OSAS in General (See Also Guideline
on Pediatric OSAS)
Type of treatment of OSAS in craniosynostosis is determined by
severity of the symptoms and location of the obstruction, and is
aimed at improving upper airway patency. Treatment may be
pharmacological, for example, nasal corticosteroid spray or anti-
biotics; surgical, for example adenotonsillectomy; or nonsurgical,
for example, nocturnal O2 administration or continuous/bi-level
positive airway pressure ((continuous positive airway pressure
(CPAP) or bilevel positive airway pressure (BiPAP)).318–321
Conservative measures are often successful in the milder types
of OSAS, such as extensive nasal irrigation (saline lavage and air
spraying), treatment of intercurrent infections, and assuring a
specific sleep position.Copyright © 2015 Mutaz B. Habal, MD. Unautho
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after having confirmed that the hypercapnia will not worsen as a
result of reduced breathing activity after loss of the hypoxic drive in
chronic hypercapnia.
Adenotonsillectomy
Adenotonsillectomy is almost always the treatment of first
choice (also when adenoid and tonsils are not notably enlarged)
from toddler-age in healthy children with more prominent OSAS.
Little is known about the effect of adenotonsillectomy on OSAS
symptoms in children with syndromic craniosynostosis. Amonoo-
Kuofi322 conducted a retrospective analysis on the effect of ade-
notonsillectomy in a group of 26 children with syndromic cranio-
synostosis and moderate or severe OSAS. The criteria for mild,
moderate, or severe OSAS had been established by the researchers
themselves from a combination of clinical observation and a sleep
study. Adenotonsillectomy had been performed at a mean age of 4.5
years (range 1.6–13.9 years). Preoperatively, OSAS was severe in 7
children, moderate in 11, and mild in 7. Postoperatively, severe
OSAS was still found in 3 children, moderate in 6, mild in 1, while 5
children had no longer symptoms of OSAS. The authors concluded
that respiration had improved in 60% of the children. Therefore,
adenotonsillectomy is the treatment of first choice in children with
syndromic craniosynostosis and sleep-related respiratory problems.
The authors propose that adenotonsillectomymay be beneficial also
if the tonsils are small, and emphasize that multiple factors may
underlie the respiratory problems and that supplementary therapy
may be needed.
In craniofacial deformities, suturing of the tonsillar pillars may
be considered, upon which scar retraction may further contribute to
widening of the airways.
Nasopharyngeal Tube
Occasionally, placement of a nasopharyngeal tube (NTP) may
be necessary before more definitive treatment is initiated.
Ahmed323 evaluated the effect of initial NTP placement on mod-
erate or severe OSAS in 27 children with a syndromic craniosy-
nostosis. Mean age at nocturnal penile tumescence (NPT)
placement was 12.3 months, range 0.5–48 months. Seventeen
children had severe OSAS; 10 children moderate OSAS. After
NPT placement, airway obstruction and saturation profile had
improved in 26 of the 27 children (96%). The criteria for mild,
moderate, or severe OSAS had been established by the researchers
themselves from a combination of clinical observation and a sleep
study. For 26 of the 27 children, treatment could be evaluated at the
longer term. After 6 weeks, 24 children still had the NPT in place (1
child still underwent tracheotomy and 1 child died from a cause
unrelated to the respiratory tract). Nocturnal penile tumescence
remained the sole treatment in 23 of the 26 children, 6 months after
placement and in 17 of the 26 children 12 months after placement.
Having a NTP in place, however, may be very uncomfortable and
even not be tolerated, may cause mucosal retention, and lead to
comorbidity, such as fibrosis in the nasal cavity or chronic otitis
media. In the study of Ahmed,323 however, there were few com-
plications and tolerance was high.
Craniofacial Surgery
Mandibular distraction techniques and midface advancement
have been widely applied in syndromic craniosynostosis for several
years. Foreward advancement of bony structures will increase the
posterior–anterior diameter of the pharynx.324
Six recent studies looked into the effect of a Le Fort III
correction or a monobloc advancement procedure. In 5 of the 6
studies, a retrospective analysis was performed.rized reproduction of this article is prohibited.
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distraction procedure in 25 children with syndromic craniosynos-
tosis (age 10.4 4.2 years), 18 children of whom preoperatively had
respiratory problems. Six of these 18 children had a tracheostomy
preoperatively, and decannulation was possible in 5 postopera-
tively. Preoperatively, 9 children received respiratory support with
CPAP or BIPAP, which could be discontinued in 6 children after the
operation. Polysomnography was performed both preoperatively
and postoperatively in the 12 children without tracheostomy. In 10
children, the respiratory index improved from 33.4 to 12.6
(P< 0.05). In 2 children with a Chiari malformation associated
with severe central apneas, the respiratory index did not improve.
The authors concluded that a Le Fort III distraction has a clearly
positive effect on the airway obstruction and that the improvement
is dependent on the operative technique used. The authors point out
that a number of children showed persisting respiratory problems
postoperatively, as a consequence of insufficient widening, central
apneas, or respiratory problems located below the level of the
nasopharynx. The auteurs recommend assessing level of obstruction
(endoscopy or dynamic MRI) before undertaking a Le Fort III
procedure.
Fearon181 retrospectively evaluated the effect of a Le Fort III
procedure with halo distraction in 51 children with syndromic
craniosynostosis (mean age 8 years, range 3–16 years). Preopera-
tive and postoperative PSG had been performed in 12 children.
Postoperatively the respiratory index had improved from 24/hr. to
11/hr. (P¼ 0.004). Four children had a tracheostomy, which could
be removed in three. The authors concluded that in 13 of the 16
children with respiratory tract problems the operation had led to
improved respiration. They commented, however, that although
maxillary hypoplasia plays a central role, multiple factors may
underlie airway obstruction.
Arnaud144 prospectively investigated in a group of 36 children
with syndromic craniosynostosis (mean age 5.2 years) the effect of
frontofacial monobloc advancement with the use of an internal
distractor. Sixteen children showed upper airways problems, for
which 6 needed a tracheostomy, while in the other 10 children
saturation regularly decreased to <95%. Postoperatively, 4 of 6
children could be decannulated and desaturations were no longer
seen in 8 of the 10 children.
Witherow209 retrospectively analyzed long-term outcome (mean
follow-up 24 months, range 6 months to 4 years) of monobloc
advancement with distraction in 20 children (mean age 7.8 years,
range 2–16 years). Seventeen children had an upper airway obstruc-
tion, but test results or PSG are not mentioned. Of the 7 children
who needed a tracheostomy, 5 could be decannulated and CPAP
could be stopped in 2 of the 5 children treated with CPAP.
Mathijssen compared the effect on respiration of a Le Fort III
procedure (n¼24, mean age 6 years, range 4 months to 18 years)
with that of a frontofacial monobloc (N¼ 35, mean age 4.5 years,
range 7 months to 13 years).326 Respiratory problems were classi-
fied as mild in the case of snoring in combination with normal PSG,
and as severe if saturation decreased to below 90% or if the child
had a tracheostomy. Nine children who underwent a Le Fort III
procedure showed respiratory problems preoperatively, 7 children
had a tracheostomy. Postoperatively, 4 children could be decannu-
lated and symptoms disappeared in 2 children with mild or severe
respiratory problems. Respiratory symptoms recurred in 2 children.
Twenty-five children who underwent a monobloc procedure
showed respiratory problems preoperatively. Of the 6 children with
a tracheostomy, 4 could be decannulated. Symptoms improved in
17 of the 19 children with mild or severe respiratory problems.
Flores327 retrospectively analyzed airway changes in 20 children
with syndromic craniosynostosis after a Le Fort III distraction
procedure. In children with respiratory problems, PSG wasCopyright © 2015 Mutaz B. Habal, MD. Unautho
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disturbances during sleep was classified on the guidance of a
respiratory disturbance index (RDI): mild 2–5, moderate 5–10,
and severe >10. Disturbances were severe in 10 children, of whom
2 needed a tracheostomy. Postoperatively, 1 child could be decan-
nulated; in the second child this was not feasible on account of a
subglottic stenosis. Of the other 8 children with severe disturbances,
3 underwent PSG postoperatively, which showed lowering of the
RDI. The remaining 5 children showed subjective improvement of
the OSAS symptoms.
Bannink328 retrospectively evaluated the effect of a monobloc
(N¼ 3) or a Le Fort III procedure in 11 children with syndromic
craniosynostosis who received respiratory support on account of
airway problems. Respiratory support consisted of oxygen (N¼ 3),
CPAP (N¼ 3), NTP (N¼ 1) or tracheostomy (N¼ 4). Polysomno-
graphy had been performed in 6 children preoperatively, using the
following criteria: mild OSASAHI 1–5, moderate OSASAHI 6–
25, and severe OSAS AHI >25. On the basis of these criteria, 3
children had moderate OSAS, and 3 children had severe OSAS. At
long-term follow-up, 4 of the 11 children still needed respiratory
support (3 CPAP and 1 tracheostomy), whereas 1 child still showed
severe OSAS symptoms (respiratory support had been discontinued).
The above studies made clear that follow-up studies are needed
to demonstrate if mandibular distraction techniques have a lasting
effect on OSAS. It is not fully known how long and to what extent
improvement will be sustained, and what factors are involved. On
the other hand, it is known that both the mandible and the maxilla
will not grow in anterior direction postoperatively, which may
perhaps necessitate reoperation at a later stage (Bachmayer,
1986).196 Correction of the nasal septum may also be beneficial
in the treatment of OSAS.
Tracheotomy
In the above-mentioned studies reporting on the results of
craniofacial surgery, from 20% to 41% of children with respiratory
problems had undergone tracheostomy placement. Age at tracheot-
omy is mentioned in only 1 study.328 In total, 42 tracheostomies
(34%) were performed in 122 children with respiratory problems.
After a Le Fort III or monobloc procedure, 29 of 42 children (69%)
could be decannulated.
Continuous positive airway pressure or bilevel positive airway
pressure
Respiratory support by means of noninvasive treatment with
CPAP or BIPAP is an accepted treatment in children. A fitting
nasofacial mask, however, may not be available for children with
facial deformities. In addition, anatomic narrowing of the naso-
pharynx may complicate application of CPAP or BIPAP. Treatment
of respiratory problems with the use of CPAP or BIPAP was
described in 3 recent studies.209,325,328 It was applied in 17 of
the 46 children with respiratory problems in total, and could be
discontinued in 8 of these17 children after a Le Fort III or monobloc
procedure (47%).
Earlier, in 1996, Gonsalez et al329 reported on the effectiveness
of CPAP in the treatment of OSAS in children with syndromic
craniosynostosis.329 It was successful in 5 of the 8 children (age
2.2–15 years). Of the other 3 children, 1 did not tolerate the system,
second withdrew from the study, and the third showed a complete
obstruction of the upper airways by an enlarged adenoid.
ConclusionsLevel 2rized rThe diagnosis and severity of OSAS should be established with
the use ofPSG.eproduction of this article is prohibited.
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1776B Brietzke, 2004310Level 3 In children with syndromic craniosynostosis, the prevalence of
OSAS is high. The prevalence is highest in patients with Apert,
Crouzon, or Pfeiffer syndrome (range 24%–67%).C De Jong, 201054C Fearon, 2009147C Ja¨rund, 1996301C Ja¨rund, 1999303C Kakitsuba, 1994302C Pijpers, 2004304C Sirotnak, 1995305Level 3 The clinical diagnosis of moderate or severe OSAS can, in all
likelihood, be excluded if the clinical history does not point at
nocturnal breathing problems.C Bannink, 2010307Level 3 Adenotonsillectomy is the surgical therapy of choice from toddler
age if syndromic craniosynostosis is associated with OSAS.C Amonoo-Kuofi, 2009322Level 3 Nasopharyngeal tube placement may serve as temporary
treatment for upper airway obstruction.C Ahmed, 2008323Level 3 Continuous positive airway pressure or bilevel positive airway
pressure can be an effective treatment for OSAS.C Gonsalez,1996329C Nelson, 2008325C Witherow, 2008209C Bannink, 2010328Level 3 Nasopharyngeal tube placement may serve as temporary treatment
for upper airway obstruction.C Nelson, 2008325C Witherow, 2008209C Arnaud, 2007144C Mathijssen, 2006326C Flores, 2009327C Bannink, 2010328Level 3 Tracheostomy may be indicated in children with a severe upper
airway obstruction.C Ahmed, 2008323Level 3 It is likely that a Le Fort III or a monobloc procedure improves upper
airway problems.C Nelson, 2008325C Witherow, 2008209C Arnaud, 2007144C Mathijssen, 2006326C Flores, 2009327C Bannink, 2010328Considerations
Dependent on the severity of the symptoms in children with a
craniosynostosis syndrome, it is recommended to first determine a
nocturnal saturation profile. This is done by measuring the baseline
saturation (normally 94%) and next the number of desaturations
per hour (saturation <90% or 4% decreased compared with the
baseline value during 10 seconds (ODI¼ oxygenation desaturation
index)).Subsequently, additional PSG is indicated in children with
an abnormal saturation profile or a strongly suspicious clinical
history in combination with a normal saturation profile.
Many children with a syndromic craniosynostosis show an
anatomic narrowing of the nose, with mouth breathing as a result.
This complicates measurement of the nasal flow in a sleep study.
Measuring the X-flow is the alternative in this case, although this
has not yet been validated for this patient group.
There are indications that there is a relation between obstructive
respiratory problems and anICP. It is not clear, however, at what
degree of OSAS the intracranial pressure could increase. Still, it is
likely to occur both in prolonged mild OSAS and in short-lastingight © 2015 Mutaz B. Habal, MD. Unauthosevere OSAS. It is recommended, therefore, to perform comprehen-
sivePSF, including CO2 measurement, arousal detection and video
monitoring, in children with syndromic craniosynostosis who sho-
wICP.
Recommendations
In view of the high prevalence of OSAS in children with
syndromic craniosynostosis it is mandatory to screen these children
for OSAS.
If the clinical history documents nocturnal breathing problems,
further evaluation for OSAS should take place.
If the medical history does not document nocturnal breathing
problems, moderate and severe OSAS can be excluded, in all
likelihood, and further evaluation is then, in principle, not indicated.
Symptoms of OSAS in combination with an abnormal saturation
profile are strongly suspicious of OSAS. Additional PSG is indi-
cated in this case, to be performed according to the guideline on
pediatric obstructive sleep apnea syndrome (POSAS).
Polysomnography is indicated to determine OSAS severity.
Because multiple factors may underlie OSAS in children with a
syndromic craniosynostosis, endoscopy of the upper airways is
indicated to determine the level of obstruction.
Adenotonsillectomy is the surgical therapy of choice from
toddler age if syndromic craniosynostosis is associated with OSAS.
Obstructive sleep apnea syndrome in children with syndromic
craniosynostosis can be treated with the noninvasive ventilation
strategies CPAP and BIPAP.
In young children with severe OSAS a nasopharyngeal tube can
be used temporarily to ameliorate the symptoms.
A tracheotomy may be indicated in young children with severe
OSAS.
A Le Fort III procedure or monobloc advancement should be
considered in the management of respiratory problems in children
with a syndromic craniosynostosis and severe OSAS requiring
ventilator support.
The choice of treatment for OSAS is made on the basis of
severity of the OSAS, age of the patient, causal factors, and possible
other functional problems (such as ICP or exorbitism).
13. HEARING IMPAIRMENTS
Basic Questions1. Wrizhat are the prevalences, types, and causes of hearing
impairment for the different types of syndromic craniosynos-
tosis?2. What kind of screening is necessary to timely discover hearing
loss?Introduction
There are several reasons for patients with syndromic cranio-
synostosis to have hearing impairments. Hearing loss can be an
additional cause for developmental delay in children who already
have an increased risk of such delay. This chapter gives an overview
of the prevalences and types of hearing loss, and provides recom-
mendations on screening enabling early initiation of treatment qui-
ckly. Treatment itself will not be discussed, as it is in accordance
with otolaryngology guidelines.
Summary of the Literature
Since hearing loss hardly occurs in children with nonsyndromic
craniosynostosis, this chapter is restricted to syndromiced reproduction of this article is prohibited.
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reports and retrospective studies with usually a very low number
of patients, provides no clarity about the prevalence and the cause of
hearing loss in these patients.
Otitis media with effusion (OME) is reported in all types of
syndromic synostosis. Reported prevalence rates range from that
equal to that of healthy peers330 to 80% to 90% of the affected
children.331–334
The most recent article we found concerns a retrospective
review of CT scans of the petrous parts of the temporal bone of
20 patients with Apert syndrome.335 All 20 had middle ear and inner
ear deviations shown on CT. These patients were treated with
tympanostomy tubes and/or hearing aids. The authors make a plea
for CT scanning of the petrous part of the temporal bone of every
patient with Apert syndrome, especially if the air-bone gap should
persist after placing the tubes.334 For patients with Apert syndrome
the presence of a cleft palate makes no difference.
One longitudinal study describes how, over time, persisting
OME led to permanent sequelae such as atelectasis, perforation,
and cholesteatoma in patients with Crouzon syndrome.336 In this
study, ear and hearing impairment rates increased from 37% in
infancy to 62% in older patients. In Pfeiffer syndrome, anatomic
abnormalities of the external auditory canal and middle ear were
reported in a case report on 9 patients. Four of those patients had
OME as well.332
In Saethre-Chotzen syndrome, congenital middle ear abnorm-
alities are reported in a case report on 4 patients.330
In Muenke syndrome, mild to moderate perceptive hearing loss
in the lower and middle frequencies was found in from one third337
up to 95% of the reported patients.333 Honnebier146 finds in 7 of 10
patients with Muenke syndrome in whom audiometry was per-
formed an almost identical, mild (30 dB), symmetric perceptive
hearing loss in the low and middle frequencies. For 2 patients a mild
asymmetric and for 1 patient a mild bilateral mixed hearing loss was
found. In a retrospective analysis of 167 syndromic patients,
hearing loss is reported in 72% of the patients with Apert syndrome,
50%with Crouzon syndrome/Pfeiffer syndrome, 67%with Muenke
syndrome, and 37% with Saethre-Chotzen.54
Based on the auditory brainstem response (ABR) in syndromic
craniosynostosis and event-related potentials (ERP) in children,335
including patients with frontal plagiocephaly,338 there are indica-
tions that these children have an increased risk of auditory proces-
sing disorders. The relevance and consequences of this finding are
uncertain at this moment.
ConclusionsLevel 3Copy
# 2015 MIn all children with syndromic craniosynostosis the possibility
of OME should be considered.C Corey, 1987336C Doherty, 2007333C Prager, 2008330C Vallino-Napoli, 1996332C Zhou, 2009334Level 3 Congenital abnormalities of the inner ear, middle ear, and outer ear are
regularly seen in children with syndromic craniosynostosis.C Corey, 1987336C Doherty, 2007333C Prager, 2008330C Vallino-Napoli, 1996332Level 3 Mild to moderate perceptive hearing loss occurs especially in patients
with Muenke syndrome, with a prevalence of 33% to 95%.C Doherty, 2007333C Honnebier, 2008146C De Jong, 200954right © 2015 Mutaz B. Habal, MD. Unautho
utaz B. Habal, MDrized rD Hollway, 1998337Level 3 There are indications that auditory processing disorders occur in
children with syndromic craniosynostosis. So far, it has not been
documented whether this is the result of the synostosis or of the
often associated OME. Furthermore, the relevance of this disorder
and possible therapy are not clear.C Corey, 1987336C Church, 2007335D Balan, 2002338Considerations
As of 2006, all newborns in the Netherlands are screened for
hearing problems through the neonatal hearing screening program
(OAE/OAE/Algo through child and adolescent health care and
Algo/Algo on NICUs). Screening is scheduled to be performed
in the first 2 weeks of life, on NICUs sometimes, a bit later. The
screening can reveal both conductive and perceptive losses. After an
abnormal screening result for 1 or both ears, the children will be
referred to a dedicated regional audiological center. In the audio-
logical center, the child will be further tested until the nature of the
loss and the therapeutic possibilities are clear. The goal is to start
with an appropriate intervention (hearing aids) before the age of 6
months.
Any congenital losses (perceptive and conductive) are most
likely identified in the neonatal hearing screening. One should be
alert to problems that may occur later in life, especially OME.
Persistent conductive losses after treatment of OME require atten-
tion, especially monitoring by imaging. An early CT scan of the
petrous part of the temporal bone is useful to predict hearing
problems and to decide whether treatment should consist of a
hearing aid or a tympanostomy tube.
Recommendations
In the first 4 years of life an annual hearing test is indicated,
with tympanometry and otoacoustic emissions, and, if possible,
a pure-tone audiogram (from the age of 4 years, or somewhat
earlier depending on the level of development and the capacity to
follow instructions). After an unclear result, ABR and/or free field
testing are performed, which can take place at the local audiological
center.
The first skull-CT should include adequate sections of
the petrous parts of the temporal bone, so that any structural
abnormalities in the outer/middle and inner ear are identified at
an early stage and appropriate therapy can be chosen without
delay.
The therapy depends on the type of hearing loss (conform
otolaryngology guidelines) and may consist of tympanostomy
tubes, hearing aids (conventional, BAHA), or cochlear implant.
Treatment is performed by the audiologist, either local or at the
center. Reconstructive surgery for congenital middle ear abnorm-
alities can take place at a later age.
Speech/language monitoring commences at the age of 2 years
with standard speech and language assessment tests.
14. DENTOFACIAL DEFORMITIES
Basic Questions1. What is the prevalence and nature of dentofacial deformities in
syndromic craniosynostosis?2. What orthodontic care is indicated in syndromic craniosynos-
tosis?eproduction of this article is prohibited.
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Nature of Dentofacial Deformities in
Syndromic Craniosynostosis?
The literature does not contain reports on the prevalence of
dentofacial deformities in syndromic craniosynostosis. Below, we
address only publications describing the nature of the deformities:
Dentofacial deformities occur in almost all syndromic types of
craniosynostosis. It is not clear if patients with the syndrome of
Saethre-Chotzen and patients with the syndrome of Muenke are
affected as severely. Only one article on dental deformities is
available, describing 8 patients with the syndrome by Muenke.146
Dentofacial deformities are aggravated by the necessary surgical
corrections. Twenty-one articles report on dentofacial growth and
development in syndromic craniosynostosis.
The orthodontic and dental problems in syndromic craniosy-
nostosis are related to abnormal growth of the maxilla both in
vertical, transversal, and sagittal direction, on account of which the
maxilla is too hypoplastic in all dimensions.155,339–341 Normal
maxillary growth takes place by growth of the sutures around
the maxillary sutures, including the median suture.342,343 This leads
to forward and downward displacement of the maxilla (primary
displacement). In addition, growth of the skull base proceeding
from the synchondroses leads to forward and downward displace-
ment of the maxilla (secondary displacement). Moreover, apposi-
tion and resorption processes take place at the bone surface of the
maxilla.344 In normal development, growth at the level of the base
of the orbits is largest until the age of 8 years.345
The underlying mechanisms are probably twofold, that is synos-
tosis of the palatinal suture and the sutures around the maxilla, as
well as retarded growth from the cranial base. Reduced outgrowth
of the maxilla and the associated restriction of the upper respiratory
tract lead to mouth breathing and consequently to excessive open
bites.346–348 The maxillary transversal hypoplasia in addition leads
to a unilateral or bilateral cross bite.347,348
The maxillary hypoplasia results in an anomalous sagittal
relation between the upper and lower jaws. Furthermore, it nearly
always leads to severely delayed eruption of the dentition, retention,
and considerable ‘crowding’ in the upper dental arch.347–349 The
delayed dental development is probably the cause of abnormal
eruption patterns.350 Authors describe a narrow, high-arched palate
with co-occurring large lateral gingival swellings. The palatal
constriction and lateral swellings will intensify with age.347–
348,351 Gingival thickness probably contributes to the delayed
eruption of the dentition.347,352 Ectopic eruption of the first per-
manent molars occurs more frequently than in the normal popu-
lation, that is, in 50% of patients with the Apert syndrome and in
40% of patients with the Crouzon syndrome.353
Hypodontia is another frequently reported condition.348,349
Shape and size of the teeth may be abnormal,347,349 but this was
not found in the study by Letra.348 Good oral hygiene may be
problematic in these patients, not only because of insufficient space,
but also, for example, on account of the syndactyly in patients with
the syndrome of Apert.354,355 In addition, many patients breathe
through the mouth, so that inflammation of the gum tissue will be
resolved less easily.356,357
Compensatory changes in the lower dental arch are seen that are
related to the disturbed maxillary growth.358
One article makes clear that in view of the large number of
dental deformities orthodontic care is quite essential in patients with
syndromic craniosynostosis.349 Dental development is delayed by
at least 1 year, and this delay, next to other local factors, is
responsible for delayed eruption of the dentition.350 A number of
dentofacial characteristics, such as crowding, malocclusion, and
gingival swellings worsen during growth, but orthodontic treatmentCopyright © 2015 Mutaz B. Habal, MD. Unautho
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fewer parodontal problems.348
Basic Question 2: What Orthodontic Care Is
Indicated in Syndromic Craniosynostosis?
In view of the many dentofacial deformities (see above under
question 1), extensive orthodontic care and guiding, including space
management and eruption guidance, should start at a young age.
The general standard for current-day orthognathic treatment is
both pre- and postoperative orthodontic treatment.359 The ortho-
dontic-surgical intervention must be planned carefully, also on
account of the skeletal malalignment of the jaws.359,360 It is not
clear whether distraction osteogenesis to resolve airway problems,
exophthalmia, or other objective problems could lead to further
midface growth inhibition. The degree of mandibular growth is not
clear.154 As long as the face has not fully grown, it is not possible to
reach the ultimate goal on occlusion level.155,157,197 Insufficient
information is available on the stability of the Le Fort III distraction
osteogenesis (see facial deformities).181 Orthognathic surgery after
reaching the skeletal age of 18 years is usually indicated to obtain
normal alignment of the jaws and occlusion.
The following factors should be taken into account when plan-
ning treatment: patient’s emotional age, mental age, and the related
degree of cooperation.344 There is no research available on the
retention phase after orthodontic treatment in syndromic craniosy-
nostosis patients. It is not likely that this would be different from
that in patients without syndromic craniosynostosis. From a study,
in nonsyndromic craniosynostosis patients it appeared that retention
is necessary after orthodontic treatment.361
ConclusionsLevel 3rized reIt is plausible that the orthodontic and dental problems associated
with syndromic craniosynostosis are related to the abnormal
growth of the maxilla both in vertical, transversal, and sagittal
direction, on account of which the maxilla is too hypoplastic
in all dimensions.B Kreiborg, 1981340Level 3 There are indications that dental development is delayed with at least
1 year, which results in delayed eruption and abnormal eruption
patterns of the permanent teeth.B Kaloust, 1997350Level 3 The maxillary hypoplasia leads to skeletal malalignment of the upper
and lower jaws and to severely delayed eruption of the dentition,
retention, and severe crowding of teeth in the upper dental arch.C Dalben, 2006349B Kaloust, 1997350C Letra, 2007348C Kreiborg, 1992347Level 3 There are indications that the eruption of the dentition is delayed
by thickened gingival tissue.C Kreiborg, 1992347C Solomon, 1973352Level 3 Ectopic eruption of the first permanent molars occurs much more
frequently than in the normal population.C Cohen, 1996353Level 3 Reduced growth of the maxilla and the associated restriction of the
upper airways lead to mouth breathing and consequently to
excessive
open bites.C Letra, 2007348C Kreiborg, 1992347B Peterson-Falzone, 1981346Level 3 A number of dentofacial characteristics worsen during growth;
orthodontic treatment could reduce the worsening.C Letra, 2007348production of this article is prohibited.
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# 2015 MuThe experts agree that the teeth may be abnormally shaped and sized.C Dalben, 2006349C Kreiborg, 1992347Considerations
Syndromic craniosynostosis is classified among the ‘rare dis-
eases’ and from the above analysis of the available literature it
appears that there is hardly any or no evidence at all. It is of great
importance, therefore, that treatment centers both nationally and
internationally apply a standard documentation schedule. This
would allow for data pooling and gaining more knowledge on
the clinical course of the syndromic craniosynostosis over time as
well as the effects of interventions.
Especially for this group of patients it is more difficult to obtain
an adequate level of oral hygiene with orthodontic treatment. This is
in part because of developmental and behavioral problems (see
Chapter 18) but also to physical problems such as hand deformities
(see Chapter 15).
Regarding the deciduous teeth, the focus is on space manage-
ment and eruption guidance. At this stage, surgery on orbital and
dentofacial level is to be avoided, if possible, in view of further
growth of the orbits and the location of the odontoblasts. Three-
dimensional x-ray examination should be performed as soon as
combined orthodontic-surgical treatment is scheduled (surgical
aspects are dealt with in detail in Chapter 7).
During the first and second dentition transition phases various
treatment strategies are feasible, such as dental or skeletal maxillary
widening, eruption guidance and series extraction, or a combination
of both. Any permanent teeth extractions should be done with future
surgery in mind. Delayed dental development and abnormal erup-
tion patterns are reasons to continue with regular orthodontic check-
ups. Functional problems may necessitate coordinated orthodontic
treatment and surgical intervention as integral parts of the com-
prehensive management of syndromic craniosynostosis. If hyper-
telorism is present necessitating facial bipartition, orthodontic space
between the central incisives must be provided.
Combined orthognathic treatment in sagittal direction is less
obvious in patients aged between 12 and 18 years. The skeleton has
not yet fully grown and puberty is starting.
Still, transversal corrections can take place in this period in
preparation to the definitive sagittal corrections. In view of the
three-dimensional complexity it would seem obvious to first perform
the transversal and next the sagittal correction. Because in syndromic
craniosynostosis patients the maxillary suture closes earlier, trans-
versal distraction osteogenesis will mostly be indicated at this stage.
The expansion device may be either tooth borne or bone borne.
The definitive sagittal correction is performed as soon as
sufficient coordination of the dental arches has been reached at
the age from 18 to 20 years.
Orthodontic-surgical management requires careful three-dimen-
sional cephalometric planning in consultation with the surgeon.
Presurgical orthodontic treatment is aimed at alignment of the
dental arches and preparing for surgery. A rigid or semirigid dental
anchoring construction is needed if surgery is performed in com-
bination with distraction osteogenesis. In internal distraction osteo-
genesis, traction both at dental and skeletal level is needed to
guarantee maximum stability, security, and optimal vector control
during the active phase ( 1 month) and retention phase ( 3
months) of the distraction osteogenesis. Bone anchoring is a must,
traction at dental level only is advised against in all cases. During
the internal distraction osteogenesis, (extra) internal traction can be
used such as a face mask. In all patients, postoperative stabilization
should be achieved using intermaxillary elastic bands and/or a face
mask. Orthognathic surgery is needed (also on account of theight © 2015 Mutaz B. Habal, MD. Unautho
taz B. Habal, MDcharacteristic open bite) to achieve the optimal end result, that
is, normal alignment of the jaws and occlusion. On the other hand,
psychosocial problems and (low) level of cognitive functioning may
dictate compensating orthodontic management only.
Provided the oral hygiene allows for this, permanent retention is
achieved by means of retention wires and in addition a retention
device that stabilizes the dental arches in relation to each other.
Regular monitoring is essential and evaluation should take place at
least 2 years after treatment.
There is no solid evidence that orthodontic management and
counseling of patients with syndromic craniosynostosis should be
teamwork. Still, in view of the complex multidisciplinary nature of
the problems this would seem obvious; the necessity of teamwork
has been accepted worldwide for conditions such as cleft, to name
one. From the perspectives of the patient and parents/care takers,
however, the burden will be heavy as usually multiple stages of
active orthodontic therapy are indicated, and treatment con-
sequently will continue over several years. A patient and
parents/care takers will have to visit the treatment center at least
10 times a year. Thus, a balance must be found between a limited
number of centers for the orthodontic management of craniofacial
deformities and good geographical distribution nationwide.
Recommendations
Oral hygiene must be monitored more intensively in comparison
with the normal population.
Regular orthodontic monitoring is necessary in view of delayed
dental development and abnormal eruption patterns (1 to 4 times a
year).
In case of surgical intervention, coordinated orthodontic-surgi-
cal treatment is an integral part of the comprehensive management
of syndromic craniosynostosis (surgical aspects are dealt with in
detail in Chapter 7).
Immediately after surgery/distraction osteogenesis, orthodontic
retention is indicated to stabilize the result and prevent relapse.
Provided the oral hygiene allows for this, permanent retention is
achieved by means of retention wires and in addition a retention
device that stabilizes the dental arches in relation to each other.
To ensure stability of the combined orthodontic-surgical inter-
ventions, orthodontic and facial orthopedic monitoring of the
development into adulthood is indicated by means of standard
protocol. Evaluation at least 2 years after treatment is required.
Instruction: Orthodontic Management. Monitoring
in a Multidisciplinary Setting
To ensure stability of the combined orthodontic-surgical inter-
ventions, orthodontic and facial orthopedic monitoring of the
development into adulthood is indicated, to be scheduled in relation
to the characteristic developmental stages of the head and dentition.
It is recommended to follow the schedule below (this is the
recommended minimum set of records).
0 year Frized reprirst consultation soon after birth: 3608 stereo image
or digital face and skull photographs (preoperatively).0 to 2 yrs. The craniofacial team proceeds along the lines of the care
path for cranial (surgical) problems.2 to 4 yrs. First meeting with the craniofacial team: digital intra- and
extraoral photographs, three-dimensional stereo image,
global dentofacial assessment.6 yrs. Team and orthodontic check-up, documentation, if necessary
treatment and monitoring (digital intra- and extraoral photographs,
radiologic skull profile (RSP), orthopanthomogram (OPT),
three-dimensional stereo image, models).9 yrs. Team and orthodontic check-up, documentation, if necessary
treatment and monitoring (digital intra- and extraoral
photographs, RSP, OPT, three-dimensional stereo
image, models).oduction of this article is prohibited.
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(preorthodontic
treatment)
TCopyrigh
1780eam and orthodontic check-up, documentation (cone beam
computed tomography (CBCT), or in second instance RSP,
OPT), digital photographs, three-dimensional stereo image,
models).Postorthodontic
treatment
Team and orthodontic check-up, documentation (CBCT,
or in second instance RSP, OPT), digital photographs,
three-dimensional stereo image, models).End documentation
(end of growth)
Team and orthodontic check-up, documentation (CBCT, or in
second instance RSP, OPT), digital photographs,
three-dimensional stereo image, models). If desired,
definitive correction can be jointly planned. In principle
this is the end of the team care path.15. DEFORMITIES OF THE EXTREMITIES
Basic Questions1. What are the nature and prevalence of the deformities of the
upper and lower extremities for the different types of syndromic
craniosynostosis?2. What kind of screening is required to diagnose these
deformities and how to proceed?Introduction
As part of the phenotype of the craniosynostosis syndromes,
deformities of the extremities are frequently seen, varying from
very mild with hardly any functional consequences to very complex
with very severe functional limitations. Deformities of the extre-
mities that co-occur with a functional limitation need treatment, for
which both timing and method are of relevance.
Summary of the Literature
Deformities of the hands and feet and, in less severe conditions,
of the elbows, shoulders, knees, and hips, are reported for the
syndromic types of craniosynostosis.
Deformities of the extremities are described for the following
syndromes:1) Apert2) Crouzon/Pfeiffer3) Saethre-Chotzen4) MuenkeApert Syndrome
Hands
Complex (bony) syndactyly is practically symmetrically present
in both hands, with involvement of at least the index finger, middle
finger, and ring finger. Finger movement is only possible at the
metacarpophalangeal (MCP) level and sometimes at the level of the
proximal interphalangeal (PIP) joint in the little finger.362All other IP
joints are either present or stiff. Stiffness is a constant symptom, even
after the fused middle 3 fingers are separated at an early stage.363
Upton364 and Cohen365 both describe a classification system for
severity of the syndactyly. The classification system of Upton is the
one most commonly used:
Type 1) Complex syndactyly of the digits 2, 3, 4, while digits 1
and 5 are separated. There is a simple syndactyly of the digits
4 and 5. The thumb is short, broad, and deviates radially (in
45% of the Apert hands).t © 2015 Mutaz B. Habal, MD. UnauthoriType 2) Complex syndactyly of the digits 2, 3, 4 with simple
syndactyly of digits 1 and 5. Synonychia of digits 2, 3, 4 and 5 is
seen, although digit 5 may have its own nail. There is slight
webbing of the soft tissue of the first web space. The thumb is
short, broad, and deviates radially (in 39% of the Apert hands).
Type 3) Complex syndactyly of all fingers. All fingernails
show synonychia, which often gives rise to ingrowth of nails
and, consequently, to nail bed infections. Preaxial and postaxial
polydactyly may occur. The thumb is often poorly developed (in
16% of the Apert hands).Radiography: The thumb always has 2 phalanges: a better devel-
oped distal phalanx and a proximal deltaphalanx. This does not apply
to type3hands.Over time, fusion of theproximal anddistal phalanges
of the thumb can be seen. The MCP joints are always visible as such.
Depending on the hand type there can be fusion between the end
phalanges of the digits 2 and 3; 2, 3, and 4; or between all. Sometimes
there is fusion between the basis metacarpal (MC) 4 andMC 5 (never
in type 1, 77% in the remaining types).366 Carpal fusion between the
capitate bone and hamate bone may occur.
Additional anatomic deformities of the hands consist of a
deviating vein pattern and nerve pattern, especially distal on the
MC level,364 deformities of the flexor retinaculum, flexor tendons,
extensor tendons, and intrinsic hand muscles. All these anatomic
variations have implications for the surgical treatment.
Elbows
In the majority of the 10 Apert patients who were evaluated, the
elbow functions were normal and less than half had radiologic
deformities.364 Limited elbow functionality had a strong positive
correlation with the severity of the hand and foot deformities.
Progression toward synostosis will occur in patients with no elbow
movement at birth. A proximal underarm synostosis between the
radius and ulna was not reported.
Shoulders
Upton364 evaluated 19 Apert patients and found a prominent
acromion, a broad major tuberositas, a small glenoid fossa of
scapula, an indistinctly defined anatomic neck of the humerus,
and an ovoidal shape of the humerus head. The glenoid dysplasia is
most consistent. The range of motion in abduction, anteflexion and
external rotation is limited and is further limited by growth.364,367
Murnaghan368 reports limited movement of the shoulder in the
majority of Apert patients as well, especially by flexion and
abduction. These are notably caused by the inclination of the
inferior glenoid and rather not by soft tissue abnormalities or
degenerative deformities.
Feet
The hands are always more severely affected than the feet.
Children with Apert walk at a relatively late age (10–34 months). It
is not reported why they are walking at a late age.369 The big toe
may be bifid.
The classification of the foot deformities parallels that of the
hand;
Type 1) Digits 2, 3, and 4 are fused. The big toe is short,
shortens progressively, and often deviates medially.
Type 2) Digits 2, 3, 4, and 5 are fused.
Type 3) All toes are fused (in most patients).
Progressive fusion of the tarsus and metatarsus is seen making
the movement of foot and ankle increasingly difficult over time.370zed reproduction of this article is prohibited.
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TABLE 17. Grading of OSAS Severity
Mild Moderate Severe
Guilleminault309
Apneaþ hypopnea 1–5 events/hr 5–24 events/hr >24 events/hr
Sheldon448
AHI 1–4 5–10 >10
Desaturation 86–91 76–85 75
Peak end tidal CO2 >53 >60 >65
End tidal CO2 %TST 10–24 25–49 50
Arousals per hour with EEG >11 >11 >11
Galland449
Apnea index or 1–4 events/hr 5–9 events/hr >10 events/hr
Desaturation in association with obstruction Nadir of 87%–91% Nadir of 76%–85% Nadir of <75%
Hypoventilation 10%–24% total sleep time 25%–49% total sleep time >50% total sleep time
Goroza450
AHI 5–15 events/hr 16–30 events/hr >30 events/hr
Desaturations 81%–90% 71%–80% <71%
AHI, apnea-hypopnea index; EEG, electroencephalogram; TST, total sleep time.
TABLE 18. General Overview of the Treatment and Timing of Apert Hands by
Upton
Age Procedure
1–6 months Incision and drainage of macerations and nail bed infections
First web release
6–18 months Separating the fingers
Release of joints
4–6 years Release of clinodactylic thumb
Excision of metacarpal synostosis
Nail bed revision
7 yrs-adolescence Osteotomy of the fingers
Osteotomies
Web revisions
Metacarpal and carpometacarpal arthroplasty
Soft tissue debulking
The Journal of Craniofacial Surgery  Volume 26, Number 6, September 2015 Diagnoses of CraniosynostosisThe first digit shortens with medial deviation from the big toe,
secondary to growth deformities and a delta phalanx. In the toes
with 2 phalanges, fusion occurs while retaining minimal movement
in the metatarsophalangeal (MTP) joints. The midfoot and hindfoot
characteristically fuse in a supination position. The fifth metatarsal
is prominent with callus formation under the small head of the fifth
and third metatarsal bones.364
Knees and Hips
Upton364 finds no functional deformities of the knee and hip in
19 patients.
Therapy
The aim of treatment is to create a deep, first web, to treat and
prevent nail bed infections, to correct the position and length of the
thumb and to divide the fingers to improve the pincer grip.364
Upton advises early treatment of macerations and nail bed
infections, approximately at the age of 1 to 6 months. Experience
has shown that this is an important problem for very young Apert
patients, but specific numbers cannot be found in the literature.
Literature is conclusive about the necessity for an early initial
web release in type 3 hands. Fereshetian371 performs web release in
between 3 and 6 months in type 3 hands, Zucker372 and Fearon373 at
6 months, and Guero374 in between 6 and 9 months. Guero374
advocates a bilateral correction as well.
In general, it is advised to separate the remaining fingers
between the ages of 6 and 18 months.366,371,372–374
Corrective osteotomy of the thumbs is recommended at the age
of 2 to 2.5 years by Chang,375 at 4 to 6 years by Fereshetian,371 at
6 to 9 years by Fearon,373 and at 4 to 6 years by Upton.376
Corrective osteotomy of the fingers is recommended at between
ages 4 and 7 years,371 6 and 9 years,373 and from 7 years.376
InMathes’s textbook entitled Plastic Surgery, Upton376 provides
a general overview of the treatment and timing of Apert hands
(Table 18):
Regarding the outcome of the hand functions at a later age,
Upton reports that in general the first web is shallow, the fingers
short and stiff, but that the strength of the pincer grip is
almost normal.376 Strength of the grip function is 30% of the
normal value as a result of the lack of IP movement of the second,
third, and fourth finger and distal IP movement of the fifth finger.
For type 3 hands the release of theMC synostosis provides themostCopyright © 2015 Mutaz B. Habal, MD. Unautho
# 2015 Mutaz B. Habal, MDimportant functional improvement by enabling the thumb-pink
pincer grip.
Literature about the treatment of feet deformities in Apert
syndrome is considerably rarer than that about hand deformities.
Fearon sometimes recommends corrective osteotomy to the head of
MC 2 when this is prominent at the plantar side of the foot.373 The
aim is to have a smooth underside. Usually specially adapted
footwear is sufficient for adequate function, without surgical treat-
ment. In case of problems, a combination of specially adapted
footwear and surgical correction of prominent MC heads and/or
excessive callus formation is indicated to obtain maximum func-
tionality.370
Saethre-Chotzen Syndrome
Anderson describes the radiologic hand deformities of 15
patients with Saethre-Chotzen syndrome (solely based on the
phenotype).377 All patients in prepuberty showed delayed skeletal
development. Most frequent finding (7/15) was an enlarged epi-
physis of the distal phalanx of the thumb, followed by flattening of
the distal epiphysis of the radius (4 patients), pseudoepiphyses in the
metacarpals (3 patients), and individuals with camptodactyly,
clinodactyly, hypoplasia of the middle phalanx, long metacarpals,
and Kirner’s deformity of the distal phalanx of the little finger.rized reproduction of this article is prohibited.
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Panthaki reports brachysyndactyly with cutaneous syndactyly of the
second and third finger and clinodactyly as characteristic of
Saethre-Chotzen syndrome.378
Two studies are most reliable, because they only describe
patients with a genetically confirmed TWIST1 mutation or
deletion.60,379
Trusen reports deformities found in a population with geneti-
cally proven Saethre-Chotzen syndrome.379 A double distal phalanx
of the big toe was found in 12/35 patients and a triangle epiphysis of
the distal phalanx of the big toe in 10/35 patients. These 2
deformities turn out to be pathognomonic for Saethre-Chotzen.
Furthermore, additional hand and foot deformities were described
in respectively 28 and 27 patients (Table 19).
Kress60 found soft tissue syndactyly of the second and third
fingers in 52 of the 71 Saethre-Chotzen patients (with proven
TWIST1 deletion of mutation) and bifid hallux in 44.
Muenke Syndrome
In 1997, Muenke described a large series of patients with the
FGFR3 P250R mutation and their phenotype.49 Patients with this
mutation are later diagnosed as havingMuenke syndrome. The hand
deformities described in this study consist of brachydactyly (13/44),
clinodactyly (14/33), coned epiphyses (6/8), carpal fusion (2/16),
thimble-like midphalanx (12/20), and an absent or fused midpha-
lanx of the pink (2/19). The foot deformities are a broad hallux (6/
23), brachydactyly (11/42), coned epiphyses (6/7), calcaneocuboid
fusion (6/17), and a short and broad midphalanx (2/16).
Kress compares 71 Saethre-Chotzen patients (proven TWIST1
mutation or deletion) with 42 Muenke patients (proven P250R
FGR3 mutation).60 Cutaneous syndactyly of the second and third
finger or a bifid hallux was seen in none of the Muenke patients.
Trusen described hand and feet deformities of patients with
Muenke and Saethre-Chotzen syndrome.379 Calcaneocuboid fusion
is seen only in patients with Muenke syndrome.379 Additional hand
deformities in 8 patients with Muenke are given in Table 20.
Crouzon/Pfeiffer Syndrome
Before the discovery of the FGFR2 mutation that causes both
Crouzon and Pfeiffer syndromes, the distinction between these 2
clinical diagnoses was based on the deformities of the extremities.
In most patients of hand and foot deformities, the diagnosis was
Pfeiffer syndrome. Because a number of identical FGFR2Copyright © 2015 Mutaz B. Habal, MD. Unautho
TABLE 19. Additional Hand and Foot Deformities in Saethre-Chotzen Syn-
drome, According to Trusen
Hand Brachyphalangy 21
Clinodactyly 17
Syndactyly—second web 15
Syndactyly—third web 2
Carpal fusion 8 (NN¼ 24)
Trapezium-trapezoid fusion 6
Cone-shaped epiphyses 9 (NN¼ 17)
Foot Brachyphalangy 10 (NN¼ 26)
Clinodactyly 12
Partial syndactyly 14
Tarsal fusion 10 (NN¼ 25)
Cone-shaped epiphyses 15 (NN¼ 17)
Duplication distal phalanx hallux 12
Triangular epiphysis distal
phalanx hallux 0
1782mutations are reported in patients who were clinically diagnosed
with either Crouzon or Pfeiffer syndrome, the distinction between
these 2 syndromes seems to be of less relevance.
Cohen describes Pfeiffer syndrome, in which the deformities of
the extremities consist of broad thumbs and halluces with radial or
medial deformities, brachydactyly, and a varying degree of syn-
dactyly.380 Progressive ankylosis of the elbows is possible.
Anderson describes mild radiologic deformities of the feet, such
as deformities in shape, fusion or underdevelopment of the pha-
langes, metatarsalia, and tarsalia.381 Only 3 of the 18 patients had no
deformities.
The FGFR1 P25R mutation shows characteristic hand and foot
deformities with partial webbing of the fingers with broad thumbs
and big toes, deviating toward medial, and characteristic syndactyly
of the second web and sometimes of the third web.382 The patients
of the reported 3 families had, however, minimal or no craniosy-
nostosis. Some patients had ankylosis of the elbow.
Therapy: surgical corrections of the hands are necessary in only
very few patients.
ConclusionsLevel 1rized rep
TABLE 20. Ad
Trusen
Hand
FootIt has been shown that Apert syndrome always co-occurs with
severe deformities of the upper and lower extremities.A2 Wilkie, 1995383A2 Bochukova, 2008384Level 1 Crouzon/Pfeiffer, Saethre-Chotzen, and Muenke syndrome co-occur
with mild deformities of the hands and feet.A2 Muenke, 199749B Kress, 200660B Trusen, 2003379Level 3 It seems likely that type 3 hand deformity in Apert syndrome
requires early correction (between 3 and 6 months).C Fereshetian,1991371C Guero, 2005374C Upton, 1991364C Zucker, 1991372D Upton, 2006376Considerations
Patients with (still) unoperated hands frequently show parony-
chia. Hardly anything about this condition, however, is reported in
the medical literature. These infections cause a lot of discomfort forroduction of this article is prohibited.
ditional Hand Deformities in Muenke Syndrome, According to
Brachyphalangy 8
Clinodactyly 4
Syndactyly second web 1
Syndactyly third web 1
Carpal fusion 1
Trapezium-trapezoid fusion 1
Cone-shaped epiphyses 4 (NN¼ 7)
Brachyphalangy 5
Clinodactyly 1
Partial syndactyly 5
Tarsal fusion 2
Cone-shaped epiphyses 6 (NN¼ 7)
Duplication distal phalanx hallux 0
Triangular epiphysis distal
phalanx hallux 0
# 2015 Mutaz B. Habal, MD
The Journal of Craniofacial Surgery  Volume 26, Number 6, September 2015 Diagnoses of Craniosynostosisthe patient and require intensive care. Early treatment of the
complex syndactyly improves this situation. Therefore, either pre-
vention or treatment of paronychia is an additional reason to
commence with early treatment of the hand deformity.
Recommendations
The functions of the upper and lower extremities of Apert patients
need to be monitored during time with physical examinations and
radiography. Treatment of the hands should commence at the earliest
age possible, especially for type 3, and preferably performed simul-
taneously for both hands by a pediatric surgeon.
Monitoring of the lower extremities is performed by a pediatric
orthopedic surgeon/pediatric rehabilitation physician/pediatric plastic
surgeon.
16. COGNITIVE FUNCTIONING AND BEHAVIOR
Basic Questions1. WC
# 2hat is the prevalence of cognitive and/or behavioral problems
for the different types of nonsyndromic and syndromic
craniosynostosis?2. What are the possible risk factors for cognitive and/or
behavioral problems in patients with craniosynostosis?3. What kind of screening (nature and frequency) is indicated for
the detection and treatment/guidance of the problems?NONSYNDROMIC CRANIOSYNOSTOSIS
Introduction
There is a large body of research on the cognitive functions
and behavior of children with nonsyndromic craniosynostosis.
The results of these studies, however, differ greatly; some
researchers report hardly any cognitive and/or behavioral problems
in children with nonsyndromic craniosynostosis,39,141,385–387
whereas others report very high percentages (up to 100%) of
cognitive and/or behavioral problems. This discrepancy can often
be explained by the methodological limitations that characterize
many of these studies. A few of the most prevalent methodological
limitations are- insufficient description of how patients were recruited, so that it
is not clear whether the patient group is representative, or
whether there may be a selection bias;- the studied groups are often small; moreover, the ages of the
children vary greatly, necessitating the use of many different
measurement instruments;- often measurements instruments are applied that are not
standardized, validated, or normalized;- in studies on the prevalence of behavioral or learning problems,
the results are often not corrected for IQ;- the established prevalence of, for example, behavioral problems
or a low IQ, is not compared with that of the general population.
In this chapter, only those studies with a reasonably reliable
design (level B or C) are used to answer the above-mentioned basic
questions. All articles that do not have minimally level C are
disregarded.opyright © 2015 Mutaz B. Habal, MD. Unautho
015 Mutaz B. Habal, MDSummary of the Literature
Question 1: What Is the Prevalence of
Cognitive and/or Behavioral Problems for the
Different Types of Nonsyndromic
Craniosynostosis?
Intelligence
In 2 large studies (N¼ 167 and N¼ 86) on trigonocephaly, it
was shown that children with nonsyndromic trigonocephaly (tri-
gonocephaly without other birth defects) as a group have an average
IQ-score that does not differ from that of the standard group.39,387 In
the study by Lajeunie, the average IQ-score of this group was 103
(N¼ 127, SD¼ 12),39 in the study by Van der Vlugt387 it was 104
(N¼ 60, SD¼ 20). These studies also showed that children with
nonsyndromic trigonocephaly are not more likely to have an
intellectual disability.
In a smaller study, (N¼ 24) Kapp-Simon388 found that very
young children with trigonocephaly (average test age 7.3 months)
had an average score (MDI-score¼ 94; SD¼ 6) on the mental scale
of the Bayley Scales of Infant Development (BSID-II), but a low
mean score (PDI-score¼ 84; SD¼ 11) on the motoric scale of the
BSID-II. Speltz389 and Starr390 found in respectively 27 and 35
children with trigonocephaly scores comparable with those reported
by Kapp-Simon388 on the mental scale of the BSID-II (Speltz:
MDI¼ 95, SD¼ 7; Starr: MDI¼ 92) and on the motoric scale of the
BSID-II (Speltz: MDI¼ 87, SD¼ 14; Starr: MDI¼ 84). The
articles of Kapp-Simon388, Speltz,389 and Starr390 seem to deal
with the same patient group, to which patients are added. It appears
to be a prospective, multicenter study. The preoperative test data of
the children are reported in Kapp-Simon388 and Speltz.389 The mean
age of the children was 7.3 months in the study by Kapp-Simon and
6.5 months in the study by Speltz. Starr390 reports both the pre-
operative and the postoperative test data of the children. The latter
study only analyzed data of those children for whom both pre-
operative and postoperative test data, however, were available.
And, while the response rates in the studies by Kapp-Simon and
Speltz are high (respectively 83% and 89%), the response rate drops
to 55% when only the data are analyzed from the children for whom
both preoperative and the postoperative test data are available. The
average age of the children at postoperative testing was 18.4
months.
There are, therefore, some differences in the results of the
studies between, on the 1 hand, the studies by Lajeunie39 and Van
der Vlugt387 and on the contrary, those from Kapp-Simon,388
Speltz,389 and Starr.390 Lajeunie and Van der Vlugt report that
children with nonsyndromic trigonocephaly as a group have
an average IQ-score and no increased risk of intellectual
disability. The patient group from Kapp-Simon, Speltz, and Starr
obtained as a group an average score on the mental scale of the
BSID-II (MDI¼ 94, 95, and 92), but a lower mean or even a low
mean score on the motoric scale of the BSID-II (PDI¼ 84, 87,
and 84).
One possible explanation for these differences is that the data of
the children with nonsyndromic and with syndromic trigonocephaly
in the studies by Lajeunie and Van der Vlugt are represented in
comparison. From these data, it appears that children with syn-
dromic trigonocephaly have a strongly increased risk of intellectual
disability (IQ< 70). The patient groups of Kapp-Simon, Speltz, and
Starr consisted of both children with nonsyndromic and with
syndromic trigonocephaly. Only data from the group as a whole,
however, are presented. It is, therefore, possible that the lower
scores they found might be on account of the lower scores of the
children with syndromic trigonocephaly in particular.rized reproduction of this article is prohibited.
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difference in age: the children in the study by Kapp-Simon388
and Speltz389 were very young (mean 7.3 and 6.5 months, respect-
ively); those in the studies by Lajeunie39 and Van der Vlugt387 were
older (mean 1.13 year and 7 years, respectively). Moreover, the
standard scores of the BSID are considered insufficient by the
COTAN (Dutch Committee on Testing Practices), especially for
children younger than 12 months. Also, the MDI and PDI scores on
the BSID at a very young age (4 months) are poor predictors for the
IQ-score at a later age (4.5 years).391 It is also remarkable that the
control group, as reported in the article of Speltz,389 obtained
significantly lower scores as well at the BSID-II in comparison
with the standard group.
Mathijssen103 found that more than 90% of 220 children with
frontal plagiocephaly (with and without the P250R FGFR3
mutation) had an IQ of >90. There was no significant difference
in IQ between children with and without the P250R mutation. In
studies from 1993 and 1998 in 17 and 35 patients with plagioce-
phaly, respectively, Kapp-Simon392,393 found that they as a group
obtained average scores on the mental scale of the BSID-I (N¼ 17,
MDI¼ 101, N¼ 35, MDI¼ 98).
The results of the multicenter study by Kapp-Simon,388
Speltz,389 and Starr,390 similar to the trigonocephaly group, deviate
slightly from those of the above-mentioned studies. Kapp-Simon
reports data of 18 patients with plagiocephaly. The mean score of
these children on the mental scale of the BSID-II (MDI) was 93; that
on the motoric scale 85. Speltz390 reports data of 28 children with
plagiocephaly, theMDI was 90 and the PDI 83. In the study by Starr
(response rate 55%) in 36 children, the MDI was 88 and the PDI 82.
A number of studies showed that the mean IQ of children with
scaphocephaly does not deviate from that of the standard group and
that children with scaphocephaly do not have an increased risk of
intellectual disability.141,233,385,386,393
In their most recent study, Kapp-Simon,388 Speltz,389 as well as
Starr,390 however, report that children with scaphocephaly score
significantly lower on the BSID-II than the standard group: Kapp-
Simon: N¼ 49, MDI¼ 90, PDI¼ 85; Speltz: N¼ 62, MDI¼ 91,
PDI¼ 84; and Starr: N¼ 86, MDI¼ 94, PDI¼ 84.
Summarizing, the results of most of these studies show that the
children with nonsyndromic craniosynostosis as a group do not
significantly deviate from the standard group with regard to intelli-
gence and do not have an increased risk of intellectual disability. In
the multicenter studies by Kapp-Simon, Speltz, and Starr children
with craniosynostosis as a group, however, scored significantly
lower than the standard group on both the mental and the motoric
scale of the BSID-II. In the study by Kapp-Simon, the MDI scores
distribution in the patient group, however, differed significantly
from that of the standard group. Children with craniosynostosis had
no increased risk of a score <85 on the mental scale of the BSID-II
(more than 1 SD lower than the average of 100). Remarkably, none
of the children in the patient group, however, had an MDI> 115.
Total 48% of the studied children scored <85 on the motoric scale
of the BSID-II (versus 16% in the standard group). Not a single
child from the patient group also scored>115 on the motoric scale,
whereas this was 16% in the standard group. Moreover, in the
studies by Kapp-Simon, Speltz, and Starr, the study findings are not
presented separately for children with nonsyndromic and with
syndromic craniosynostosis, which may have led to lower test
scores.
Language
Kapp-Simon388 used the Preschool Language Scale III (PLS-III)
to evaluate the expressive and receptive language skills of 100
children with isolated craniosynostosis (mean age 7.3 months).
The PLS-III has 2 scale indices: the respective (PLS-AC) and theCopyright © 2015 Mutaz B. Habal, MD. Unautho
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is 100 with a standard deviation of 15. The average score of the total
patient group was 90 on the receptive and 96 on the expressive scale.
And, even though both scores arewithin the standard range (85–115),
these are significantly lower than the norm score.
The 24 children with trigonocephaly obtained an average score
of 91 (SD¼ 13) on the receptive scale and an average score of 98
(SD¼ 13) on the expressive scale. For children with plagiocephaly
(N¼ 18), the average score was 89 on the receptive scale and 97 on
the expressive scale. And for the 49 children with scaphocephaly,
the average score on the receptive scale was 91 and on the
expressive scale was 95. A group of 9 children with lambdoid
synostosis obtained an average score of 88 on the receptive and 94
on the expressive scale of the PLS-III. In the (same) study by
Speltz389 in 125 children, the average scores on both the receptive
and the expressive scale of the PLS-III of the craniosynostosis group
did not significantly differ from those of the control group. But both
the groups scored somewhat lower than the standard group on both
scales (craniosynostosis group: PLS-III-AC¼ 92, PLS-III-EC¼ 97;
control group: PLS-III-AC¼ 95 and PLS-III-EC¼ 97).
A study by Shipster233 in 76 children with scaphocephaly (mean
age 4 years and 7 months) seems to show that these children have a
significantly increased risk (37% versus 6% in the general popu-
lation) of specific speech/language problems (¼ speech/language
problems that are not the result of a low IQ), notably expressive
language problems.
Other Cognitive Functions
Young children with nonsyndromic craniosynostosis obtained
memory and response inhibition task scores that did not deviate
significantly from the scores of a control group without craniosy-
nostosis.394
Behavior
Children with trigonocephaly who have an IQ of 85 or higher,
have no increased risk of behavioral problems.387 Children with
trigonocephaly who have an IQ lower than 85, have a (strongly)
increased risk of behavioral problems, similar to all other children
(without craniosynostosis) who have an IQ of lower than 85.387,395
Bolthauser386 studied the behavior of 24 children with scapho-
cephaly using the Child Behavior Checklist (CBCL). The average
scores of the patient group (CBCL total score, CBCL internalizing
score, and CBCL externalizing score: T¼ 52.9, T¼ 53.0, and
T¼ 52.53, respectively) were within the normal range (40–60).
SYNDROMIC CRANIOSYNOSTOSIS
Introduction
There are only a few studies reporting on cognitive functions and
behavior in children with syndromic craniosynostosis. Only very
few of these studies are on B or C level; and are even lacking for
some syndromes. In the latter patients, studies may not meet the C-
level criteria and therefore may not be very reliable as well.
Summary of the Literature
Question 1: What Is the Prevalence of Cognitive
and/or Behavioral Problems for the Different
Types of Syndromic Craniosynostosis?
Intelligence
Children with syndromic trigonocephaly (¼trigonocephaly
together with other birth defects) have a significantly increased
risk of intellectual disability. In the study by Lajeunie39 more than
34% of the children had an IQ< 70. In the study by Van derrized reproduction of this article is prohibited.
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was 83 (N¼ 32; SD¼ 22) in the study by Lajeunie and 89 (N¼ 26;
SD¼ 20) in the study by Van der Vlugt.
Mathijssen103 found that more than 90% of 220 children with
frontal plagiocephaly (with and without the P250R FGFR3
mutation) had an IQ of >90. There was no significant difference
in IQ between children with and without the P250R mutation.
Children with Apert syndrome seem to have a strongly increased
risk of intellectual disability.265,396,397 Patton397 reported that 52%
of the 29 patients in his study had an IQ lower than 70. In the study
by Renier,265 this percentage was 50%.
The average IQ of the patient group of Lefebvre396 was 74, that
of Renier265 62.
In a study by Shipster398 on cognitive functions, speech and
language skills of children with Apert syndrome, the cognitive
functions, however, were on an average level. The cognitive
functions were studied using the Core Subscales of the British
Ability Scales (BAS-II). These consist of 2 verbal tests and 2 tests
on nonverbal functions. These 4 subtests provide a score for the
general cognitive ability (GCA) and a nonverbal composite (NVC),
based on the 2 nonverbal subtests. For both scales, the norm score is
100 with a standard deviation of 15. The children with Apert
syndrome obtained an average score of 94 on the verbal scale
(GCA) and an average score of 96 on the nonverbal scale (NVC).
True, this study was conducted in only 10 children, but seeing
that only 12 children met the eligibility criteria (all children with
Apert syndrome aged 4–6 years at the Craniofacial Unit of the
Great Ormond Street Hospital), the response rate was 83%. One of
the 2 eligible children who did not participate in the study had been
previously tested and found to have an average intelligence. The
second child functioned on a low average level at school.
So far, there is no reliable study on the cognitive functions and
the behavior of children with Saethre-Chotzen syndrome. The few
available studies have serious methodological limita-
tions.59,60,399,400 These studies seem to suggest that children with
Saethre-Chotzen syndrome have an increased risk of cognitive
problems. This risk seems to be larger in the case of a deletion
than in the case of a mutation.
Even though the studies by Kress,60 Muenke,49 and Flapper401
on Muenke syndrome have serious methodological limitations,
their studies suggest that patients with the FGFR3 P250R mutation
(¼Muenke syndrome) possibly have an increased risk of intellec-
tual disability.
Mathijssen103, however, reported an average IQ in children
with a mild form of Muenke syndrome and concluded that
these children’s IQ does not differ significantly from that of
children with frontal plagiocephaly without FGFR3 P250R
mutation.
Even though the study by Flapper401 (2009) has serious meth-
odological limitations, this study seems to suggest that children with
Crouzon syndrome and Pfeiffer syndrome have an increased risk of
intellectual disability.
Language
Since different types of syndromic craniosynostosis (eg, Apert
syndrome, Muenke syndrome) are associated with hearing loss,
clinicians should remain alert about the speech/language develop-
ment in children with these syndromes.398
In the study by Shipster398 on the cognitive functions, speech
and language development of children with Apert syndrome, 8 of
the 10 tested children had language difficulties. All 8 children had
expressive language problems and 4 of them had problems with
receptive language skills as well, despite the fact that the intellectual
capacities of the group was of average level.Copyright © 2015 Mutaz B. Habal, MD. Unautho
# 2015 Mutaz B. Habal, MDBehavior
Intellectual disability often coincides with behavioral problems.
And since children with syndromic craniosynostosis seem to have
an increased risk of intellectual disability, the likelihood of beha-
vioral problems also appears to be higher for this group. Children
with intellectual disability have a 50% to 60% chance to develop
behavioral problems.395
In summary, children with syndromic craniosynostosis seem to
have an increased risk of cognitive and/or behavioral problems.
There, however, are large differences in outcome between the
different syndromes. And even within a syndrome, outcomes may
range widely; for example, Renier265 reports a 10 to 114 range in IQ
score.
Basic Question 2: What Are the Possible Risk
Factors for Cognitive and/or Behavioral Problems
in Patients With Craniosynostosis?
In different studies, researchers have tried to uncover factors that
could correlate with the (worse) cognitive functions of children with
craniosynostosis. Factors studied are the following:- wrihether or not to perform surgery;- severity of the malformation;- age at time of surgery;- presence or absence of brain abnormalities;- sex;- socioeconomic status;- maternal IQ.
So far, no significant relationship has been found between on the
one hand the above-mentioned factors and on the contrary, cogni-
tive functions of children with nonsyndromic craniosynosto-
sis.141,233,385,388,390,392,393,402–409
Basic Question 3: What Kind of Screening (Nature
and Frequency) Is Indicated for the Detection and
Treatment/Guidance of These Problems?
There are indications that children with (syndromic) craniosy-
nostosis have an increased risk of behavioral problems. By mapping
these problems at an early stage, child and parents can be timely
referred to appropriate intervention (eg, speech-language therapy,
physiotherapy, parent counseling, or parent management training)
and adequate education for the child can be found.
Based on clinical experience, it appears useful to start psycho-
diagnostic testing of children who have an increased risk of
cognitive and/or behavioral problems at the age of 2 years, testing
for example, personal development, speech and language develop-
ment, and behavior. The psychodiagnostic test should be preceded
by testing for any auditory disorders.
It is important, too, to provide for testing of cognitive functions
and behavior when it is time to choose the best type of elementary
school. Screening for learning disabilities could take place later,
between ages 7 and 9 years.
ConclusionsLevel 2zed reprChildren with nonsyndromic craniosynostosis have
no increased risk of an intellectual disability
(IQ< 70).C Kapp-Simon, 1993392C Arnaud, 1995141oduction of this article is prohibited.
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Standard psychologic testing of all children with craniosynos-
tosis (nonsyndromic and syndromic) places a large burden on the
team, while it is often not necessary. It is advisable to apply testing
as sensibly as possible. Routine screening on developmental and
behavioral problems is indicated to identify patients who mayt © 2015 Mutaz B. Habal, MD. Unauthodevelop problems during time. This screening should take place
at least at a young age, approximately, the time of entering primary
school, and between ages 7 and 9 years to discover any learning
disabilities. The team will have to make arrangements on who will
perform this screening, and when indicated, fast referral to the
psychologist is necessary.
Auditory processing disorders are regularly seen in children with
syndromic craniosynostosis (see the chapter on hearing impair-
ments), increasing the chance of speech/language problems for
these children.
Recommendations
Children with scaphocephaly and Apert syndrome need to be
tested for speech and language problems from the age of 2 years
approximately.
Children with syndromic craniosynostosis need to be screened
on a regular basis for cognitive and behavioral problems and, after
referral, to be evaluated psychologically. These children are to be
screened at least when they are 2 to 3 years old, at the moment of
(primary) school choice, and between ages 7 and 9 years for any
learning disabilities.
Psychologic testing on children with craniosynostosis is pre-
ferably conducted in the hospital where the child is under treatment
for his or her craniosynostosis. If these tests are conducted else-
where, it is important that the results of these tests are reported to the
psychologist in the craniofacial team.
17. PATIENTS’ AND PARENTS’ PERSPECTIVES
Opinions of patients and of the parents of patients are important
when it comes to creating guidelines. We (advisor of Department of
Professional Quality of the Dutch Order of Medical Specialists,
social worker, and nurse specialist) felt the need to enter into
dialogue with parents and patients in a focus group addressing
their experiences with the care and counseling of the child with
craniosynostosis. Furthermore, we wished to make an inventory of
the wishes and expectations about this counseling.
Via patient association LAPOSA, parents of children with
craniosynostosis as well as older patients themselves were invited
to participate in the focus group. Our aimwas to provide for as much
diversity as possible, that is, different treatment location; both
nonsyndromic and syndromic craniosynostosis, different treatment
techniques, and variety in ages. In the end, we held 2 evening
sessions. In the first session, 9 parents of young children (1–6 years)
attended. The second session was with parents of school-going
children (6–18 years), and older patients (15þ), and partners. The
number of participants was 8 and we interviewed 2 externally.
The focus group discussions were mediated by Teus van
Barneveld, advisor in the Department of Professional Quality of
the Dutch Order of Medical Specialists and involved in the
development of the guideline. Both social worker Francien Meer-
tens and nurse practitioner Hansje Bredero-Boelhouwer attended
as well.
The topics addressed were the topics dealt with in the guideline:
Intake/diagnosis; treatment; aftercare.
A summary of these sessions is presented below:
Intake
Even before intake, there was often considerable uncertainty
about the condition, resulting in: mrizeany referrals (general practitioner>> pediatrician>>
specialized center); late referrals;
 unnecessary or inaccurate or incorrect diagnostics;d reproduction of this article is prohibited.
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# 201eceiving incomplete or incorrect information.All this is a source of great agitation/stress for the parents. It
forces them to solve everything on their own.
Wishes/Needs
Education to child health clinics, obstetricians, general prac-
titioners, and pediatricians.Short interval between suspicion of
craniosynostosis to first contact.Clear information (written/inter-
net) alongside the opportunity to ask questions and guidance when
processing the information.Easy access to a member of the team.
This contact must be able to handle coordination issues but also
medical/psychosocially emotional issues.
Diagnosis and Treatment
Different treatment methods are available, but the how, what,
and why of each method are unclear for the parents. This
brings uncertainty and makes it difficult to make a well-balanced
choice. Some parents indicated that the period between first
contact and intervention was very long. They started to worry
increasingly about the health of their child. Furthermore, the effect
that the diagnosis can have on the family and the future raises
concern. Even after the first treatment of children with syndromic
craniosynostosis, the parents are still worried. Then, many ques-
tions arise, for example, on the child’s development, auditory
perceptions, and visual acuity. Parents notice that quite some
things tend to go wrong or almost wrong, because of insufficient
knowledge of other disciplines (eg, technicians). And, in general,
they were not satisfied with the postoperative pain management
as well.
Wishes/Needs Being able to choose the treatment. This means that they want
to hear objectively from their treating physician which
possible treatments are available, with all advantages and
disadvantages. Once again, easy access to a member of the team. This contact
should have an overview of all medical/psychosocial aspects.
In addition, he or she should be able and allowed to
independently undertake steps outlined in the treatment plan.
To be able to coordinate multidisciplinary care is seen as
important. Clear information from the physicians involved (which
includes being able to talk to everybody), a personal
approach. The need for social work. This is more important for parents
with children with syndromic craniosynostosis. The team has
to become actively involved here. Contact with a clinical geneticist should be offered whenever
relevant. Contact with peers. This may be via the Internet (eg, Hyves,
Facebook, blogs) or via patient associations. Educating disciplines involved in the treatment.
 Good postoperative pain management.Aftercare
In this period, patients and parents are still confronted with the
consequences of the condition. Questions and/or problems arise
especially about choosing a school, dealing with practical issues,pyright © 2015 Mutaz B. Habal, MD. Unautho
5 Mutaz B. Habal, MDaccepting the abnormal appearance, resilience, and the physical/
mental limitations. It is not always easy to smooth the contact
between the care and educational sectors.
In the case of invasive procedures, active preparation and
counseling by the team both in the home or home substituting
situation and at school are highly appreciated.
When a child is being managed in multiple healthcare facilities,
it is not easy to keep track. Sometimes, the parents and patient are
even confused who should be doing what and when.
Regarding insurance: this usually gives the necessary problems.
The Dutch Exceptional Medical Expenses Act (AWBZ) always is a
source of problems. The basic health insurance package usually
presents no problems. There appear to be many differences between
the various health insurance packages.
The transition from child to adult care is a complex topic (eg,
Who is the contact, which care can be left to the child itself?). The
transfer to the adult hospital is certainly experienced as very
suddenly.
In general, parents indicated that they managed to find their way
in handling the situation. Support from the team in dealing with this
process, however, can be valuable.
Wishes/Needs Arizelso in the aftercare period, there is a need for a contact
person to whom questions can be addressed, even if these do
not seem to be directly related to craniosynostosis. Proactive involvement of the psychosocial team during the
periods of treatment and the transition periods of the different
developmental stages of the child. Guidance in choosing a school with behavioral/mental issues.
Guidance may also be provided in a peripheral setting, but the
team should give active attention to this issue. Communication between peripheral treatment providers and
the team. Easy access to social work.
 Contact with a clinical geneticist when planning a new
pregnancy.
 Preparation and guidance for the transition process.18. PSYCHOSOCIAL FUNCTIONING
Basic Questions
What psychologic problems are the child, parents, and family
faced with in the following phases:
period of diagnosis up until the first treatment;
follow-up treatment/follow-up, coinciding with the school-
going age;
aftercare, the period during adolescence and inventory of the last
treatment.
What psychosocial care, for parents and patient, is indicated at
what moment?
The questions mentioned above spring from the fact that not
only the condition itself but also the medical treatment of cranio-
facial disorders influences psychosocial aspects. It can influence not
only the child itself, but also his or her parents, brothers/sisters,
(extended) family, friends, school, job of the parents. A whole
system is involved in the treatment of a child with a craniofacial
deformity. From a psychosocial perspective, it concerns the psychic
(intrapsychic), relational (interpsychic), and social aspects of his or
her life.d reproduction of this article is prohibited.
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craniosynostosis and those with nonsyndromic craniosynostosis. In
general, it appears that for syndromic craniosynostosis treatment
lasts much longer, includes more surgical procedures and has a
more sustaining influence on the life of the patient, possibly causing
more psychosocial problems.
Summary of the Literature
Parents of children with a syndromic malady are confronted with
long-term care paths, many different social workers and health
professionals from different organizations. Many already receive
support from different agencies (eg, MEE Foundation, Child pro-
tection, and Mental Health Care). Not all parents appreciate to
receive support from the team. It is important to make an inventory
of the psychosocial situation of the family on a regular basis.410 In
particular, the periods of interventions or transitions are important.
During the entire route, it is important to make it easy to contact
a member of the team.411 Apart from medical knowledge about the
diagnosis, this person should also have an overall (both medical and
psychosocial) insight (holistic approach).
Period Up to and Including the First Treatment
During this period, psychosocial care of the parents will be
central, because this period usually coincides with the baby and
infant stage.
The following bottlenecks for the parents, or rather the family,
can be identified: long-term uncertainty about the diagnosis, anxiety
about a new pregnancy, uncertainty about the expected develop-
ment, difficulty in choosing a school, coping of the patient and
parents with the condition and the abnormal appearance, education,
and having to deal with contrasting explanations in the hospi-
tal.412,413
Diagnostics and Treatment
Parents indicate that there is a lack of knowledge at child health
clinics and among general practitioners. Moreover, in the peripheral
hospitals, they do not know what tests to perform and in what order.
This results in a repetition of tests, very often leading to uncertainty
and more stress for the parents.
In different studies and international guidelines, it is
shown that during this first period a number of issues are
important.412,413Education/information about recommended
treatments, options, risk factors, advantages, and costs to support
them in- mC
17aking a well-balanced decision in the interest of the child (all
advantages and disadvantages, locations, timing, procedures,
experience, etc.).- preparing the child and themselves for all recommended
procedures.
To be alert to psychosocial problems/medical history411 in
syndromic conditions, a focus/psychoeducation on emotional pro-
cesses in parents/other family members during different phases of
life.413,414
Information must be easily understandable, tailored to the
cognitive level, the social/emotional, and the medical situ-
ation.415,416 There is also a need for written information or web-
based information.412,417
Social Support
Brooke indicates that social support to the parents is an import-
ant protecting factor.418opyright © 2015 Mutaz B. Habal, MD. Unautho
88Processing, Acceptance, Parenthood, and
Relationship
Supporting the parents to help them build self-confidence and to
come to accept their situation, is considered to be one of the main
tasks of the craniofacial team. In this case, the amount of time the
team dedicates to the parents influences their perceived amount of
support, and relatedly, the amount of stress. Both from clinical
experience and the literature, it is clear that a too heavy burden
increases parental stress. Even though the studies are small, similar
results are found in multiple studies.412,413,417
Clinical impression shows that parents with a child with a very
visible deformity may be more inhibited in accepting this condition.
Research by Sarimsky414 confirms this for children with Apert
syndrome.
Syndromic conditions are an additional stress factor to the
relationship of the parents. In 60% of the divorced parents, the
relationship between the parents, however, was already in jeopardy
before the birth of the child. If the relationship is good, this stress
factor is less prominent. Within the framework of ‘‘Early Inter-
vention,’’ it is sensible to pay attention to this as well.419
Follow-Up Treatment(s) and Follow-Up
Behavioral issues arise often if the child is already a bit older
(this chapter deals with toddler, kindergarten, and high school age).
Some behavioral issues are the result of a lower IQ (see chapter 16),
some arise from the embarrassment of the parent to become
involved in the upbringing, for example, as a result of the cranio-
synostosis (clinical experience), and some are because of reasons
that are currently unclear.
During this period, psychosocial care initially is still strongly
focused on the parents and the child is often counseled through the
parents. As the child grows older, the focus will be more on the
individual child.
School
At the time when the parents have to choose a school for the
child, they may have questions about his or her cognitive functions.
In particular, this is to be expected for children with syndromic
craniosynostosis. There is no literature available about school
choice. From clinical experience, we know that, if the parents have
a problem, they will be looking for agencies that can support them
and they regularly find answers on their own initiative. In the focus
group, the parents mentioned that they appreciate backup support
from the team.
Appearance/Resilience
If children are becoming more aware of their abnormal appear-
ance, the parents will also question how they can support their child
in this regard, for example, when it is bullied or when it is extremely
shy. Literature describes that in this period, emotional and peda-
gogical support of the parents is of importance, because the amount
of parental resilience influences the resilience of their child.420
Upbringing
Clinically, it is seen that a number of parents, because of the
craniosynostosis (irrespective if it is syndromic or not) find it
difficult to exert their educational tasks in such a way that they
feel they have a grip on the child’s behavior. For various reasons
related to the craniosynostosis, this may result in a mismatch
between the required and provided upbringing. Information to
the parents and screening for problems with the child’s behavior
possibly followed by treatment from the craniofacial team are
reported as important interventions to prevent problems.412,413rized reproduction of this article is prohibited.
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Based on clinical experience, the following issues deserve
attention.
For children and adolescents, a hospital admission, a medical
test, or surgery can sometimes become a traumatic experience,
causing posttraumatic stress syndrome (PTSS) symptoms (eg,
problems with sleeping, separation anxiety, extreme fear for phys-
icians, hospitals, etc.). Naturally, it is important to prevent this.
Here, as well clinical experience shows that professional prep-
aration of the child as well as the parents by a pedagogical worker is
valuable and can prevent PTTS symptoms. Children with PTSS
symptoms can receive treatment from a psychologist. There is no
literature on this topic with reference to children with craniosy-
nostosis.
Some medical treatments (such as wearing an external frame or
other types of distractor devices) require a strong motivation and a
high perseverance of the child and his or her family. It is important
as well that the child is able to sustain such treatment.421,422 For
families for whom the burden exceeds their coping ability, treat-
ment success is an important risk factor. De Sousa411 and
Lefebvre423 indicate that the timing of the treatment is important
and that it preferably should take place when the family shows
sufficient coping ability. In addition, Lefebvre423 indicates that
expectations about the treatment should be realistic. Good infor-
mation and an estimation of the child’s coping ability but also that
of the family are essential. The medical social workers should be
able, if desirable, to adapt their language use to the level of the
child.415,416
Adolescence, Aftercare, Adulthood
Adolescence is the period when a child separates himself or
herself from his or her parents.
The craniofacial team often encounters the following issues:
AppearanceþOwn Meaningfulness
Over one third of these adolescents experience stigmatization
because of the abnormal appearance. Many adolescents are able to
deal with this in a robust manner. It, however, is important to ensure
psychologic support when problems arise. Counseling is aimed at
the psychosocial adaptation and the self-understanding, social
skills, and the self-image of these adolescents.424,425 Information
itself is not enough especially for these ‘‘experienced’’ adolescents;
it is important that they learn more about the procedures.416 In this
manner, they are involved in the decision-making, which in turn has
a positive influence on their cooperation, satisfaction, and self-
management.415
Transition
Young persons are, according to the Dutch Medical Treatment
Act, fully responsible for the decisions about their treatment from
the age of 16. For those with a syndromic condition, for whom the
parents have been making decisions for a long time, this can be a
complicated transition. It may be desirable to offer support to the
parents and/or adolescent in finding a new balance. In that case, it
would seem important to develop the adolescent’s autonomy and to
find a way for the parents to continue with their parental duties.
Finally, there should be continuity in the transition of care toward
the adult care system.426 This whole process will be influenced if
there is a developmental delay.
Posttraumatic Stress Disorder (PTSD)
Posttraumatic stress disorder occurs as a result of experiencing a
traumatic event. A traumatic event is understood to be an eventCopyright © 2015 Mutaz B. Habal, MD. Unautho
# 2015 Mutaz B. Habal, MDcharacterized by the violation of the physical integrity and/or threat
of death. From a young age, children with craniosynostosis experi-
ence stressful events and events that can cause their physical
integrity to be violated; they are often handled by more than 1
adult at the same time to receive intravenous therapy against their
will or to be x-rayed. Also pain, being away from their familiar
environment, and separation from the parents are stress-increasing
factors for the child.
The parents of these children may experience many stressful
events as well. Parents often have to look on helplessly while their
child suffers and can often do very little to help the child. For
parents, the cranial surgery on their young child and the subsequent
hospital admission is usually also a traumatic event. As a result of
these stressful events, both parents and the child can develop acute
stress responses. For most parents and children, these responses
disappear during time, but they will be sustained in some parents
and children, so that the events are not properly processed. This will
cause PTSD.
A study by Bronner427 shows that 1 of every 10 children and
parents develop PTSD after admission of the child to the intensive
care unit. Stress responses of the parents (especially of the mother)
are important indicators for PTSD in the child. The most important
indicator of PTSD in the parents is their psychiatric vulnerability
and the way parents deal with the admission to the intensive care
unit. It is estimated that PTSD is present in approximately 8% of the
general population.428 Posttraumatic stress disorder symptoms co-
occur with symptoms of stress, and can manifest both as physical
and mental problems. Posttraumatic stress disorder left untreated
has a severe negative impact on the development and the psycho-
social functions.429 Prevention of PTSD as well as early recognition
and treatment of PTSD can improve the patient’s quality of life.430ConclusionsLevel 3rized rePosttraumatic stress disorder is present in 10% of children
admitted to an intensive care unit and in their parents.C Bronner, 2008427Level 3 Stress reactions of parents (especially of the mother) are important
predictors of PTSD in children.C Bronner, 2008427Level 3 Parents with a limited coping ability and a psychiatrically
burdening background are more prone to stress.C Coulter, 1991412Level 3 A too large burden for the parents leads to more stress.C Campis, 1991413C Coulter, 1991412Level 3 In treatment and intake for nonsyndromic craniosynostosis
and syndromic craniosynostosis, the psychosocial situation
of the family must have been mapped.C Coulter, 1991412C Sarimsky, 1998414C St. John, 2003419Level 3 Training/group work, aimed at social resilience
(for parents and/or child) can strengthen the self-image.C Robinson, 1996420Level 3 The timing of the interventions should be in accordance with
the family’s coping ability.C Lefebvre, 1978423C de Sousa, 2008411Level 3 In syndromic conditions, there is an increased risk of
psychosocial problems.C Sarimsky, 1998414C St. John, 2003419Level 3 An easily accessible contact person is a great support for the parents.C de Sousa, 2008411production of this article is prohibited.
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1790Medical social workers should take into account the patients’
level of development.C Chapados, 2000416C Lefebvre, 1982415Level 3 Besides oral information, adequate written (digital) information
is also required.C Coulter, 1991412C Trulsonn, 2003417Level 3 Social support is considered very important as well as
contact with peers.C de Sousa, 2008411Level 3 Adolescents do not always have realistic expectations of the
treatments and this should be taken into account when
preparing them for the treatments.C de Sousa, 2008411Level 3 Adult craniosynostosis patients have psychosocial problems
on a regular basis.C Sousa, 2008411Considerations
There is some reluctance in the regular health care system to
initiate treatment and counseling routes because sufficient knowl-
edge of the condition in question is not always present. For patients
and their systems, recognition is often an important tool to develop
new coping strategies. The team should contain social workers who
have obtained enough expertise about the craniofacial deformity
allowing them to treat individual mental problems, system problems
(parents/family) as well as to deal with practical questions and
problems. In view of possible system problems, it is recommend-
able that the medical social worker should be familiar with these
methods.
Pedagogical care is a valuable support when preparing the child
and parents for interventions/procedures.
There is a clinical impression that it is valuable for a group of
parents to discuss their reactions and emotions with a specialized
psychosocial worker. Normalizing the reactions and helping to
integrate ambivalent emotions aids the parents in exercising their
parental duties in such a way that this will benefit the child in
learning to develop himself or herself.
Recommendations
The craniofacial center needs to provide good information both
orally (tailored to the level of the client system) and on a website/as
flyer material.
Both in nonsyndromic and syndromic craniosynostosis, a
primary contact within the team (the care coordinator) is available
who at initial screening can answer both medical and psychosocial
questions and if necessary can refer to specialized social work.
Parents/patients have easy access to the care coordinator. The
care coordinator has an overview of the treatment path.
It is highly recommended that the multidisciplinary team can
offer psychosocial care during each phase of the treatment.
Throughout the years, easy access to a psychosocial worker is
offered on a regular basis to map the transitory phases of the
families and thereby prevent psychosocial problems as much as
possible (prevention).
Individual child treatments are offered as well as family treat-
ments and parent counseling, tailored to the level of the client
system.
When the child is reaching school-going age, a specialized
social worker will inquire after the choice of school and counseling
will be provided for questions and problems arising here. This
specialized social worker is expected to be familiar at least with the
organization of the educational system, so that he or she can refer
correctly if necessary.ght © 2015 Mutaz B. Habal, MD. UnauthoPedagogical care is standard for surgical procedures and avail-
able when necessary at the outpatient department to support chil-
dren and their parents with the preparation/care.
During the entire medical treatment of the child, it is necessary
to regularly inquire after symptoms of PTSD in child/parents (eg, by
a nurse practitioner).
On suspicion of PTSD in the parents or child, her or she
needs to be referred to the psychologist of the craniofacial
team or to a psychologist in (the neighborhood of) the place of
residence.
Adolescents who wish surgical treatment need to be offered at
least 1 contact with a specialized social worker to check whether
their expectations are realistic.
The craniofacial center needs to have an Early Intervention
Program/peer supervision group in place to increase resilience.
During long sustained treatments that require a lot of motivation
from the patient psychosocial screening and, if necessary, support,
is desirable.
Patients and their parents are offered contact with peers/a patient
association.
Knowledge transfer from the craniofacial team to the periphery
(Child Health Clinic; general practitioner; pediatricians) should be
well organized.
19. CRITERIA FOR THE CRANIOFACIAL CENTER
AND ITS TEAM MEMBERS
Basic Questions
What are the criteria a craniofacial center and its team members
should meet?
How is the care for patients with craniosynostosis coordinated in
the Netherlands?
How to manage quality control of the craniofacial center?
Question 1: What Are the Criteria a
Craniofacial Center and Its Team Members
Should Meet?
Introduction
The management of patients with nonsyndromic or syndromic
craniosynostosis requires a multidisciplinary approach, as the care
is complex. Because craniosynostosis is a rare condition, centrali-
zation of care is desirable resulting in a maximum of expertise,
ensuring a high quality of care, and permitting scientific research
aimed at improving care. Multidisciplinary care requires good
coordination and communication within the team and with external
health professionals and the patients and parents. Responsibilities
and tasks of the various care providers within the team need to be
clearly defined.
Comparative studies of the results of different craniofacial teams
make benchmarking possible and can exert a positive effect on the
quality of care. Benchmarking may take place both on a national
and on an international level. Team and overall audits will provide
an important contribution to the quality of care, but also to multi-
center studies and innovation.
Summary of the Literature
There appear to be 2 types of team organizations worldwide:
A team focused on craniofacial deformities only, or a craniofacial
team that also treats cleft lip/palate. In the United States and
Asia, we generally see a combination of the cleft lip and
palate team and the craniofacial team, with an overwhelming
majority of cleft lip and palate patients.8,9,23,431–437 In Europe,rized reproduction of this article is prohibited.
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teams.2,24,438,439 In Great Britain, there are 4 recognized cranio-
facial centers nationwide.2 The separate craniofacial teams treat a
larger concentration of patients with craniosynostosis and other
craniofacial growth deformities (hemifacial microsomia, Trea-
cher-Collins syndrome, craniofrontonasal dysplasia, clefts, and
craniofacial tumors). Also, the team composition varies, as sum-
marized in Table 21.
Apart from the specialties mentioned in Table 21, the following
disciplines may also be part of the team: pediatric IC/neonatal
IC,9,24,432–434,440 photographer,439 medical illustrator,433,438 and
coordinator.23,437
The following additional requirements are mentioned: TCo
TABLE
lit
431
22
432
433
434
440
439
435
24
438
9
437
23
8
5
3
AN
neuros
Ps, pla
chairm
Th
# 201otal 1 or 2 representatives of each specialty should be
available—and preferably 2 especially for the core special-
ties—thereby benefiting flexibility, clinical support, collab-
oration, and quality.432 The craniofacial team should always include a neurosur-
geon.24
24 The presence of a specialized IC is strongly encouraged or a
requirement.9 Team members should possess appropriate knowledge and
skills.9,23,437,439 The noncore specialties do not have to be present at every
consultation, but should be available for consultations.432 The different team members come into action at the proper
moment during the treatment path.440
9,23,432,437 A team leader should be appointed.
 Teams should organize themselves and preferably certify
themselves.2,432 Teams should exchange data on an international level
(education, research).433 A pediatrician should always be involved for a patient with
Apert syndrome. 1
9,23,431–435,437 Joint consultations should be held.
 The team should convene on a regular basis.9,23,433–435,437
 Conduct a survey to evaluate patient satisfaction.9pyright © 2015 Mutaz B. Habal, MD. Unautho
21. Team Composition
Ps oms ns ot od De pa sw ps op n
4 x x x x X X x x
x x x x x x x
x x x x x X x x x x
4 2 1 4 1 1 1 1 x
x x x x x x x
x x x x x x X x
X x x x x x x x
x x x x x x x x x
23 12 22      x 12-23 
X x x x x x x
x x x x x x x x x x
x x x x x x x x x x
x x x x x x x 66% 66% x
X x x x x x x x
x x x x x x x x
3 x 2 x x x x x x x
, anesthesiologist; AP, anthropology; AU, audiology; CA, cardiology; DE, denti
urgery; NU, nursing; OMS, oral and maxillofacial surgery; OP, ophthalmology; OR, or
stic surgery; ps, psychology/psychiatry; PT, physiotherapy; RA, radiology; RM, reh
an.
ese specialties were not mentioned in this survey.
5 Mutaz B. Habal, MDIn the literature, the roles of the different specialties are not
always discussed. The ACPA does not even mention specialties, but
9it does mention the necessary specialist knowledge and skills.
Roles of the specialists mentioned are the following: Prize
p se
2

x
x
x
stry; DH
thodont
abilitatlastic surgeon: operative correction of cranial/facial
deformities, including outer ear/hands8,432–434,438,439 Neurosurgeon: trepanning with/without reconstruction;
analysis and therapy of brain malformations8,433–434,438,439 Oral and maxillofacial surgeon, surgical correction of the
maxilla and mandible: if necessary surgical correction of the
face with plastic surgery8 Otolaryngology/audiology/speech therapy, hearing: speech
and breathing analysis and treatment8,9,432–435,438–439,441 Orthodontist: collecting data for monitoring craniofacial
growth, assisting in the decision about the treatment modality,
orthodontic treatment in accordance with surgical require-
ments, participation in perioperative care and retention, and
evaluation of treatment results433,442 Dentist/prothetist/dental hygienist: dental care (including
position of the teeth) and shape of the jaw, possibly with
occlusion images432–434,436 Pediatrician: analysis of general health, growth and devel-
opment in children8,432–434 Ophthalmology, eye direction, and eye function (visual
acuity, strabismus, fundoscopy)8,433–434,438 Genetics, analysis of congenital defects and heredity: gene/
chromosome analysis8,432,434,438,441 Anesthesiologist, perioperative monitoring of vital signs,
anesthetics, and pain management8,433,438 Radiologist assesses the imaging tests and helps select the
optimal treatment8 Psychology/social work: psychometric/psychologic screen-
ing and treatment/guidance, social, and financial family
counseling8,432–434,438,439 Nurse practitioner, care coordinator, guiding the patient and
parents, dietary guidance, monitoring of growth and
development8,433,434d reproduction of this article is prohibited.
ge au slp nu di an Other/Remarks
x x x x x pt
x x ps and/or oms; ap
x x x x x x pm, ra, pr
2 pr, ca, pr; 1 to 2 per spec
x x x x pr, rm
x x x x ra, pm
x x Pr
x x x x pr, mo
19      of the 23 teams
x x x ra, ap
x x x x x ra, ap,pr; special CF training
x x x ps and/or oms; ra
x x x x ps and/or oms; pr, ra
x x x x x Ra
x
x x x x
, dental hygienist; DI, dietitian; GE, genetics; NP, nurse practitioner; NS,
ics; OT, otolaryngology; PA, pediatrics; PM, prenatal medicine; PR, prothetists;
ion medicine; SE, secretary; SLP, speech therapy; SW, social work; X, team
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1792etter (protocol based) care and coordination (eg, improve-
ment of quality by concentration of care)3,8,9,431,433–439
3,9,431,437 Lesser burden for the patients/parents
 Higher satisfaction of the patients/parents3,431
 More efficient utilization of resources3,9,434
 Better information provision3,9,431,437
 Conduct a survey to evaluate the patient’s satisfaction9Furthermore, an important aim for the craniofacial team should
be: To organize meetings for parents, patients, relatives, other
health care professionals, and the community in a broader
sense to enhance understanding of craniofacial deformities9
9 To organize or support parents’ associationsConclusionsLevel 3pyright ©It seems likely that multidisciplinary teams provide better
care in the management of craniofacial deformities. The
concentration of craniofacial care is higher in ‘‘pure’’
(ie, without cleft lip and palate) craniofacial teams.C Mathijssen, 200724C Parameters ACPA, 20079C Standards USA, 2008437C Strauss, 199823C White, 20092D Anderson, 1985431D Capone, 2007432D Chen, 1988433D Chin, 1990434D David, 1977439D Holt, 1984435D Munro, 1975438D Pruzansky, 1980436D Strohecker, 19938Level 3 A craniofacial team includes at minimum: plastic surgery,
neurosurgery, oral and maxillofacial surgery,
otolaryngology (with audiology and speech therapy),
orthodontics, pediatrics, social work, psychology/
psychiatry, ophthalmology, genetics, and anesthesiology.
Furthermore, it is highly recommendable to supplement
the team with: nurse practitioner, secretary, nursing,
radiology, and prenatal medicine. Availability of:
physiotherapy, dietetics, dentist, prothetist, rehabilitation
medicine, photographer, cardiology, and dental hygienist.
A team leader needs to be appointed and plastic surgery
is mentioned most frequently in the literature.C Mathijssen, 200724C Parameters ACPA, 20079C Standards USA, 2008437C Strauss, 199823C White, 20092D Anderson, 1985431D Capone, 2007432D Chen, 1988433D Chin, 1990434D David, 1977439D Holt, 1984435D Munro, 1975438D Pruzansky, 1980436D Strohecker, 19938 2015 Mutaz B. Habal, MD. UnauthoLevel 3rized reprodPresence of a specialized ICU is either strongly
encouraged or mandatory.C Mathijssen, 200724C Parameters ACPA, 20079D Capone, 2007432D Chen, 1988433D Chin, 1990434D Clifford, 1978440Level 3 Team members should possess the appropriate knowledge
and skills and should come into action at the proper
moments during the treatment path.C Parameters ACPA, 20079C Standards USA, 2008437C Strauss, 199823D Clifford, 1978440D David, 1977439Level 3 Joint consultations must be provided and the team
should meet regularly.C Parameters ACPA, 20079C Standards USA, 2008437C Strauss, 199823D Anderson, 1985431D Capone, 2007432D Chen, 1988433D Chin, 1990434D Holt, 1984435Level 4 Total 1 or 2 representatives of each specialty should
be available—and preferably 2 especially for the core
specialties—thereby benefiting flexibility, clinical
support, collaboration, and quality.D Capone, 2007432Level 4 The noncore specialties do not have to be present
at every consultation, but should be available
for consultations.D Capone, 2007432Considerations
Pedagogical care is a valuable tool to prepare the child and his or
her parents for the surgical procedures/treatments (see chapter 18).
Recommendations
Craniofacial care needs to be provided within a multidisciplin-
ary setting, in which cleft lip/palate is not treated by the craniofacial
team (‘‘pure’’ craniofacial). A treatment path needs to be estab-
lished and the team members’ roles should be defined clearly. Joint
consultations are held with the core specialties present and the other
team members available for consultation.
A craniofacial center offers the following health care providers
and facilities:Health care provider/facilityuction of this 
#Nonsyndromicarticle is proh
2015 Mutaz B. HSyndromicPediatrician x xClinical geneticist x xPediatric anesthesiologist x xPediatric intensivist x xNeurosurgeon x xOphthalmologist x xPediatric radiologist x xPlastic surgeon x xOral and maxillofacial surgeon x xOrthodontist xOtolaryngologist xPsychologist xSocial worker x xibited.
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# 2015 Mutaz B. Habal, MDNonsyndromic B. Habal, MDSyndromicSpeech therapist xPedagogical worker x xTeam leader (1 of the core specialists) x xCare coordinator (nurse practitioner) x x(three-dimensional-)imaging, x-ray, CT x xMRI xPediatric-IC x xPolysomnography xA back up of the core specialties (thus at least 2 specialists for
neurosurgery, plastic surgery, and oral and maxillofacial surgery) is
advised to guarantee continuity of health care.
The health care provided by the team is based on the protocols,
which are yearly reviewed. Adjustment of the multidisciplinary care
for each individual patient is regularly discussed in team meetings.
Outcomes will be communicated to the patient and parents and to
any other health care provider not belonging to the team.
One teammember will act as team leader and will as such ensure
that the teammeets all its requirements. Besides, there will be a care
coordinator, usually a nurse practitioner/nursing specialist, who
assures the coordination of the care and who is the contact person
for the patient and for other health care providers not belonging to
the team. The coordinator of the craniofacial team will ensure that
the different examinations (inside or outside the center) are con-
ducted on the recommended moments and that the results are
provided to the primary responsible health care provider.
It is the team’s task to provide and optimize high-standard
protocol-based craniofacial care. Good coordination, lesser burden
of patient/parents, high satisfaction of patient/parents, efficient
utilization of resources, better information provision, organization
of meetings for parents, patients, relatives, other health care pro-
fessionals and the community in a broader sense, and organization
or support of parent associations are core duties. National and
international profiling and certifications are essential.
Question 2. How Is the Care for Patients
With Craniosynostosis Coordinated in the
Netherlands?
Summary of the Literature
The (minimal) team size is discussed in few publications; the
central idea is that quality of care will improve by concentrating this
specific care. One team per 10 to 20 M inhabitants439
 One team per 30 to 40 M inhabitants438
 Four teams per 56 M inhabitants (current situation in Great
Britain)2 Compared with kidney transplantation: when teams perform
25 surgical procedures yearly, the mortality rate higher than
when teams perform more than 100 surgical procedures
yearly438 Benchmarking 23 teams by the ISCFS resulted in the
following division of the number of intracranial surgical
procedures: 0 to 11 surgeries in 9% of the teams; 12 to 23 in
9%; 24 to 35 in 30%; 36 to 51 in 17%; 52 or more in 35%24 American Cleft Palate-Craniofacial Association concludes
that a sufficient number of patients needs to be treated for a
craniofacial team to obtain and maintain expertise, maar does
not specify any numbers9 Establishing formally recognized craniofacial centers (4 for
56 million people) will lead to a concentration of craniofacial
care2. UnauthoCentralization and Coordination of Care in the Netherlands
With an incidence of 1 in every 2100 to 2500 births, craniosy-
nostosis is a rare disease. The syndromic variant of craniosynostosis
is even rarer. Each year, an estimated 100 children with craniosy-
nostosis are born in the Netherlands. Care for these patients requires
the support of multiple medical, dental, and paramedical specialties,
whereby the coordination of care is essential, as indicated in the
discussion of basic question 1 of this chapter. This is achieved by
treating patients in a multidisciplinary team meeting a number of
requirements:1. Crizomposition of the team (see the above-mentioned recom-
mendations under basic question 1)2. Experience with treatment of craniosynostosis3. Having the necessary facilities4. Good accessibility5. Guaranteed continuity of the team as a whole and of its
individual members6. Systematic evaluation of the results7. Innovation and scientific researchThese requirements can only be met when the care of
patients with craniosynostosis is centralized. A few studies
demonstrate the value of centralization of craniosynostosis care.
In the study of Haas,89 it is shown that treating a low number of
patients annually is associated with perioperative blood loss.
Nine nonsyndromic patients are presented, who underwent
surgery within a period of 10 months. The average duration of
surgery was 6.4 hours, which is unusually long. Blood loss was
proportionally high with an average value of 846mL. In a
comparable study, Kang443 presents 43 patients during a period
of 10 years, and also reports exceptionally long duration of
surgery (4 hours for correcting scaphocephaly). In 23.3% of
the patients, respiratory problems that were not anticipated
occurred directly after recovery from anesthesia: of these 10
patients, 6 had cerebral edema, 3 were inadequately weaned off
mechanical ventilation, and 1 bled persistently; 1 patient died.
Hilling concluded that with increasing experience of the surgeon,
the prevalence of temporal depressions after plagiocephaly or
trigonocephaly decreases.102–123 Considering the many develop-
ments in the management of craniosynostosis, as, for example, in
the surgical treatment of scaphocephaly, centralization is the only
way to arrive at proper evaluation of new methods of treatment
and comparative studies.
Furthermore, the criteria on experience in surgical treatments
are important in the discussion about centralization. Based on
learning curve and maintaining a level of competence, the Dutch
Health Care Inspectorate (IGZ) and a number of scientific
societies have set a minimum number of 20 operations each
year per surgeon for low-frequent and highly complex care.444–
446 A report of the Dutch Cancer Society in 2010 also recom-
mends concentration of health care on the basis of criteria
concerning the infrastructure, volume, and the degree of special-
ization of the hospital and verifiable good results of the health
care provided. The Cochrane447 review of the National Pediatric
Oncology Centre (NKOC) provides the scientific foundation for
the proposition that the higher number of patients and/or further
specialization leads to a lower mortality rate in pediatric oncol-
ogy. It would seem self-evident that the minimum of 20 patients
each year per surgeon should also apply to the surgical treatment
of craniosynostosis (nonsyndromic and syndromic craniosynos-
tosis surgeries together).ed reproduction of this article is prohibited.
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in the Netherlands requires at most 2 centers. Considering the fact
that in the Netherlands facial surgeries for syndromic craniosynos-
tosis, as in Le Fort III, monobloc, and facial bipartition, are rare
(estimated 10 annually) and are associated with a higher surgical
risk in the case of skull expansion, it is essential that these
procedures are performed in only 1 center. It is an explicit
wish of the patients and their parents and of the patient society
LAPOSA that this highly complex care is provided in a center
located in the Netherlands. Centralization on a European level is
considered undesirable because of the language barriers and the less
easy access. Considering the complexity of the pathology and
treatment of syndromic craniosynostosis and the very low inci-
dence, centralization of this treatment in the Netherlands in 1 center
is desirable.
Considerations
The literature is not conclusive about the minimal mass for a
team: 1 team per 15 to 20M inhabitants is the median (range 10–
40M, with minimally 35 essential procedures performed each year
(range from several to over 100)). In anypatient, a sufficient number
of patients must be treated to obtain and maintain expertise.9 Based
on the number of patients in the Netherlands, 1 center could
theoretically be enough. Having (a maximum of) 2 centers has
the advantage of creating demographic spread within the Nether-
lands, providing innovations in health care by allowing for com-
parative studies between the 2 centers, being less dependent on 1
center, and providing the possibility of asking for a second opinion
within the Netherlands. It seems advisable, in thispatient, to treat
syndromic craniosynostosis within 1 center, considering the highly
complex pathology involved in this matter. The working group
considers it essential to analyze the results of these specific facial
surgeries on a European/international level.
Recommendations
There is room for 1 craniofacial team for the management of
patients with nonsyndromic and syndromic craniosynostosis and 1
craniofacial team for nonsyndromic craniosynostosis in the Nether-
lands. Both centers work together in the areas of education,
research, patient careand quality-improving activities (such as a
national audit).
The minimum number of intracranial surgeries for craniosynos-
tosis is 20 each year per surgeon.
Question 3: How to Manage Quality Control of
the Craniofacial Center?
The literature provides little information, except Grol17 who
mentions that the use of medical audits in the general practitioner
practice for improvement of quality is hopeful. In the United
Kingdom, experience has been gained during a few years now
with an annual audit of the formally recognized craniofacial centers.
The participants consider these meetings as valuable and these have
been an incentive to set up multicenter studies.
Recommendations
Every team publishes an annual report and at least once yearly
there will be a team meeting addressing:ItemCopyright © 2015 Mutaz B. H
1794Nonsyndromicabal, MDSyndromicNumber of surgeries per diagnosis x xNumber of surgeries per type of surgery x xNumber of patients treated according to protocol x xPerioperative dura and brain damage x x. UnauthoItemrized reproduction of this artic
# 2015Nonsyndromicle is proh
Mutaz B. HSyndromicExcessive loss of blood x xDuration of surgery x xInfections x xUnplanned surgical readmission x xProblems with equipment (springs, distractors, helmet) x xQuality of life xAppearance x xBehavior xNeurocognitive behavior xOSAS xICP x xHydrocephalus xHearing xSpeech/language skills x1 xVisual acuity x2 x1¼ only for scaphocephaly.
2 ¼ only for plagiocephaly.
New patients with craniosynostosis are registered with the Dutch
Association for Cleft Palate and Craniofacial Anomalies (NVSCA).
Quality of care could be further evaluated by conducting b-annual
audits of the treatment centers in the Netherlands and abroad.
20. SUMMARY
A schematic overview is given in appendix I.
Management in the Primary Care Sector
Application of the flow diagram (appendix II) is essential to
optimize recognition of craniosynostosis in the primary and sec-
ondary care sectors.3
Upon recognition of an abnormal skull shape, the primary care
health professional refers to the pediatrician, without additional
diagnostics. On suspicion of craniosynostosis, this is done at the
shortest possible term.
Management in the Secondary Care Sector
The pediatrician further evaluates the child with suspected
craniosynostosis by performing a general and a specific physical
examination. Imaging studies in the secondary care sector are
advised against, unless proper arrangements have been made with
the craniofacial center on performing and interpreting cranial
images—and this does not lead to delay in further referral. On
suspicion of craniosynostosis, the pediatrician refers to the tertiary
craniofacial center at the shortest possible term.
Management in the Craniofacial Center
After referral to a craniofacial center, the craniofacial team
distinguishes between nonsyndromic and syndromic craniosynos-
tosis on the basis of a comprehensive physical examination and the
family history on the occurrence of abnormal skull shape and other
congenital anomalies.
The craniofacial center is expected to provide good information, both oral and via website and
brochures. appoint a care coordinator within the team who is qualified to
screen for both medical and psychosocial problems and can
refer to specialized health care if necessary. facilitate parents/patients to have easy access to the care
coordinator, who has an overview of the treatment path. offer regular and low-threshold psychosocial care.ibited.
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# 201tandardly involve educational care when children undergo
surgery or visit the outpatient clinic visits, so as to help
children and their parents prepare for procedures. facilitate contacts with peers and patient associations.
 provide for good knowledge transfer to health professionals in
peripheral institutions.Nonsyndromic Craniosynostosis
In principle, mild presentations of craniosynostosis, such as a
metopic ridge and partial synostosis of the sagittal suture with few
morphologic abnormalities, are not indications for surgical correc-
tion. In all other types, operative correction of the deformity is
indicated on both functional and cosmetic grounds.
Nonsyndromic Craniosynostosis
In principle, mild presentations of craniosynostosis, such as a
metopic ridge and partial synostosis of the sagittal suture with few
morphologic abnormalities, are not indications for surgical correc-
tion. In all other types, operative correction of the deformity is
indicated on both functional and cosmetic grounds.
Intake
A skull x-ray or ultrasonogram and a three-dimensional skull CT
are performed to confirm the diagnosis. Genetic diagnostics are
offered whether one or both coronal sutures are involved or when
there is a family history of craniosynostosis.
Screening for increased ICP using fundoscopy is indicated
before the initial cranial remodeling is performed. Its need has
not been demonstrated in the case of early surgery (before the age of
6 months), but fundoscopy is recommended then.
Orthoptic and ophthalmologic evaluations are required at the first
referral for unilateral coronal suture synostosis. These can be per-
formed by any ophthalmologist in collaboration with an orthoptist.
Ophthalmologically complex cases (such as absence of ocular
muscles or keratitis) should be referred to a specialized center.
Cranial Vault Expansion
Operative correction of nonsyndromic craniosynostosis is pre-
ferably performed within the first year of life. In case of orbital
involvement, the orbit is also corrected in the same operation.
Performing strip craniectomy for nonsyndromic craniosynosto-
sis without additional measures is advised against. The choice of
other techniques for correction of scaphocephaly (ie, extended strip
craniectomy, complete cranial remodeling, and strip craniectomy in
combination with molding helmet or springs) is based on age at
presentation and severity of the deformity.
The anesthesiologic goals in craniofacial surgery can only be
achieved in specialized pediatric centers, as laid down in the
guideline ‘‘Surgery in children’’ issued by the Netherlands Associ-
ation of Anesthesiologists. Invasive monitoring is recommended in
open procedures with expected massive blood loss.
Availability of a bed in a PICU postoperatively must be ensured.
In less extensive interventions, medium care may suffice, although
it should be realized that these patients mostly are very young
children with a smaller circulating blood volume in whom even
little postoperative blood loss must be well monitored.
Administration of paracetamol will be adequate to relieve post-
operative pain (guideline on postoperative pain management).
Follow-Up
Screening for increased ICP using fundoscopy is performed at
least at the ages of 2 and 4 years. This ophthalmologic evaluation
can be performed by any ophthalmologist.pyright © 2015 Mutaz B. Habal, MD. Unautho
5 Mutaz B. Habal, MDThe care coordinator in the craniofacial team is responsible for
having the fundoscopies performed at the recommended moments
and for communicating the results to the most responsible phys-
ician.
If papilledema has been confirmed, a CT or MRI scan is
made to assess changes in ventricle size (hydrocephalus).
Other pathology that could contribute to increased ICP, such
as OSAS, is excluded. Revision of the diagnosis of nonsyndromic
craniosynostosis is reconsidered. An invasive ICP measurement is to
be considered in case of unexplainedworsening of vision, progressive
vertex bulge without papilledema, or when decision-making on
reoperation is complicated by doubt about the extent of ICP increase.
The choice of treatment for increased ICP is dependent on the causal
factors; a cranial vault expansion is preferred.
Children diagnosed with a scaphocephaly should be evaluated
for speech- and language problems from the age of þ2 years.
Psychologic assessment of children with craniosynostosis can either
be performed in the hospital where the child is being treated for the
craniosynostosis, or regionally. If the assessment takes place else-
where, it is important that the results are communicated to the
psychologist in the craniofacial team. The psychologist in the team
provides support in cases of nonsyndromic craniosynostosis when a
child’s behavioral problems are suspected to be related to the
craniosynostosis.
Follow-up of patients with a nonsyndromic craniosynostosis is
recommended up to the age of 18 years, at which age skull growth
has been completed.
SYNDROMIC CRANIOSYNOSTOSIS
Intake
If multiple dysmorphias/visible congenital abnormalities are
seen, additional diagnostic procedures are indicated as early as
in the first weeks of life. Targeted DNA diagnostics can be
requested if a clinical syndrome diagnosis has been made. More
extensive evaluation is indicated in cases of syndromic craniosy-
nostosis without clinical diagnosis (¼ a nonclassifiable, complex
craniosynostosis) or a clinical diagnosis, which was genetically not
confirmed.
Screening for increased ICP using fundoscopy is indicated in
syndromic craniosynostosis preceding the initial cranial remodel-
ing.
A skull x-ray or ultrasonogram and a three-dimensional skull CT
(including sections of the petrous parts of the temporal bones) are
made preoperatively as well as brain MRI to screen for Chiari
malformation and to serve as baseline image of ventricle width.
Patients with ventriculomegaly should be followed by means of
MRI scanning and 6 monthly fundoscopy. A multidisciplinary
treatment plan is drawn up if a patient shows progressively increas-
ing ventricle width or papilledema.
Orthoptic and ophthalmologic evaluations are required in all
syndromic types of craniosynostosis at the first referral. These can
be performed by any ophthalmologist in collaboration with an
orthoptist. Depending on the results, follow-up examination and
treatment is arranged. Ophthalmologically, complex cases (such as
absence of ocular muscles or keratitis) should be referred to a
specialized center.
For all syndromic types of craniosynostosis, a hearing test
is indicated in the first year of life with tympanometry
and otoacoustic emissions. In case of an ambiguous result,
brainstem evoked response audiometry and/or free-field audio-
metry is performed in the local audiology center. If the CT scan
shows structural abnormalities of the outer-, middle- and/or inner
ear, adequate therapy is chosen at an early stage. Standardrized reproduction of this article is prohibited.
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coordinator is expected to see to it that hearing tests are per-
formed (and that action is undertaken if necessary). The treating
otorhinolaryngologist is expected to undertake the necessary
action after an abnormal result of a hearing test.
Screening for OSAS is essential in view of the high prevalence
of OSAS in children with a syndromic craniosynostosis. Further-
more, evaluation of OSAS is indicated only if the medical history
points at nocturnal breathing problems. Parents should be instructed
to recognize symptoms indicative of OSAS and to contact the team
coordinator if symptoms occur. Clinical symptoms of OSAS in
combination with an abnormal saturation profile are strongly
suggestive of OSAS, in which patient (additional) polysomnogra-
phy is performed to determine severity of the OSAS (in conformity
with the guideline on pediatric OSAS).
As OSAS in children with a syndromic craniosynostosis is a
multifactorial condition, endoscopy of the upper airways is indi-
cated to determine the level of obstruction. Treatment for OSAS is
selected based on the severity of OSAS, the patient’s age, causal
factors, and any other functional problems (such as increased ICP or
exorbitism).
Treatment of the hand deformities in Apert patients is started as
early as possible and is performed by a (pediatric) hand surgeon. In
view of the complexity of the hand deformities in the Apert
syndrome, it is strongly recommended to concentrate care in a
specialized center for congenital hand deformities. The treatment
and follow-up of any elbow-, shoulder-, foot- and hip problems is
performed by a pediatric orthopedist, rehabilitation expert or plastic
surgeon. The care coordinator maintains contacts with the health
professionals outside the center that is responsible for the Apert
patient’s care.
Abnormalities of the lower extremities in the Crouzon/Pfeiffer,
Saethre-Chotzen, and Muenke syndromes are usually so mild that
surgical treatment is not needed. If functional problems are seen, the
patient should be referred to a specialized team for congenital hand
deformities.Initial Cranial Vault Expansion
The initial cranial vault expansion in Apert or Crouzon/
Pfeiffer syndrome is an occipital expansion; in Saethre-Chotzen
of Muenke syndrome a fronto-orbital advancement. Monobloc
advancement with distraction, however, should be considered
as initial intervention if the patient shows vision-threatening
exorbitism and/or severe OSAS. The initial cranial vault
expansion in syndromic craniosynostosis is performed within
the first year of life. In view of the great risk of increased
ICP in the Apert and Crouzon/Pfeiffer syndromes and the some-
what limited risk in Saethre-Chotzen syndrome, we recommend
performing it approximately the age of 6 to 9 months, or earlier in
case of proven increased ICP. For patients with the Muenke
syndrome, it may be advisable to perform the operation between
9 and 12 months, as they apparently have a lower risk of
increased ICP and the esthetic results of surgery may fall short
of expectations.
The anesthesiologic goals in craniofacial surgery can only be
achieved in specialized pediatric centers, as laid down in the
guideline ‘‘Surgery in children’’ issued by the Netherlands Associ-
ation of Anesthesiologists. Availability of a bed in a PICU post-
operatively must be ensured. Administration of paracetamol will be
adequate to relieve postoperative pain after cranial remodeling
(guideline on postoperative pain management).Copyright © 2015 Mutaz B. Habal, MD. Unautho
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In syndromic craniosynostosis, screening for increased ICP
using fundoscopy should take place at least annually until the age
of 6 years. Muenke syndrome seems to be an exception to this
rule, but considering the limited scientific underpinning, the
same recommendation applies. If papilledema is confirmed
during the follow-up period, a CT of MRI scan is made to
evaluate changes in ventricle width (hydrocephalus). Other path-
ology that could contribute to increased ICP, such as OSAS, is
excluded. An invasive ICP measurement is to be considered in
case of unexplained worsening of vision, progressive vertex
bulge without papilledema, or when decision-making on reopera-
tion is complicated by doubt about the extent of ICP increase.
Treatment of increased ICP is determined by causal factors in the
individual patient.
The care coordinator in the craniofacial team is expected to see
to it that the fundoscopies are performed at the recommended
moments and that the results are communicated to the most
responsible physician.
Hydrocephalus should be distinguished from ventriculomegaly
by means of serial imaging with repetition of MRI in any case at 4
years of age, and earlier if clinical symptoms occur. Patients
diagnosed with ventriculomegaly should be followed using MRI
and 6 monthly fundoscopy. A multidisciplinary treatment plan is
drawn up if progressively increasing ventricle width or papilledema
is seen.
Shunting is contraproductive to cranial vault expansion. There-
fore, efforts should be directed at treating the increased ICP in
hydrocephalus by means of cranial vault expansion whenever
possible. Shunt placement is to be considered if increased ICP is
sustained on the long term (2 months) after adequate cranial vault
expansion.
Follow-up screening for the presence of Chiari malformations
in patients with Crouzon/Pfeiffer syndrome by means of MRI
scanning is strongly recommended at the age of 4 years and as
well on clinical suspicion of Chiari I malformation. Surgical
treatment of Chiari malformations is recommended only if the
patient is symptomatic. Otherwise, the pediatric neurosurgeon
initiates active follow-up with sixth monthly assessment of neuro-
logic symptoms and the presence of papilledema, as well as an
annual MRI of MRV. If occipital decompression (for Chiari) is
indicated, abnormal occipital venous drainage must be excluded
preoperatively.
Children diagnosed with the syndrome van Apert should be
evaluated for speech- and language problems from the age of 2
years. Children with a syndromic craniosynostosis should undergo
cognitive and behavioral testing at a young age and again around the
age when type of (elementary) school is chosen. Repeat testing is
recommended at age 8 or 9 to identify any learning disorders.
Psychologic testing of children with a syndromic craniosynostosis
is preferably done by the psychologist of the treating craniofacial
team.
Psychosocial care for the family should be easily accessible
during the entire treatment path, and counseling should be based on
a system perspective.
Adolescents who wish surgical treatment need to be offered at
least 1 contact with a specialized social worker to check whether
their expectations are realistic. The craniofacial center should have
an Early Intervention Program/peer supervision group in place to
increase resilience. During long sustained treatments that require a
lot of motivation from the patient psychosocial screening and, if
necessary, support, is desirable.rized reproduction of this article is prohibited.
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is indicated annually in the first 4 years of life, with tympano-
metry and otoacoustic emissions, and if possible with a pure tone
audiogram from age 4 years. Therapy is selected based on
the type of hearing loss (in conformity with guideline KNO)
and may consist of tympanostomy tubes, conventional
hearing aids or BAHA, cochlear implant, and reconstructive
surgery for congenital middle ear abnormalities possibly at later
age.
Oral hygiene must be monitored more intensively than in the
general population. Regular orthodontic checkups are necessary on
account of delayed dentition and abnormal eruption patterns (1 to 4
times yearly).
The Le Fort III distraction procedure for the correction of the
maxillary hypoplasia (including exorbitism) in Apert and Crou-
zon/Pfeiffer patients is usually performed between ages 8 and 12
years, or from 18 years onwards. Vision-threatening severe
OSAS and/or severe exorbitism may be reason to perform this
intervention at a younger age (see chapter on OSAS). A mono-
bloc distraction is preferred for young children (6 years),
depending on earlier interventions. As 12 to 18 year olds have
a higher risk of psychosocial problem or may have unrealistic
expectations, the Le Fort III procedure is preferably not per-
formed at these ages (see chapters 17 and 18). The Le Fort III
distraction with external frame is the method of choice in view of
ease of placement and removal of the frame and the optimal
vector control.
Monobloc distraction in syndromic craniosynostosis patients is
indicated in case of severe exorbitism (globe luxation and/or
corneal injury) with1. sC
# 2evere OSAS at the time of the protocol-dictated initial cranial
vault expansion2. severe OSAS in combination with increased ICPMonitoring of occlusion is indicated after the Le Fort III or
monobloc procedure. Orthognatic surgery is recommended if mal-
occlusion is found (eg, Le Fort I, bilateral sagittal split osteotomy).
The operation is planned after age 18 years.
Hypertelorism is preferably corrected from the age of 4 or
5 years on using the facial bipartition technique (with or
without midface advancement by means of distraction). The
orbital box osteotomy technique can be applied after sufficient
eruption of the maxillary dentition (from approximately the age
of 14 years) and can be well combined with additional orthog-
natic surgery.
Immediately after surgery/distraction osteogenesis, orthodontic
retention is indicated to stabilize the result and prevent relapse.
Provided the oral hygiene allows for this, permanent retention is
achieved by means of retention wires and in addition, a retention
device that stabilizes the dental arches in relation to each other. To
ensure stability of the combined orthodontic-surgical interventions,
orthodontic and facial orthopedicmonitoring of the development into
adulthood is indicated by means of standard protocol. Evaluation at
least 2 years after treatment is required.
If a SARME procedure is performed in syndromic craniosy-
nostosis patients, a tooth-borne distractor is preferred during
a bone-borne distractor. A bone-borne distractor, however,
is indicated when the maxilla is extremely narrow and there
is not enough space for a tooth-borne distractor (Hyrax). The
thick palatal mucosa impedes the placement of a bone-borne
distractor. A SARME procedure is performed from the age of 14
to 15 years.opyright © 2015 Mutaz B. Habal, MD. Unautho
015 Mutaz B. Habal, MDFollow-up of patients with a syndromic craniosynostosis is
recommended until the age of 18 years, at completion of cranial
and facial growth.
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